(lp1
(dp2
S'cdsr_filename'
p3
VCD009987 v. 2.4 Decentralising HIV treatment in lower- and middle-income countries.rm5
p4
sS'pmc_id'
p5
S'PMC2924332'
p6
sS'cdsr_refcode'
p7
VSTD-Humphreys-2010
p8
sS'pm_filename'
p9
V20687955.xml
p10
sS'pdf_filename'
p11
S'bf/8e/1472-6963-10-229.PMC2924332.pdf'
p12
sa(dp13
g3
g4
sg5
S'PMC2943483'
p14
sg7
VSTD-Fatti-2010
p15
sg9
V20877631.xml
p16
sg11
S'3e/c3/pone.0012888.PMC2943483.pdf'
p17
sa(dp18
g3
VCD007146 v. 8.0 Interventions for preventing falls in older people living in the community.rm5
p19
sg5
S'PMC1832184'
p20
sg7
VSTD-Lannin-2007
p21
sg9
V17355644.xml
p22
sg11
S'75/26/1472-6963-7-42.PMC1832184.pdf'
p23
sa(dp24
g3
g19
sg5
S'PMC3116775'
p25
sg7
VSTD-Spink-2011
p26
sg9
V21680622.xml
p27
sg11
S'b1/59/bmj.d3411.PMC3116775.pdf'
p28
sa(dp29
g3
g19
sg5
S'PMC2876235'
p30
sg7
VSTD-Haran-2010
p31
sg9
V20501583.xml
p32
sg11
S'cf/ba/bmj.c2265.PMC2876235.pdf'
p33
sa(dp34
g3
g19
sg5
S'PMC2956530'
p35
sg7
VSTD-Conroy-2010
p36
sg9
V20823124.xml
p37
sg11
S'e3/0d/afq096.PMC2956530.pdf'
p38
sa(dp39
g3
g19
sg5
S'PMC3079648'
p40
sg7
VSTD-Dangour-2011
p41
sg9
V21526229.xml
p42
sg11
S'20/d6/pmed.1001023.PMC3079648.pdf'
p43
sa(dp44
g3
g19
sg5
S'PMC2868162'
p45
sg7
VSTD-Logan-2010
p46
sg9
V20460331.xml
p47
sg11
S'03/e3/bmj.c2102.PMC2868162.pdf'
p48
sa(dp49
g3
VCD005067 v. 6.0 Interventions for Old World cutaneous leishmaniasis.rm5
p50
sg5
S'PMC1891315'
p51
sg7
VSTD-Nilforoushzadeh-2007
p52
sg9
V17466071.xml
p53
sg11
S'bb/c5/1472-6882-7-13.PMC1891315.pdf'
p54
sa(dp55
g3
VCD005482 v. 4.0 Structured treatment interruptions (STI) in chronic suppressed HIV infection in adults.rm5
p56
sg5
S'PMC539050'
p57
sg7
VSTD-Papasavvas-2004
p58
sg9
V15630469.xml
p59
sg11
S'ad/a8/pmed.0010064.PMC539050.pdf'
p60
sa(dp61
g3
VCD005458 v. 6.0 Antibiotics for mastitis in breastfeeding women.rm5
p62
sg5
S'PMC2364471'
p63
sg7
VSTD-Hager-1996
p64
sg9
V18476075.xml
p65
sg11
S'5f/cd/IDOG-04-097.PMC2364471.pdf'
p66
sa(dp67
g3
VCD006726 v. 4.0 Psychological therapies for the treatment of post-traumatic stress disorder in children and adolesce.rm5
p68
sg5
S'PMC2685130'
p69
sg7
VSTD-Catani-2009
p70
sg9
V19439099.xml
p71
sg11
S'16/f5/1471-244X-9-22.PMC2685130.pdf'
p72
sa(dp73
g3
VCD008728 v. 2.0 Interventions for preventing falls in people after stroke.rm5
p74
sg5
S'PMC2876235'
p75
sg7
VSTD-Haran-2010
p76
sg9
V20501583.xml
p77
sg11
g33
sa(dp78
g3
VCD005547 v. 5.0 Effect of administration of antihelminthics for soil transmitted helminths during pregnancy.rm5
p79
sg5
S'PMC1352364'
p80
sg7
VSTD-Elliott-2005
p81
sg9
V16371154.xml
p82
sg11
S'9b/47/1471-2334-5-115.PMC1352364.pdf'
p83
sa(dp84
g3
VCD006706 v. 2.0 Interventions for the prevention and treatment of herpes simplex virus in patients being treated for.rm5
p85
sg5
S'PMC2247066'
p86
sg7
VSTD-Selby-1989
p87
sg9
V2539180.xml
p88
sg11
S'35/4d/brjcancer00125-0114.PMC2247066.pdf'
p89
sa(dp90
g3
g85
sg5
S'PMC1976928'
p91
sg7
VSTD-Anderson-1984
p92
sg9
V6378236.xml
p93
sg11
S'c5/bf/brjcancer00105-0047.PMC1976928.pdf'
p94
sa(dp95
g3
VCD008726 v. 1.0 Different classes of antibiotics given to women routinely for preventing infection at caesarean sect.rm5
p96
sg5
S'PMC1784814'
p97
sg7
VSTD-Noyes-1998
p98
sg9
V9894177.xml
p99
sg11
S'b0/ae/9894177.PMC1784814.pdf'
p100
sa(dp101
g3
VMR000008 v. 7.0 Methods to increase response to postal and electronic questionnaires.rm5
p102
sg5
S'PMC1459867'
p103
sg7
VSTD-Finsen-2006
p104
sg9
V16646970.xml
p105
sg11
S'32/c5/1471-2288-6-19.PMC1459867.pdf'
p106
sa(dp107
g3
g102
sg5
S'PMC1280926'
p108
sg7
VSTD-Cockayne-2005
p109
sg9
V16250910.xml
p110
sg11
S'48/00/1471-2288-5-34.PMC1280926.pdf'
p111
sa(dp112
g3
g102
sg5
S'PMC534094'
p113
sg7
VSTD-Roberts-2004
p114
sg9
V15533256.xml
p115
sg11
S'9c/d3/1472-6963-4-30.PMC534094.pdf'
p116
sa(dp117
g3
g102
sg5
S'PMC1190172'
p118
sg7
VSTD-McKenzie_x002d_McHarg-2005
p119
sg9
V16091137.xml
p120
sg11
S'2c/e0/1472-6963-5-52.PMC1190172.pdf'
p121
sa(dp122
g3
g102
sg5
S'PMC1201139'
p123
sg7
VSTD-Kenyon-2005
p124
sg9
V16109160.xml
p125
sg11
S'94/f8/1472-6963-5-55.PMC1201139.pdf'
p126
sa(dp127
g3
g102
sg5
S'PMC2427026'
p128
sg7
VSTD-Lavelle-2008
p129
sg9
V18507819.xml
p130
sg11
S'dd/58/1472-6963-8-113.PMC2427026.pdf'
p131
sa(dp132
g3
g102
sg5
S'PMC534787'
p133
sg7
VSTD-Harrison-2004
p134
sg9
V15537429.xml
p135
sg11
S'eb/40/1472-6963-4-31.PMC534787.pdf'
p136
sa(dp137
g3
g102
sg5
S'PMC449720'
p138
sg7
VSTD-Moses-2004
p139
sg9
V15222889.xml
p140
sg11
S'25/dd/1472-6963-4-14.PMC449720.pdf'
p141
sa(dp142
g3
g102
sg5
S'PMC64502'
p143
sg7
VSTD-Clark-TJ-2001
p144
sg9
V11782286.xml
p145
sg11
S'7a/0a/1471-2288-1-12.PMC64502.pdf'
p146
sa(dp147
g3
VCD003474 v. 15.3 Bisphosphonates and other bone agents for breast cancer.rm5
p148
sg5
S'PMC2409647'
p149
sg7
VSTD-Body-2004
p150
sg9
V15026791.xml
p151
sg11
S'3f/2c/90-6601663a.PMC2409647.pdf'
p152
sa(dp153
g3
VCD005989 v. 4.0 Herbal interventions for chronic asthma in adults and children.rm5
p154
sg5
S'PMC2275406'
p155
sg7
VSTD-Ziboh-2004
p156
sg9
V15154607.xml
p157
sg11
S'e3/f2/CDI-11-013.PMC2275406.pdf'
p158
sa(dp159
g3
VCD003543 v. 10.0 Interventions to improve antibiotic prescribing practices for hospital inpatients.rm5
p160
sg5
S'PMC3369588'
p161
sg7
VSTD-Fridkin-2002
p162
sg9
V12095438.xml
p163
sg11
S'9a/b6/01-0465_FinalR.PMC3369588.pdf'
p164
sa(dp165
g3
VCD003650 v. 8.0 Micronutrient supplementation in children and adults with HIV infection.rm5
p166
sg5
S'PMC1891438'
p167
sg7
VSTD-Luabeya-2007
p168
sg9
V17593956.xml
p169
sg11
S'b3/a4/pone.0000541.PMC1891438.pdf'
p170
sa(dp171
g3
VCD009153 v. 5.0 Antiretroviral therapy for prevention of HIV transmission in HIV-discordant couples.rm5
p172
sg5
S'PMC2871073'
p173
sg7
VSTD-Del-Romero-2010
p174
sg9
V20472675.xml
p175
sg11
S'81/04/bmj.c2205.PMC2871073.pdf'
p176
sa(dp177
g3
VCD008440 v. 2.0 Antiretroviral therapy (ART) for treating HIV infection in ART-eligible pregnant women.rm5
p178
sg5
S'PMC1949842'
p179
sg7
VSTD-Tonwe_x002d_Gold-2007
p180
sg9
V17713983.xml
p181
sg11
S'87/db/pmed.0040257.PMC1949842.pdf'
p182
sa(dp183
g3
VCD006386 v. 4.0 Interventions for the treatment of oral cavity and oropharyngeal cancer chemotherapy.rm5
p184
sg5
S'PMC2363468'
p185
sg7
VSTD-Domenge-2000
p186
sg9
V11189100.xml
p187
sg11
S'ef/25/83-6691512a.PMC2363468.pdf'
p188
sa(dp189
g3
VCD008207 v. 2.0 Continuous passive motion for preventing venous thromboembolism after total knee arthroplasty.rm5
p190
sg5
S'PMC2386789'
p191
sg7
VSTD-Lenssen-2008
p192
sg9
V18442423.xml
p193
sg11
S'7c/94/1471-2474-9-60.PMC2386789.pdf'
p194
sa(dp195
g3
VCD005465 v. 7.10 Interventions for preventing falls in older people in care facilities and hospitals.rm5
p196
sg5
S'PMC2565754'
p197
sg7
VSTD-Kerse-2008
p198
sg9
V18845605.xml
p199
sg11
S'27/c9/bmj.a1445.PMC2565754.pdf'
p200
sa(dp201
g3
g196
sg5
S'PMC415557'
p202
sg7
VSTD-Crotty-2004b
p203
sg9
V15066200.xml
p204
sg11
S'e1/69/1472-6963-4-6.PMC415557.pdf'
p205
sa(dp206
g3
g196
sg5
S'PMC1766476'
p207
sg7
VSTD-Stenvall-2007
p208
sg9
V17061151.xml
p209
sg11
S'9e/35/198_2006_Article_226.PMC1766476.pdf'
p210
sa(dp211
g3
VCD004143 v. 6.0 Long term hormone therapy for perimenopausal and postmenopausal women.rm5
p212
sg5
S'PMC2330032'
p213
sg7
VSTD-EPHT-2006
p214
sg9
V18366766.xml
p215
sg11
S'e3/33/1472-6874-8-5.PMC2330032.pdf'
p216
sa(dp217
g3
VCD003868 v. 11.0 Oral morphine for cancer pain.rm5
p218
sg5
S'PMC2376845'
p219
sg7
VSTD-Lauretti-2003
p220
sg9
V14647133.xml
p221
sg11
S'9b/c4/89-6601365a.PMC2376845.pdf'
p222
sa(dp223
g3
VCD000255 v. 8.0 Antithrombotic drugs for carotid artery dissection.rm5
p224
sg5
S'PMC3476141'
p225
sg7
VSTD-Campos-2007
p226
sg9
V17563840.xml
p227
sg11
S'10/76/10194_2007_Article_387.PMC3476141.pdf'
p228
sa(dp229
g3
VCD006103 v. 12.0 Nicotine receptor partial agonists for smoking cessation.rm5
p230
sg5
S'PMC3281242'
p231
sg7
VSTD-Rennard-2011
p232
sg9
V22080588.xml
p233
sg11
S'5a/d4/ntr220.PMC3281242.pdf'
p234
sa(dp235
g3
VCD001359 v. 12.0 Olanzapine for schizophrenia.rm5
p236
sg5
S'PMC2956152'
p237
sg7
VSTD-Avasthi-2001
p238
sg9
V21407865.xml
p239
sg11
S'c8/cd/IJPsy-43-257.PMC2956152.pdf'
p240
sa(dp241
g3
VCD008653 v. 2.0 Febuxostat for treating chronic gout.rm5
p242
sg5
S'PMC2888216'
p243
sg7
VSTD-Becker-2010
p244
sg9
V20370912.xml
p245
sg11
S'97/5b/ar2978.PMC2888216.pdf'
p246
sa(dp247
g3
VCD006275 v. 11.0 Non-pharmacological management of infant and young child procedural pain.rm5
p248
sg5
S'PMC1950500'
p249
sg7
VSTD-Curtis-2007
p250
sg9
V17640375.xml
p251
sg11
S'dc/84/1471-2431-7-27.PMC1950500.pdf'
p252
sa(dp253
g3
VCD009401 v. 3.3 Interventions to improve the use of systematic reviews in decision-making by health system managers.rm5
p254
sg5
S'PMC2936828'
p255
sg7
VSTD-Dobbins-2009
p256
sg9
V19775439.xml
p257
sg11
S'c4/88/1748-5908-4-61.PMC2936828.pdf'
p258
sa(dp259
g3
VCD009157 v. 4.0 Tiotropium versus long-acting beta-agonists for stable chronic obstructive pulmonary disease.rm5
p260
sg5
S'PMC1913175'
p261
sg7
VSTD-Rutten_x002d_van-Molken-2007
p262
sg9
V17370096.xml
p263
sg11
S'df/c9/10198_2007_Article_39.PMC1913175.pdf'
p264
sa(dp265
g3
VMR000030 v. 3.0 Consolidated standards of reporting trials (CONSORT) and the completeness of reporting of randomised.rm5
p266
sg5
S'PMC2679061'
p267
sg7
VSTD-Ethgen-2009
p268
sg9
V19358717.xml
p269
sg11
S'35/2e/1471-2288-9-24.PMC2679061.pdf'
p270
sa(dp271
g3
g266
sg5
S'PMC2886040'
p272
sg7
VSTD-Yu-2010
p273
sg9
V20482769.xml
p274
sg11
S'7e/31/1745-6215-11-59.PMC2886040.pdf'
p275
sa(dp276
g3
g266
sg5
S'PMC2844941'
p277
sg7
VSTD-Hopewell-2010
p278
sg9
V20332510.xml
p279
sg11
S'03/1b/bmj.c723.PMC2844941.pdf'
p280
sa(dp281
g3
g266
sg5
S'PMC2788535'
p282
sg7
VSTD-Partsinevelou-2009
p283
sg9
V19930576.xml
p284
sg11
S'87/b5/1745-6215-10-106.PMC2788535.pdf'
p285
sa(dp286
g3
g266
sg5
S'PMC2216683'
p287
sg7
VSTD-Prady-2008
p288
sg9
V18270568.xml
p289
sg11
S'16/16/pone.0001577.PMC2216683.pdf'
p290
sa(dp291
g3
g266
sg5
S'PMC2822812'
p292
sg7
VSTD-Montan_x00e9_-2010
p293
sg9
V20067642.xml
p294
sg11
S'16/37/1472-6904-10-2.PMC2822812.pdf'
p295
sa(dp296
g3
VCD002143 v. 12.0 Palliative radiotherapy regimens for non-small cell lung cancer.rm5
p297
sg5
S'PMC2361948'
p298
sg7
VSTD-Senkus_x002d_Konefka-2005
p299
sg9
V15770205.xml
p300
sg11
S'8b/d7/92-6602477a.PMC2361948.pdf'
p301
sa(dp302
g3
g297
sg5
S'PMC1977779'
p303
sg7
VSTD-MRC-1992
p304
sg9
V1377484.xml
p305
sg11
S'60/ac/brjcancer00070-0150.PMC1977779.pdf'
p306
sa(dp307
g3
VCD008511 v. 3.0 Social skills groups for people aged 6 to 21 with autism spectrum disorders (ASD).rm5
p308
sg5
S'PMC2890979'
p309
sg7
VSTD-Frankel-2010
p310
sg9
V20058059.xml
p311
sg11
S'83/85/10803_2009_Article_932.PMC2890979.pdf'
p312
sa(dp313
g3
VCD003267 v. 6.2 Interventions for providers to promote a patient-centred approach in clinical consultations.rm5
p314
sg5
S'PMC2375236'
p315
sg7
VSTD-Brown-2001
p316
sg9
V11720460.xml
p317
sg11
S'7f/2a/85-6692073a.PMC2375236.pdf'
p318
sa(dp319
g3
VCD007825 v. 8.0 Collaboration between local health and local government agencies for health improvement.rm5
p320
sg5
S'PMC3116927'
p321
sg7
VSTD-Florence-2011
p322
sg9
V21680632.xml
p323
sg11
S'3b/18/bmj.d3313.PMC3116927.pdf'
p324
sa(dp325
g3
VCD009577 v. 2.0 Long-acting FSH versus daily FSH for women undergoing assisted reproduction.rm5
p326
sg5
S'PMC2777786'
p327
sg7
VSTD-ENGAGE-2009
p328
sg9
V19684043.xml
p329
sg11
S'e5/cd/dep291.PMC2777786.pdf'
p330
sa(dp331
g3
VCD008657 v. 3.0 Housing improvements for health and associated socio-economic outcomes.rm5
p332
sg5
S'PMC2658826'
p333
sg7
VSTD-Howden_x002d_Chapman-2008
p334
sg9
V18812366.xml
p335
sg11
S'3c/24/bmj.a1411.PMC2658826.pdf'
p336
sa(dp337
g3
VCD008331 v. 2.0 Tocilizumab for rheumatoid arthritis.rm5
p338
sg5
S'PMC2638601'
p339
sg7
VSTD-Nishimoto-2009-_x0028_SATORI_x0029_
p340
sg9
V18979150.xml
p341
sg11
S'd6/37/10165_2008_Article_125.PMC2638601.pdf'
p342
sa(dp343
g3
VCD008454 v. 2.0 Non-steroidal anti-inflammatory drugs as disease-modifying agents for Parkinson's disease evidence .rm5
p344
sg5
S'PMC3023971'
p345
sg7
VSTD-Driver-2011-age-matched
p346
sg9
V21252104.xml
p347
sg11
S'b1/0d/bmj.d198.PMC3023971.pdf'
p348
sa(dp349
g3
g344
sg5
S'PMC3023971'
p350
sg7
VSTD-Driver-2011-age_x002b_-matched
p351
sg9
V21252104.xml
p352
sg11
g348
sa(dp353
g3
VCD003189 v. 13.2 Granulopoiesis-stimulating factors to prevent adverse effects in the treatment of malignant lymphoma.rm5
p354
sg5
S'PMC3216418'
p355
sg7
VSTD-Burton-2006
p356
sg9
V16508640.xml
p357
sg11
S'dc/12/94-6602975a.PMC3216418.pdf'
p358
sa(dp359
g3
VCD009118 v. 2.0 Osmotic and stimulant laxatives for the management of childhood constipation.rm5
p360
sg5
S'PMC3232099'
p361
sg7
VSTD-Rafati-2011
p362
sg9
V22615652.xml
p363
sg11
S'0c/61/DARU-19-154.PMC3232099.pdf'
p364
sa(dp365
g3
VCD009593 v. 3.3 Xpert MTBRIF assay for pulmonary tuberculosis and rifampicin resistance in adults.rm5
p366
sg5
S'PMC3126807'
p367
sg7
VSTD-Rachow-2011
p368
sg9
V21738575.xml
p369
sg11
S'8b/dd/pone.0020458.PMC3126807.pdf'
p370
sa(dp371
g3
g366
sg5
S'PMC3144192'
p372
sg7
VSTD-Scott-2011
p373
sg9
V21814495.xml
p374
sg11
S'54/53/pmed.1001061.PMC3144192.pdf'
p375
sa(dp376
g3
g366
sg5
S'PMC3144215'
p377
sg7
VSTD-Lawn-2011
p378
sg9
V21818180.xml
p379
sg11
S'20/8c/pmed.1001067.PMC3144215.pdf'
p380
sa(dp381
g3
VCD006086 v. 4.2 Nutritional supplements for people being treated for active tuberculosis.rm5
p382
sg5
S'PMC2957385'
p383
sg7
VSTD-Pakasi-2010
p384
sg9
V20920186.xml
p385
sg11
S'4b/5c/1475-2891-9-41.PMC2957385.pdf'
p386
sa(dp387
g3
g382
sg5
S'PMC2767482'
p388
sg7
VSTD-Martins-2009
p389
sg9
V19858174.xml
p390
sg11
S'61/34/bmj.b4248.PMC2767482.pdf'
p391
sa(dp392
g3
VCD007064 v. 4.6 Psychosocial interventions to improve quality of life and emotional wellbeing for recently diagnosed.rm5
p393
sg5
S'PMC2607225'
p394
sg7
VSTD-Johansson-2008
p395
sg9
V19018255.xml
p396
sg11
S'b9/3f/6604789a.PMC2607225.pdf'
p397
sa(dp398
g3
VCD004070 v. 8.0 Vaginal chlorhexidine during labour for preventing maternal and neonatal infections (excluding Group.rm5
p399
sg5
S'PMC2364551'
p400
sg7
VSTD-Eriksen-1997
p401
sg9
V18476153.xml
p402
sg11
S'5f/54/IDOG-05-286.PMC2364551.pdf'
p403
sa(dp404
g3
VCD008370 v. 5.0 Somatostatin analogues for pancreatic surgery.rm5
p405
sg5
S'PMC3108665'
p406
sg7
VSTD-Katsourakis-2010
p407
sg9
V21694864.xml
p408
sg11
S'00/d3/ceg-3-179.PMC3108665.pdf'
p409
sa(dp410
g3
VCD007072 v. 4.0 Nicotine vaccines for smoking cessation.rm5
p411
sg5
S'PMC2432028'
p412
sg7
VSTD-Cornuz-2008
p413
sg9
V18575629.xml
p414
sg11
S'4f/ec/pone.0002547.PMC2432028.pdf'
p415
sa(dp416
g3
VCD001546 v. 7.0 Laparoscopic versus open surgery for suspected appendicitis.rm5
p417
sg5
S'PMC3015793'
p418
sg7
VSTD-Ricca-2007
p419
sg9
V17663093.xml
p420
sg11
S'52/f7/jsls-11-1-54.PMC3015793.pdf'
p421
sa(dp422
g3
VCD005331 v. 4.0 Psychosocial interventions for conversion disorder.rm5
p423
sg5
S'PMC3055095'
p424
sg7
VSTD-Ataoglu-2003
p425
sg9
V12923337.xml
p426
sg11
S'a5/38/12923337.PMC3055095.pdf'
p427
sa(dp428
g3
VCD007079 v. 2.0 Calcium supplementation (other than for preventing or treating hypertension) for improving pregnancy.rm5
p429
sg5
S'PMC2627861'
p430
sg7
VSTD-Ettinger-2009
p431
sg9
V19165383.xml
p432
sg11
S'e6/b7/EHP-117-26.PMC2627861.pdf'
p433
sa(dp434
g3
VCD009527 v. 2.0 Home- or community-based programmes for treating malaria.rm5
p435
sg5
S'PMC2943441'
p436
sg7
VSTD-Yeboah_x002d_Antwi-2010
p437
sg9
V20877714.xml
p438
sg11
S'21/8e/pmed.1000340.PMC2943441.pdf'
p439
sa(dp440
g3
g435
sg5
S'PMC2287184'
p441
sg7
VSTD-Kouyate-2008
p442
sg9
V18364043.xml
p443
sg11
S'b8/d1/1475-2875-7-50.PMC2287184.pdf'
p444
sa(dp445
g3
g435
sg5
S'PMC3130036'
p446
sg7
VSTD-Mubi-2011
p447
sg9
V21750697.xml
p448
sg11
S'46/c6/pone.0019753.PMC3130036.pdf'
p449
sa(dp450
g3
g435
sg5
S'PMC3104978'
p451
sg7
VSTD-Kangwana-2011
p452
sg9
V21655317.xml
p453
sg11
S'2f/3a/pmed.1000437.PMC3104978.pdf'
p454
sa(dp455
g3
VCD009350 v. 2.0 Dietary flavonoid for preventing colorectal neoplasms.rm5
p456
sg5
S'PMC2695684'
p457
sg7
VSTD-Akhter-2009
p458
sg9
V19417743.xml
p459
sg11
S'07/63/6605088a.PMC2695684.pdf'
p460
sa(dp461
g3
VCD002923 v. 11.0 Penfluridol for schizophrenia.rm5
p462
sg5
S'PMC3172444'
p463
sg7
VSTD-Channabasavanna-1987
p464
sg9
V21927264.xml
p465
sg11
S'60/e2/IJPsy-29-333.PMC3172444.pdf'
p466
sa(dp467
g3
VCD001865 v. 8.4 Personalised risk communication for informed decision making about taking screening tests.rm5
p468
sg5
S'PMC2965151'
p469
sg7
VSTD-Smith-2010
p470
sg9
V20978060.xml
p471
sg11
S'22/0d/bmj.c5370.PMC2965151.pdf'
p472
sa(dp473
g3
g468
sg5
S'PMC3106362'
p474
sg7
VSTD-Steckelberg-2011
p475
sg9
V21636633.xml
p476
sg11
S'93/22/bmj.d3193.PMC3106362.pdf'
p477
sa(dp478
g3
VCD004905 v. 7.3 Multiple-micronutrient supplementation for women during pregnancy.rm5
p479
sg5
S'PMC3100912'
p480
sg7
VSTD-Vadillo_x002d_Ortega-2011
p481
sg9
V21596735.xml
p482
sg11
S'e5/ee/bmj.d2901.PMC3100912.pdf'
p483
sa(dp484
g3
g479
sg5
S'PMC2577799'
p485
sg7
VSTD-Zeng-2008
p486
sg9
V18996930.xml
p487
sg11
S'56/39/bmj.a2001.PMC2577799.pdf'
p488
sa(dp489
g3
VCD003721 v. 7.2 Cancer genetic risk assessment for individuals at risk of familial breast cancer.rm5
p490
sg5
S'PMC2376929'
p491
sg7
VSTD-Fry-2003
p492
sg9
V12915873.xml
p493
sg11
S'b5/1e/89-6601170a.PMC2376929.pdf'
p494
sa(dp495
g3
g490
sg5
S'PMC2360713'
p496
sg7
VSTD-Young-2006
p497
sg9
V17047645.xml
p498
sg11
S'5d/58/95-6603389a.PMC2360713.pdf'
p499
sa(dp500
g3
VCD007862 v. 4.2 Active cycle of breathing technique for cystic fibrosis.rm5
p501
sg5
S'PMC2922723'
p502
sg7
VSTD-Osman-2008
p503
sg9
V19703826.xml
p504
sg11
S'da/ad/thorax111492.PMC2922723.pdf'
p505
sa(dp506
g3
VCD006370 v. 5.0 Behavioural treatments for non-epileptic attack disorder.rm5
p507
sg5
S'PMC3055095'
p508
sg7
VSTD-Ataoglu-2003
p509
sg9
V12923337.xml
p510
sg11
g427
sa(dp511
g3
VCD006201 v. 5.0 Chemotherapy for second-stage Human African trypanosomiasis.rm5
p512
sg5
S'PMC1687208'
p513
sg7
VSTD-Priotto-2006
p514
sg9
V17160135.xml
p515
sg11
S'f6/bc/pctr.0010039.PMC1687208.pdf'
p516
sa(dp517
g3
VCD006980 v. 5.0 Neonatal vitamin A supplementation for the prevention of mortality and morbidity in term neonates in.rm5
p518
sg5
S'PMC2835853'
p519
sg7
VSTD-Benn-2010
p520
sg9
V20215360.xml
p521
sg11
S'0b/7f/bmj.c1101.PMC2835853.pdf'
p522
sa(dp523
g3
VCD001141 v. 9.4 Support for healthy breastfeeding mothers with healthy term babies.rm5
p524
sg5
S'PMC2635594'
p525
sg7
VSTD-Hoddinott-2009
p526
sg9
V19181729.xml
p527
sg11
S'a7/dd/bmj.a3026.PMC2635594.pdf'
p528
sa(dp529
g3
VCD005274 v. 5.2 Interventions to reduce risky sexual behaviour for preventing HIV infection in workers in occupation.rm5
p530
sg5
S'PMC1483908'
p531
sg7
VSTD-Corbett-2006
p532
sg9
V16796402.xml
p533
sg11
S'd9/aa/pmed.0030238.PMC1483908.pdf'
p534
sa(dp535
g3
VCD004829 v. 5.2 Pain relief for women undergoing oocyte retrieval for assisted reproduction.rm5
p536
sg5
S'PMC3109380'
p537
sg7
VSTD-Coskun-2011
p538
sg9
V21789385.xml
p539
sg11
S'35/e6/cln-66-05-811.PMC3109380.pdf'
p540
sa(dp541
g3
VCD001269 v. 13.0 Vaccines for preventing influenza in healthy adults.rm5
p542
sg5
S'PMC2639595'
p543
sg7
VSTD-Beran-2009a
p544
sg9
V19149900.xml
p545
sg11
S'c9/c2/1471-2334-9-2.PMC2639595.pdf'
p546
sa(dp547
g3
VCD010610 v. 1.2 Topiramate for the prophylaxis of episodic migraine in adults.rm5
p548
sg5
S'PMC3236524'
p549
sg7
VSTD-Varkey-2011
p550
sg9
V21890526.xml
p551
sg11
S'00/b1/10.1177_0333102411419681.PMC3236524.pdf'
p552
sa(dp553
g3
VCD004778 v. 7.0 Laparoscopic repair for perforated peptic ulcer disease.rm5
p554
sg5
S'PMC2691927'
p555
sg7
VSTD-Bertleff-2009
p556
sg9
V19430829.xml
p557
sg11
S'11/4c/268_2009_Article_54.PMC2691927.pdf'
p558
sa(dp559
g3
VCD006207 v. 9.1 Physical interventions to interrupt or reduce the spread of respiratory viruses.rm5
p560
sg5
S'PMC2666722'
p561
sg7
VSTD-Chen-2009
p562
sg9
V19284644.xml
p563
sg11
S'f2/3b/1471-2458-9-81.PMC2666722.pdf'
p564
sa(dp565
g3
g560
sg5
S'PMC2364646'
p566
sg7
VSTD-Cowling-2008
p567
sg9
V18461182.xml
p568
sg11
S'20/e6/pone.0002101.PMC2364646.pdf'
p569
sa(dp570
g3
g560
sg5
S'PMC3322931'
p571
sg7
VSTD-Wu-2004
p572
sg9
V15030685.xml
p573
sg11
S'2b/17/03-0730.PMC3322931.pdf'
p574
sa(dp575
g3
g560
sg5
S'PMC2662657'
p576
sg7
VSTD-MacIntyre-2009
p577
sg9
V19193267.xml
p578
sg11
S'c3/84/08-1167_finalRCME.PMC2662657.pdf'
p579
sa(dp580
g3
g560
sg5
S'PMC3323085'
p581
sg7
VSTD-Lau-2004a
p582
sg9
V15200846.xml
p583
sg11
S'1e/e7/03-0628.PMC3323085.pdf'
p584
sa(dp585
g3
g560
sg5
S'PMC3152767'
p586
sg7
VSTD-Cowling-2010
p587
sg9
V20353566.xml
p588
sg11
S'60/bb/1471-2334-10-82.PMC3152767.pdf'
p589
sa(dp590
g3
VCD006095 v. 3.0 Probiotics for the prevention of Clostridium difficile-associated diarrhea in adults and children.rm5
p591
sg5
S'PMC3278944'
p592
sg7
VSTD-Psaradellis-2010
p593
sg9
V22371721.xml
p594
sg11
S'af/67/AMS-6-14277.PMC3278944.pdf'
p595
sa(dp596
g3
VCD005413 v. 4.0 Chemoimmunotherapy versus chemotherapy for metastatic malignant melanoma.rm5
p597
sg5
S'PMC2375173'
p598
sg7
VSTD-Atzpodien-2002
p599
sg9
V11870502.xml
p600
sg11
S'56/25/86-6600043a.PMC2375173.pdf'
p601
sa(dp602
g3
g597
sg5
S'PMC2150174'
p603
sg7
VSTD-Johnston-1998
p604
sg9
V9579834.xml
p605
sg11
S'a1/53/brjcancer00084-0086.PMC2150174.pdf'
p606
sa(dp607
g3
VCD004699 v. 7.0 Surgery for local and locally advanced non-small cell lung cancer.rm5
p608
sg5
S'PMC2063048'
p609
sg7
VSTD-Shepherd-1998
p610
sg9
V9744511.xml
p611
sg11
S'e1/4b/brjcancer00005-0127.PMC2063048.pdf'
p612
sa(dp613
g3
VCD001871 v. 13.12 Interventions for preventing obesity in children.rm5
p614
sg5
S'PMC2758893'
p615
sg7
VSTD-Gentile-2009
p616
sg9
V19765270.xml
p617
sg11
S'49/6d/1741-7015-7-49.PMC2758893.pdf'
p618
sa(dp619
g3
g614
sg5
S'PMC2040215'
p620
sg7
VSTD-Lazaar-2007
p621
sg9
V17718785.xml
p622
sg11
S'78/46/apa0096-1315.PMC2040215.pdf'
p623
sa(dp624
g3
VCD006188 v. 3.0 Surgical interventions for the rheumatoid shoulder.rm5
p625
sg5
S'PMC1964758'
p626
sg7
VSTD-Rosenberg-2007
p627
sg9
V17683577.xml
p628
sg11
S'da/61/1471-2474-8-76.PMC1964758.pdf'
p629
sa(dp630
g3
VCD000409 v. 7.0 Educational outreach visits effects on professional practice and health care outcomes.rm5
p631
sg5
S'PMC415557'
p632
sg7
VSTD-Crotty-2004
p633
sg9
V15066200.xml
p634
sg11
g205
sa(dp635
g3
g631
sg5
S'PMC1472698'
p636
sg7
VSTD-Fretheim-2006
p637
sg9
V16737349.xml
p638
sg11
S'c1/ad/pmed.0030216.PMC1472698.pdf'
p639
sa(dp640
g3
VCD004826 v. 5.0 Probiotics for maintenance of remission in Crohn's disease.rm5
p641
sg5
S'PMC394324'
p642
sg7
VSTD-Schultz-2004
p643
sg9
V15113451.xml
p644
sg11
S'ee/c8/1471-230X-4-5.PMC394324.pdf'
p645
sa(dp646
g3
VCD009021 v. 2.0 Exercise for pregnant women for preventing gestational diabetes mellitus.rm5
p647
sg5
S'PMC2890340'
p648
sg7
VSTD-Callaway-2010
p649
sg9
V20357374.xml
p650
sg11
S'90/60/zdc1457.PMC2890340.pdf'
p651
sa(dp652
g3
VCD007145 v. 2.0 Interventions for preventing excessive weight gain during pregnancy.rm5
p653
sg5
S'PMC2890340'
p654
sg7
VSTD-Callaway-2010
p655
sg9
V20357374.xml
p656
sg11
g651
sa(dp657
g3
g653
sg5
S'PMC3078095'
p658
sg7
VSTD-Korpi_x002d_Hyovalti-2011
p659
sg9
V21429234.xml
p660
sg11
S'ae/a1/1471-2458-11-179.PMC3078095.pdf'
p661
sa(dp662
g3
g653
sg5
S'PMC2681032'
p663
sg7
VSTD-Moses-2009
p664
sg9
V19279301.xml
p665
sg11
S'36/05/zdc996.PMC2681032.pdf'
p666
sa(dp667
g3
g653
sg5
S'PMC3096610'
p668
sg7
VSTD-Luoto-2011
p669
sg9
V21610860.xml
p670
sg11
S'7f/dd/pmed.1001036.PMC3096610.pdf'
p671
sa(dp672
g3
VCD007821 v. 2.0 Heated CO2 with or without humidification for minimally invasive abdominal surgery.rm5
p673
sg5
S'PMC3015252'
p674
sg7
VSTD-Ott-1998
p675
sg9
V10036122.xml
p676
sg11
S'45/50/jsls-2-4-321.PMC3015252.pdf'
p677
sa(dp678
g3
VCD004946 v. 4.0 Third trimester antiviral prophylaxis for preventing maternal genital herpes simplex virus (HSV) rec.rm5
p679
sg5
S'PMC1784606'
p680
sg7
VSTD-Scott-2002
p681
sg9
V12530483.xml
p682
sg11
S'bf/75/12530483.PMC1784606.pdf'
p683
sa(dp684
g3
VCD007303 v. 3.2 Erythropoietin or Darbepoetin for patients with cancer - meta-analysis based on individual patient d.rm5
p685
sg5
S'PMC2376376'
p686
sg7
VSTD-Boogaerts-2003
p687
sg9
V12671693.xml
p688
sg11
S'14/b8/88-6600801a.PMC2376376.pdf'
p689
sa(dp690
g3
g685
sg5
S'PMC2361228'
p691
sg7
VSTD-Wilkinson-2006
p692
sg9
V16570051.xml
p693
sg11
S'ca/12/94-6603004a.PMC2361228.pdf'
p694
sa(dp695
g3
VCD007480 v. 2.0 Vitamin A supplementation for the prevention of morbidity and mortality in infants six months of age.rm5
p696
sg5
S'PMC2835853'
p697
sg7
VSTD-Benn-2010
p698
sg9
V20215360.xml
p699
sg11
g522
sa(dp700
g3
VCD006198 v. 3.0 Vaccines for preventing malaria (pre-erythrocytic).rm5
p701
sg5
S'PMC524376'
p702
sg7
VSTD-Moorthy-2004b
p703
sg9
V15526058.xml
p704
sg11
S'fb/6f/pmed.0010033.PMC524376.pdf'
p705
sa(dp706
g3
VCD000033 v. 9.12 Barbiturates for acute traumatic brain injury.rm5
p707
sg5
S'PMC2575601'
p708
sg7
VSTD-P_x00e9_rez_x002d_B_x00e1_rcena-2008
p709
sg9
V18759980.xml
p710
sg11
S'83/b1/cc6999.PMC2575601.pdf'
p711
sa(dp712
g3
VCD009557 v. 2.0 Fibrin glue instillation under skin flaps to prevent seroma-related morbidity following breast and a.rm5
p713
sg5
S'PMC2650992'
p714
sg7
VSTD-Ko-2009
p715
sg9
V19270819.xml
p716
sg11
S'4c/6d/jkms-24-92.PMC2650992.pdf'
p717
sa(dp718
g3
VCD004492 v. 9.0 Stage-based interventions for smoking cessation.rm5
p719
sg5
S'PMC2253708'
p720
sg7
VSTD-Meyer-2008
p721
sg9
V17995993.xml
p722
sg11
S'c9/71/add0103-0294.PMC2253708.pdf'
p723
sa(dp724
g3
g719
sg5
S'PMC2268921'
p725
sg7
VSTD-Young-2008
p726
sg9
V18304363.xml
p727
sg11
S'91/0c/1471-2296-9-16.PMC2268921.pdf'
p728
sa(dp729
g3
VCD000371 v. 15.4 Deworming drugs for soil-transmitted intestinal worms in children effects on nutritional indicators.rm5
p730
sg5
S'PMC2291568'
p731
sg7
VSTD-Awasthi-2008-_x0028_Cluster_x0029_
p732
sg9
V18414647.xml
p733
sg11
S'81/21/pntd.0000223.PMC2291568.pdf'
p734
sa(dp735
g3
g730
sg5
S'PMC3161357'
p736
sg7
VSTD-Kirwan-2010
p737
sg9
V20858280.xml
p738
sg11
S'57/98/1471-2334-10-277.PMC3161357.pdf'
p739
sa(dp740
g3
VCD007253 v. 5.13 Interventions for smoking cessation and reduction in individuals with schizophrenia.rm5
p741
sg5
S'PMC2424122'
p742
sg7
VSTD-_x005e_Horst-2005
p743
sg9
V18568115.xml
p744
sg11
S'c7/de/ndt-0104-349.PMC2424122.pdf'
p745
sa(dp746
g3
VCD009318 v. 2.0 Lacosamide for neuropathic pain and fibromyalgia in adults.rm5
p747
sg5
S'PMC2845038'
p748
sg7
VSTD-Ziegler-2010
p749
sg9
V20067958.xml
p750
sg11
S'8c/ed/zdc839.PMC2845038.pdf'
p751
sa(dp752
g3
VCD009232 v. 2.0 Acupuncture or acupressure for pain management in labour.rm5
p753
sg5
S'PMC1810361'
p754
sg7
VSTD-Qu-2007
p755
sg9
V17342250.xml
p756
sg11
S'42/0d/nel053.PMC1810361.pdf'
p757
sa(dp758
g3
VCD009997 v. 1.0 Intermittent oral iron supplementation during pregnancy.rm5
p759
sg5
S'PMC3217057'
p760
sg7
VSTD-Bouzari-2011
p761
sg9
V22026956.xml
p762
sg11
S'0d/dc/1756-0500-4-444.PMC3217057.pdf'
p763
sa(dp764
g3
g759
sg5
S'PMC3233526'
p765
sg7
VSTD-Yekta-2011
p766
sg9
V22162919.xml
p767
sg11
S'b0/a9/tcrm-7-421.PMC3233526.pdf'
p768
sa(dp769
g3
VCD005566 v. 4.0 Prophylactic corticosteroids for cardiopulmonary bypass in adults.rm5
p770
sg5
S'PMC1892551'
p771
sg7
VSTD-Starobin-2007
p772
sg9
V17547746.xml
p773
sg11
S'60/fa/1749-8090-2-25.PMC1892551.pdf'
p774
sa(dp775
g3
VCD006761 v. 5.0 Conventional versus LigaSure hemorrhoidectomy for patients with symptomatic Hemorrhoids.rm5
p776
sg5
S'PMC2780654'
p777
sg7
VSTD-Tan-2008
p778
sg9
V18545884.xml
p779
sg11
S'c7/8a/10151_2008_Article_405.PMC2780654.pdf'
p780
sa(dp781
g3
VCD009513 v. 1.0 Interventions to improve adherence to antiretroviral therapy in children with HIV infection.rm5
p782
sg5
S'PMC2708138'
p783
sg7
VSTD-Wamalwa-2009
p784
sg9
V19549342.xml
p785
sg11
S'ee/5a/1758-2652-12-8.PMC2708138.pdf'
p786
sa(dp787
g3
VCD005436 v. 5.0 Oral zinc for treating diarrhoea in children.rm5
p788
sg5
S'PMC2684117'
p789
sg7
VSTD-Patel-2009
p790
sg9
V19416499.xml
p791
sg11
S'cb/5f/1741-7015-7-22.PMC2684117.pdf'
p792
sa(dp793
g3
g788
sg5
S'PMC2684117'
p794
sg7
VSTD-Patel-2009a-_x0028_zinc_x0029_
p795
sg9
V19416499.xml
p796
sg11
g792
sa(dp797
g3
g788
sg5
S'PMC2684117'
p798
sg7
VSTD-Patel-2009b-_x0028_zinc_x002b_copper_x0029_
p799
sg9
V19416499.xml
p800
sg11
g792
sa(dp801
g3
VCD001418 v. 8.0 Chemotherapy for advanced ovarian cancer.rm5
p802
sg5
S'PMC1977737'
p803
sg7
VSTD-d-SGCTG-1986
p804
sg9
V1739629.xml
p805
sg11
S'4d/8e/brjcancer00066-0137.PMC1977737.pdf'
p806
sa(dp807
g3
VCD000165 v. 14.0 Physician advice for smoking cessation.rm5
p808
sg5
S'PMC2253708'
p809
sg7
VSTD-Meyer-2008
p810
sg9
V17995993.xml
p811
sg11
g723
sa(dp812
g3
g808
sg5
S'PMC1829425'
p813
sg7
VSTD-Unrod-2007
p814
sg9
V17372796.xml
p815
sg11
S'59/5a/11606_2006_Article_69.PMC1829425.pdf'
p816
sa(dp817
g3
VCD006534 v. 4.0 Citalopram versus other anti-depressive agents for depression.rm5
p818
sg5
S'PMC2950952'
p819
sg7
VSTD-Lalit-2004
p820
sg9
V21206792.xml
p821
sg11
S'71/86/IJPsy-46-333.PMC2950952.pdf'
p822
sa(dp823
g3
VCD009620 v. 2.0 Interferon after surgery for women with advanced (Stage II-IV) epithelial ovarian cancer.rm5
p824
sg5
S'PMC2363351'
p825
sg7
VSTD-Windbichler-2000
p826
sg9
V10735496.xml
p827
sg11
S'2b/22/82-6691053a.PMC2363351.pdf'
p828
sa(dp829
g3
g824
sg5
S'PMC2364769'
p830
sg7
VSTD-Hall-2004
p831
sg9
V15305182.xml
p832
sg11
S'14/e5/91-6602037a.PMC2364769.pdf'
p833
sa(dp834
g3
VCD004912 v. 5.0 Drugs for treating uncomplicated malaria in pregnant women.rm5
p835
sg5
S'PMC2048661'
p836
sg7
VSTD-Kalilani-2007
p837
sg9
V18000538.xml
p838
sg11
S'91/d6/pone.0001166.PMC2048661.pdf'
p839
sa(dp840
g3
g835
sg5
S'PMC1533839'
p841
sg7
VSTD-Coulibaly-2006
p842
sg9
V16776817.xml
p843
sg11
S'b3/da/1475-2875-5-49.PMC1533839.pdf'
p844
sa(dp845
g3
VCD000448 v. 10.0 St John's wort for major depression.rm5
p846
sg5
S'PMC1538611'
p847
sg7
VSTD-Kasper-2006
p848
sg9
V16796730.xml
p849
sg11
S'76/fb/1741-7015-4-14.PMC1538611.pdf'
p850
sa(dp851
g3
VCD003289 v. 8.0 Tobacco cessation interventions for young people.rm5
p852
sg5
S'PMC1832131'
p853
sg7
VSTD-Horn-2007
p854
sg9
V17173716.xml
p855
sg11
S'2c/c3/PCD41A08.PMC1832131.pdf'
p856
sa(dp857
g3
VCD006317 v. 4.0 Radiofrequency ablation in the treatment of liver metastases from colorectal cancer.rm5
p858
sg5
S'PMC2817867'
p859
sg7
VSTD-McKay-2009
p860
sg9
V20148084.xml
p861
sg11
S'86/4e/HPB2009-346863.PMC2817867.pdf'
p862
sa(dp863
g3
g858
sg5
S'PMC3204557'
p864
sg7
VSTD-Kim-2011
p865
sg9
V22066097.xml
p866
sg11
S'a7/cd/jkss-81-25.PMC3204557.pdf'
p867
sa(dp868
g3
VCD004873 v. 9.0 Chest physiotherapy for acute bronchiolitis in paediatric patients between 0 and 24 months old.rm5
p869
sg5
S'PMC2946956'
p870
sg7
VSTD-Gajdos-2010
p871
sg9
V20927359.xml
p872
sg11
S'0a/b6/pmed.1000345.PMC2946956.pdf'
p873
sa(dp874
g3
VCD004736 v. 7.0 Daily oral iron supplementation during pregnancy.rm5
p875
sg5
S'PMC2577799'
p876
sg7
VSTD-Zeng-2008-_x0028_C_x0029_
p877
sg9
V18996930.xml
p878
sg11
g488
sa(dp879
g3
VCD002302 v. 5.0 Pressure-relieving interventions for treating diabetic foot ulcers.rm5
p880
sg5
S'PMC2890332'
p881
sg7
VSTD-Faglia-2010
p882
sg9
V20357377.xml
p883
sg11
S'c7/6e/zdc1419.PMC2890332.pdf'
p884
sa(dp885
g3
VCD002142 v. 13.0 Postoperative radiotherapy for non-small cell lung cancer.rm5
p886
sg5
S'PMC2074683'
p887
sg7
VSTD-MRC-LU11
p888
sg9
V8761382.xml
p889
sg11
S'30/4f/brjcancer00020-0142.PMC2074683.pdf'
p890
sa(dp891
g3
VCD006953 v. 3.6 Psychosocial interventions for reducing fatigue during cancer treatment in adults.rm5
p892
sg5
S'PMC2364007'
p893
sg7
VSTD-Faithfull-2001
p894
sg9
V11747326.xml
p895
sg11
S'e6/a3/85-6692173a.PMC2364007.pdf'
p896
sa(dp897
g3
VCD006438 v. 4.0 Open surgical procedures for incisional hernias.rm5
p898
sg5
S'PMC1913177'
p899
sg7
VSTD-de-Vries-2007a
p900
sg9
V17372669.xml
p901
sg11
S'ec/6f/268_2006_Article_502.PMC1913177.pdf'
p902
sa(dp903
g3
VCD003962 v. 6.0 Non-immunosuppressive treatment for IgA nephropathy.rm5
p904
sg5
S'PMC2409178'
p905
sg7
VSTD-Horita-2007
p906
sg9
V17497466.xml
p907
sg11
S'c0/8e/lrnf29-441.PMC2409178.pdf'
p908
sa(dp909
g3
VCD010538 v. 2.0 Topical herbal therapies for treating osteoarthritis.rm5
p910
sg5
S'PMC3302710'
p911
sg7
VSTD-Soltanian-2010
p912
sg9
V22427772.xml
p913
sg11
S'de/ad/AMS-6-6-950.PMC3302710.pdf'
p914
sa(dp915
g3
VCD005654 v. 4.0 Pelvic floor muscle training versus no treatment or inactive control treatments for urinary incont.rm5
p916
sg5
S'PMC2664121'
p917
sg7
VSTD-Castro-2008
p918
sg9
V18719756.xml
p919
sg11
S'0d/57/cln63_4p0465.PMC2664121.pdf'
p920
sa(dp921
g3
VCD005195 v. 9.0 Selenium for preventing cancer.rm5
p922
sg5
S'PMC2361644'
p923
sg7
VSTD-Michaud-2005
p924
sg9
V16175184.xml
p925
sg11
S'02/69/93-6602788a.PMC2361644.pdf'
p926
sa(dp927
g3
VCD004879 v. 9.0 Vaccines for preventing influenza in healthy children.rm5
p928
sg5
S'PMC3216983'
p929
sg7
VSTD-ba-Kissling-2011
p930
sg9
V22110695.xml
p931
sg11
S'1b/66/pone.0027622.PMC3216983.pdf'
p932
sa(dp933
g3
g928
sg5
S'PMC3019108'
p934
sg7
VSTD-ba-Valenciano-2011
p935
sg9
V21379316.xml
p936
sg11
S'35/4e/pmed.1000388.PMC3019108.pdf'
p937
sa(dp938
g3
g928
sg5
S'PMC2966412'
p939
sg7
VSTD-ab-Mallory-2010
p940
sg9
V21060780.xml
p941
sg11
S'f9/42/pone.0013755.PMC2966412.pdf'
p942
sa(dp943
g3
VCD003193 v. 6.2 Anticholinergic drugs versus non-drug active therapies for non-neurogenic overactive bladder syndrom.rm5
p944
sg5
S'PMC2721929'
p945
sg7
VSTD-Song-2006
p946
sg9
V17179687.xml
p947
sg11
S'35/ba/jkms-21-1060.PMC2721929.pdf'
p948
sa(dp949
g3
g944
sg5
S'PMC2325270'
p950
sg7
VSTD-Chancellor-2008
p951
sg9
V18324952.xml
p952
sg11
S'6d/f2/ijcp0062-0606.PMC2325270.pdf'
p953
sa(dp954
g3
VCD004294 v. 6.3 Physical rehabilitation for older people in long-term care.rm5
p955
sg5
S'PMC1368976'
p956
sg7
VSTD-Bautmans-2005
p957
sg9
V16372905.xml
p958
sg11
S'32/17/1471-2318-5-17.PMC1368976.pdf'
p959
sa(dp960
g3
g955
sg5
S'PMC2565754'
p961
sg7
VSTD-Kerse-2008
p962
sg9
V18845605.xml
p963
sg11
g200
sa(dp964
g3
g955
sg5
S'PMC2736373'
p965
sg7
VSTD-Sackley-2009
p966
sg9
V19723707.xml
p967
sg11
S'd2/98/bmj.b3123.PMC2736373.pdf'
p968
sa(dp969
g3
g955
sg5
S'PMC471553'
p970
sg7
VSTD-Chin-A-Paw-2004
p971
sg9
V15233841.xml
p972
sg11
S'ba/7a/1471-2318-4-5.PMC471553.pdf'
p973
sa(dp974
g3
VCD004310 v. 8.0 Megestrol acetate for treatment of anorexia-cachexia syndrome.rm5
p975
sg5
S'PMC2074540'
p976
sg7
VSTD-Gebbia-1996
p977
sg9
V8664133.xml
p978
sg11
S'e6/30/brjcancer00040-0126.PMC2074540.pdf'
p979
sa(dp980
g3
VCD005083 v. 7.0 Honey as a topical treatment for wounds.rm5
p981
sg5
S'PMC1891315'
p982
sg7
VSTD-Nilforoushzadeh-2007
p983
sg9
V17466071.xml
p984
sg11
g54
sa(dp985
g3
VCD002139 v. 10.0 Chemotherapy for non-small cell lung cancer.rm5
p986
sg5
S'PMC1977284'
p987
sg7
VSTD-a01-MRC-LU02
p988
sg9
V3907687.xml
p989
sg11
S'08/71/brjcancer00098-0053.PMC1977284.pdf'
p990
sa(dp991
g3
g986
sg5
S'PMC1971367'
p992
sg7
VSTD-d04-RLW-8351
p993
sg9
V1691921.xml
p994
sg11
S'41/3d/brjcancer00224-0118.PMC1971367.pdf'
p995
sa(dp996
g3
g986
sg5
S'PMC1971367'
p997
sg7
VSTD-d06-Southampton
p998
sg9
V1691921.xml
p999
sg11
g995
sa(dp1000
g3
VCD010118 v. 2.0 Preoperative physical therapy for elective cardiac surgery patients.rm5
p1001
sg5
S'PMC3063826'
p1002
sg7
VSTD-Rosenfeldt-2011
p1003
sg9
V21385466.xml
p1004
sg11
S'00/3c/1472-6882-11-20.PMC3063826.pdf'
p1005
sa(dp1006
g3
VCD002068 v. 9.0 Bisphosphonates for the relief of pain secondary to bone metastases.rm5
p1007
sg5
S'PMC2228066'
p1008
sg7
VSTD-Kylmala-1997
p1009
sg9
V9328156.xml
p1010
sg11
S'ab/11/brjcancer00171-0117.PMC2228066.pdf'
p1011
sa(dp1012
g3
VCD006924 v. 4.0 Regular treatment with formoterol and inhaled steroids for chronic asthma serious adverse events.rm5
p1013
sg5
S'PMC2228375'
p1014
sg7
VSTD-Morice-2007
p1015
sg9
V17887990.xml
p1016
sg11
S'a1/ff/ijcp0061-1874.PMC2228375.pdf'
p1017
sa(dp1018
g3
VCD006094 v. 3.0 Interventions for improving the appropriate use of imaging in people with musculoskeletal conditions.rm5
p1019
sg5
S'PMC1824772'
p1020
sg7
VSTD-Solomon-2007a
p1021
sg9
V17356969.xml
p1022
sg11
S'7c/ae/11606_2006_Article_99.PMC1824772.pdf'
p1023
sa(dp1024
g3
g1019
sg5
S'PMC1824751'
p1025
sg7
VSTD-Lafata-2007
p1026
sg9
V17356966.xml
p1027
sg11
S'13/7b/11606_2006_Article_60.PMC1824751.pdf'
p1028
sa(dp1029
g3
VCD003137 v. 10.0 Addition to inhaled corticosteroids of long-acting beta2-agonists versus anti-leukotrienes for chron.rm5
p1030
sg5
S'PMC2174463'
p1031
sg7
VSTD-Pavord-2007
p1032
sg9
V17897478.xml
p1033
sg11
S'9e/c5/1465-9921-8-67.PMC2174463.pdf'
p1034
sa(dp1035
g3
VMR000005 v. 6.0 Full publication of results initially presented in abstracts.rm5
p1036
sg5
S'PMC115863'
p1037
sg7
VSTD-Timmer-2002
p1038
sg9
V11978183.xml
p1039
sg11
S'cb/2e/1471-2288-2-7.PMC115863.pdf'
p1040
sa(dp1041
g3
VCD007470 v. 4.2 Vitamin D supplementation for prevention of mortality in adults.rm5
p1042
sg5
S'PMC2277446'
p1043
sg7
VSTD-Chel-2008
p1044
sg9
V17874029.xml
p1045
sg11
S'32/22/198_2007_Article_465.PMC2277446.pdf'
p1046
sa(dp1047
g3
VCD000543 v. 11.18 Oral 5-aminosalicylic acid for induction of remission in ulcerative colitis.rm5
p1048
sg5
S'PMC2972638'
p1049
sg7
VSTD-Ito-2010
p1050
sg9
V20049950.xml
p1051
sg11
S'85/94/ibd0016-1567.PMC2972638.pdf'
p1052
sa(dp1053
g3
g1048
sg5
S'PMC3269751'
p1054
sg7
VSTD-Kruis-2009
p1055
sg9
V18832520.xml
p1056
sg11
S'1a/2e/GUT-58-02-0233.PMC3269751.pdf'
p1057
sa(dp1058
g3
VCD006536 v. 5.0 Stem cell treatment for acute myocardial infarction.rm5
p1059
sg5
S'PMC2726958'
p1060
sg7
VSTD-Cao-2009
p1061
sg9
V19508995.xml
p1062
sg11
S'86/92/ehp220.PMC2726958.pdf'
p1063
sa(dp1064
g3
VCD000330 v. 12.0 Enemas during labour.rm5
p1065
sg5
S'PMC1468428'
p1066
sg7
VSTD-Cuervo-2006
p1067
sg9
V16545140.xml
p1068
sg11
S'15/e9/1471-2393-6-8.PMC1468428.pdf'
p1069
sa(dp1070
g3
VCD010119 v. 2.0 Integration of HIVAIDS services with maternal neonatal and child health nutrition and family pla.rm5
p1071
sg5
S'PMC2536666'
p1072
sg7
VSTD-Bahwere-2008
p1073
sg9
V18671876.xml
p1074
sg11
S'22/00/1471-2334-8-106.PMC2536666.pdf'
p1075
sa(dp1076
g3
VCD005315 v. 3.3 Sensory environment on health-related outcomes of hospital patients.rm5
p1077
sg5
S'PMC2362603'
p1078
sg7
VSTD-Kotwal-1998
p1079
sg9
V18493472.xml
p1080
sg11
S'55/7f/DTE-04-191.PMC2362603.pdf'
p1081
sa(dp1082
g3
VCD009163 v. 2.5 Antibiotics for otitis media with effusion in children.rm5
p1083
sg5
S'PMC2671765'
p1084
sg7
VSTD-Choung-2008
p1085
sg9
V19434268.xml
p1086
sg11
S'57/8d/ceo-1-201.PMC2671765.pdf'
p1087
sa(dp1088
g3
VCD009098 v. 3.0 High versus low positive end-expiratory pressure (PEEP) levels for mechanically ventilated adult pat.rm5
p1089
sg5
S'PMC2688140'
p1090
sg7
VSTD-Huh-2009
p1091
sg9
V19239703.xml
p1092
sg11
S'ec/22/cc7725.PMC2688140.pdf'
p1093
sa(dp1094
g3
VCD004085 v. 5.2 High-frequency ventilation versus conventional ventilation for treatment of acute lung injury and ac.rm5
p1095
sg5
S'PMC1269459'
p1096
sg7
VSTD-Bollen-2005
p1097
sg9
V16137357.xml
p1098
sg11
S'ce/9a/cc3737.PMC1269459.pdf'
p1099
sa(dp1100
g3
VCD006667 v. 5.0 Recruitment manoeuvres for adults with acute lung injury receiving mechanical ventilation.rm5
p1101
sg5
S'PMC154111'
p1102
sg7
VSTD-Dyhr-2003
p1103
sg9
V12617741.xml
p1104
sg11
S'2e/3c/cc1844.PMC154111.pdf'
p1105
sa(dp1106
g3
VCD009223 v. 3.0 Non-opioid drugs for pain management in labour.rm5
p1107
sg5
S'PMC3081214'
p1108
sg7
VSTD-Makvandi-2011
p1109
sg9
V21495198.xml
p1110
sg11
S'f7/af/CroatMedJ_52_0159.PMC3081214.pdf'
p1111
sa(dp1112
g3
VCD007477 v. 5.0 Deferasirox for managing transfusional iron overload in people with sickle cell disease.rm5
p1113
sg5
S'PMC1974786'
p1114
sg7
VSTD-Vichinsky-2007
p1115
sg9
V17233848.xml
p1116
sg11
S'20/3e/bjh0136-0501.PMC1974786.pdf'
p1117
sa(dp1118
g3
VCD003407 v. 13.2 Erythropoietin or darbepoetin for patients with cancer.rm5
p1119
sg5
S'PMC3241560'
p1120
sg7
VSTD-Fujisaka-2011
p1121
sg9
V21959870.xml
p1122
sg11
S'7f/eb/bjc2011395a.PMC3241560.pdf'
p1123
sa(dp1124
g3
g1119
sg5
S'PMC2362337'
p1125
sg7
VSTD-Thatcher-1999b
p1126
sg9
V10408844.xml
p1127
sg11
S'5b/a8/80-6690369a.PMC2362337.pdf'
p1128
sa(dp1129
g3
g1119
sg5
S'PMC2362337'
p1130
sg7
VSTD-Thatcher-1999a
p1131
sg9
V10408844.xml
p1132
sg11
g1128
sa(dp1133
g3
g1119
sg5
S'PMC2376376'
p1134
sg7
VSTD-Boogaerts-2003
p1135
sg9
V12671693.xml
p1136
sg11
g689
sa(dp1137
g3
g1119
sg5
S'PMC2741110'
p1138
sg7
VSTD-Smith-2003b
p1139
sg9
V12799626.xml
p1140
sg11
S'3e/f6/88-6600994a.PMC2741110.pdf'
p1141
sa(dp1142
g3
g1119
sg5
S'PMC2741110'
p1143
sg7
VSTD-Smith-2003c
p1144
sg9
V12799626.xml
p1145
sg11
g1141
sa(dp1146
g3
g1119
sg5
S'PMC2741110'
p1147
sg7
VSTD-Smith-2003a
p1148
sg9
V12799626.xml
p1149
sg11
g1141
sa(dp1150
g3
g1119
sg5
S'PMC2361228'
p1151
sg7
VSTD-Wilkinson-2006
p1152
sg9
V16570051.xml
p1153
sg11
g694
sa(dp1154
g3
g1119
sg5
S'PMC3228044'
p1155
sg7
VSTD-Pronzato-2010
p1156
sg9
V20798194.xml
p1157
sg11
S'26/97/onc935.PMC3228044.pdf'
p1158
sa(dp1159
g3
g1119
sg5
S'PMC2150364'
p1160
sg7
VSTD-Sweeney-1998
p1161
sg9
V9667681.xml
p1162
sg11
S'48/88/brjcancer00087-0288.PMC2150364.pdf'
p1163
sa(dp1164
g3
g1119
sg5
S'PMC2362337'
p1165
sg7
VSTD-Thatcher-1999
p1166
sg9
V10408844.xml
p1167
sg11
g1128
sa(dp1168
g3
g1119
sg5
S'PMC2741110'
p1169
sg7
VSTD-Smith-2003
p1170
sg9
V12799626.xml
p1171
sg11
g1141
sa(dp1172
g3
VCD006140 v. 5.0 Sustained-Release Naltrexone For Opioid Dependence.rm5
p1173
sg5
S'PMC1087493'
p1174
sg7
VSTD-Galloway-2005
p1175
sg9
V15804355.xml
p1176
sg11
S'8a/f3/1471-244X-5-18.PMC1087493.pdf'
p1177
sa(dp1178
g3
VCD008341 v. 2.0 Golimumab for rheumatoid arthritis.rm5
p1179
sg5
S'PMC2674549'
p1180
sg7
VSTD-Keystone-2009
p1181
sg9
V19066176.xml
p1182
sg11
S'5f/5b/ard-68-06-0789.PMC2674549.pdf'
p1183
sa(dp1184
g3
VCD002907 v. 8.2 Antibiotic prophylaxis for cirrhotic patients with upper gastrointestinal bleeding.rm5
p1185
sg5
S'PMC2722000'
p1186
sg7
VSTD-Jun-2006
p1187
sg9
V17043424.xml
p1188
sg11
S'33/a5/jkms-21-883.PMC2722000.pdf'
p1189
sa(dp1190
g3
VCD005575 v. 6.2 Organisational travel plans for improving health.rm5
p1191
sg5
S'PMC2680829'
p1192
sg7
VSTD-Mendoza-2009
p1193
sg9
V19413910.xml
p1194
sg11
S'dd/99/1471-2458-9-122.PMC2680829.pdf'
p1195
sa(dp1196
g3
VCD001319 v. 13.0 Colloid solutions for fluid resuscitation.rm5
p1197
sg5
S'PMC2206488'
p1198
sg7
VSTD-Gombocz-2007
p1199
sg9
V17697359.xml
p1200
sg11
S'90/ee/cc6095.PMC2206488.pdf'
p1201
sa(dp1202
g3
g1197
sg5
S'PMC1569382'
p1203
sg7
VSTD-Akech-2006
p1204
sg9
V16998584.xml
p1205
sg11
S'23/18/pctr.0010021.PMC1569382.pdf'
p1206
sa(dp1207
g3
VCD007992 v. 3.0 Omega-3 fatty acids supplementation for autism spectrum disorders (ASD).rm5
p1208
sg5
S'PMC3076562'
p1209
sg7
VSTD-Bent-2011
p1210
sg9
V20683766.xml
p1211
sg11
S'32/2c/10803_2010_Article_1078.PMC3076562.pdf'
p1212
sa(dp1213
g3
VCD008326 v. 5.0 Total disc replacement for chronic back pain in the presence of disc degeneration.rm5
p1214
sg5
S'PMC3100911'
p1215
sg7
VSTD-Hellum-2011
p1216
sg9
V21596740.xml
p1217
sg11
S'24/53/bmj.d2786.PMC3100911.pdf'
p1218
sa(dp1219
g3
VCD000544 v. 11.0 Oral 5-aminosalicylic acid for maintenance of remission in ulcerative colitis.rm5
p1220
sg5
S'PMC2972641'
p1221
sg7
VSTD-Ito-2010
p1222
sg9
V20049949.xml
p1223
sg11
S'4e/6a/ibd0016-1575.PMC2972641.pdf'
p1224
sa(dp1225
g3
g1220
sg5
S'PMC2770408'
p1226
sg7
VSTD-Kane-2008a
p1227
sg9
V19920971.xml
p1228
sg11
S'2c/ac/ppa-2-253.PMC2770408.pdf'
p1229
sa(dp1230
g3
g1220
sg5
S'PMC2564831'
p1231
sg7
VSTD-Kamm-2008
p1232
sg9
V18272546.xml
p1233
sg11
S'd5/5a/GUT-57-07-0893.PMC2564831.pdf'
p1234
sa(dp1235
g3
VCD009774 v. 2.0 Parent-mediated early intervention for young children with autism spectrum disorders (ASD).rm5
p1236
sg5
S'PMC2922697'
p1237
sg7
VSTD-Kasari-2010
p1238
sg9
V20145986.xml
p1239
sg11
S'fb/a8/10803_2010_Article_955.PMC2922697.pdf'
p1240
sa(dp1241
g3
VCD003756 v. 6.2 Intermittent preventive treatment for malaria in children living in areas with seasonal transmission.rm5
p1242
sg5
S'PMC3024263'
p1243
sg7
VSTD-Sesay-2011
p1244
sg9
V21214940.xml
p1245
sg11
S'8b/e1/1475-2875-10-2.PMC3024263.pdf'
p1246
sa(dp1247
g3
g1242
sg5
S'PMC3032552'
p1248
sg7
VSTD-Konate-2011
p1249
sg9
V21304925.xml
p1250
sg11
S'48/3b/pmed.1000408.PMC3032552.pdf'
p1251
sa(dp1252
g3
g1242
sg5
S'PMC2602973'
p1253
sg7
VSTD-Kweku-2008
p1254
sg9
V19098989.xml
p1255
sg11
S'b0/1b/pone.0004000.PMC2602973.pdf'
p1256
sa(dp1257
g3
g1242
sg5
S'PMC3032550'
p1258
sg7
VSTD-Dicko-2011
p1259
sg9
V21304923.xml
p1260
sg11
S'f4/89/pmed.1000407.PMC3032550.pdf'
p1261
sa(dp1262
g3
g1242
sg5
S'PMC2500037'
p1263
sg7
VSTD-Dicko-2008
p1264
sg9
V18611271.xml
p1265
sg11
S'd2/73/1475-2875-7-123.PMC2500037.pdf'
p1266
sa(dp1267
g3
VCD008615 v. 3.2 Sumatriptan (oral route of administration) for acute migraine attacks in adults.rm5
p1268
sg5
S'PMC1974802'
p1269
sg7
VSTD-Sandrini-2007
p1270
sg9
V17627707.xml
p1271
sg11
S'84/ed/ijcp0061-1256.PMC1974802.pdf'
p1272
sa(dp1273
g3
g1268
sg5
S'PMC3452229'
p1274
sg7
VSTD-Tfelt_x002d_Hansen-2006
p1275
sg9
V17164991.xml
p1276
sg11
S'da/ae/10194_2006_Article_333.PMC3452229.pdf'
p1277
sa(dp1278
g3
VCD000265 v. 15.0 Compression for venous leg ulcers.rm5
p1279
sg5
S'PMC3298351'
p1280
sg7
VSTD-Szewczyk-2010
p1281
sg9
V22419941.xml
p1282
sg11
S'10/a5/AMS-6-5-793.PMC3298351.pdf'
p1283
sa(dp1284
g3
VCD002063 v. 10.0 Intravenous immunoglobulin for Guillain-Barr syndrome.rm5
p1285
sg5
S'PMC3387601'
p1286
sg7
VSTD-El_x002d_Bayoumi-2011
p1287
sg9
V21745374.xml
p1288
sg11
S'5e/5a/cc10305.PMC3387601.pdf'
p1289
sa(dp1290
g3
VCD008937 v. 2.4 Psychological therapies for pathological and problem gambling.rm5
p1291
sg5
S'PMC2882846'
p1292
sg7
VSTD-Carlbring-2010
p1293
sg9
V19967577.xml
p1294
sg11
S'c2/3e/sbeh39-92.PMC2882846.pdf'
p1295
sa(dp1296
g3
VCD007587 v. 3.0 Acupuncture for tension-type headache.rm5
p1297
sg5
S'PMC3476149'
p1298
sg7
VSTD-Endres-2007
p1299
sg9
V17955168.xml
p1300
sg11
S'ad/17/10194_2007_Article_416.PMC3476149.pdf'
p1301
sa(dp1302
g3
VCD000246 v. 8.0 Prophylactic antibiotics for inhibiting preterm labour with intact membranes.rm5
p1303
sg5
S'PMC2366143'
p1304
sg7
VSTD-Watts-1994
p1305
sg9
V18472878.xml
p1306
sg11
S'0e/a7/IDOG-01-220.PMC2366143.pdf'
p1307
sa(dp1308
g3
VCD001233 v. 8.0 Mechanical methods for induction of labour.rm5
p1309
sg5
S'PMC1784771'
p1310
sg7
VSTD-Hibbard-1998
p1311
sg9
V9678143.xml
p1312
sg11
S'81/3a/9678143.PMC1784771.pdf'
p1313
sa(dp1314
g3
VCD007393 v. 4.0 Topical capsaicin (high concentration) for chronic neuropathic pain in adults.rm5
p1315
sg5
S'PMC2958861'
p1316
sg7
VSTD-Webster-2010a
p1317
sg9
V20937130.xml
p1318
sg11
S'0a/d4/1471-2377-10-92.PMC2958861.pdf'
p1319
sa(dp1320
g3
VCD002898 v. 10.0 Antiviral treatment and other therapeutic interventions for herpes simplex virus epithelial keratiti.rm5
p1321
sg5
S'PMC2704535'
p1322
sg7
VSTD-Colin-2007a
p1323
sg9
V19668521.xml
p1324
sg11
S'e4/2d/opth-1-441.PMC2704535.pdf'
p1325
sa(dp1326
g3
g1321
sg5
S'PMC2704535'
p1327
sg7
VSTD-Colin-2007b
p1328
sg9
V19668521.xml
p1329
sg11
g1325
sa(dp1330
g3
VCD005247 v. 4.0 Chemotherapy for hormone-refractory prostate cancer.rm5
p1331
sg5
S'PMC2395315'
p1332
sg7
VSTD-Albrecht-2004
p1333
sg9
V14710214.xml
p1334
sg11
S'89/35/90-6601468a.PMC2395315.pdf'
p1335
sa(dp1336
g3
g1331
sg5
S'PMC1968505'
p1337
sg7
VSTD-Francini-1993
p1338
sg9
V8512828.xml
p1339
sg11
S'a8/76/brjcancer00208-0270.PMC1968505.pdf'
p1340
sa(dp1341
g3
VCD006023 v. 6.0 Phosphate binders for preventing and treating bone disease in chronic kidney disease patients.rm5
p1342
sg5
S'PMC2781155'
p1343
sg7
VSTD-Fan-2009
p1344
sg9
V19666658.xml
p1345
sg11
S'd4/42/gfp372.PMC2781155.pdf'
p1346
sa(dp1347
g3
g1342
sg5
S'PMC2268719'
p1348
sg7
VSTD-Tzanakis-2008
p1349
sg9
V18193489.xml
p1350
sg11
S'5c/6d/11255_2007_Article_9300.PMC2268719.pdf'
p1351
sa(dp1352
g3
VCD004014 v. 8.0 Surgical management of pelvic organ prolapse in women.rm5
p1353
sg5
S'PMC2808513'
p1354
sg7
VSTD-Dietz-2010
p1355
sg9
V19834635.xml
p1356
sg11
S'88/64/192_2009_Article_1014.PMC2808513.pdf'
p1357
sa(dp1358
g3
g1353
sg5
S'PMC2774153'
p1359
sg7
VSTD-Carey-2009
p1360
sg9
V19583714.xml
p1361
sg11
S'20/ed/bjo0116-1380.PMC2774153.pdf'
p1362
sa(dp1363
g3
VCD009238 v. 3.0 Helminth therapy (worms) for allergic rhinitis.rm5
p1364
sg5
S'PMC2728895'
p1365
sg7
VSTD-Feary-2009a
p1366
sg9
V19400893.xml
p1367
sg11
S'58/96/cea0039-1060.PMC2728895.pdf'
p1368
sa(dp1369
g3
VCD004398 v. 10.0 Printed educational materials effects on professional practice and healthcare outcomes.rm5
p1370
sg5
S'PMC1904445'
p1371
sg7
VSTD-Perria-2007
p1372
sg9
V17547760.xml
p1373
sg11
S'ca/82/1472-6963-7-79.PMC1904445.pdf'
p1374
sa(dp1375
g3
VCD008141 v. 2.3 Second-generation antipsychotics for obsessive compulsive disorder.rm5
p1376
sg5
S'PMC547907'
p1377
sg7
VSTD-Carey-2005
p1378
sg9
V15667657.xml
p1379
sg11
S'cb/51/1471-244X-5-5.PMC547907.pdf'
p1380
sa(dp1381
g3
VCD004720 v. 8.0 Screening for prostate cancer.rm5
p1382
sg5
S'PMC3069219'
p1383
sg7
VSTD-Norrkoping
p1384
sg9
V21454449.xml
p1385
sg11
S'00/b1/bmj.d1539.PMC3069219.pdf'
p1386
sa(dp1387
g3
VCD003348 v. 9.0 Patient controlled opioid analgesia versus conventional opioid analgesia for postoperative pain.rm5
p1388
sg5
S'PMC3015270'
p1389
sg7
VSTD-Rosen-1998
p1390
sg9
V9876706.xml
p1391
sg11
S'98/b1/jsls-2-1-25.PMC3015270.pdf'
p1392
sa(dp1393
g3
VCD007717 v. 3.0 Telehealthcare for asthma.rm5
p1394
sg5
S'PMC2000864'
p1395
sg7
VSTD-Willems-2007a
p1396
sg9
V17662113.xml
p1397
sg11
S'79/6e/1478-7547-5-10.PMC2000864.pdf'
p1398
sa(dp1399
g3
VCD004064 v. 10.0 Chemotherapy for advanced gastric cancer.rm5
p1400
sg5
S'PMC1693922'
p1401
sg7
VSTD-Sadighi-2006
p1402
sg9
V17147808.xml
p1403
sg11
S'bc/6e/1471-2407-6-274.PMC1693922.pdf'
p1404
sa(dp1405
g3
g1400
sg5
S'PMC2361806'
p1406
sg7
VSTD-Moehler-2005
p1407
sg9
V15942629.xml
p1408
sg11
S'cb/31/92-6602649a.PMC2361806.pdf'
p1409
sa(dp1410
g3
g1400
sg5
S'PMC2033628'
p1411
sg7
VSTD-Pyrh_x00f6_nen-1995
p1412
sg9
V7533517.xml
p1413
sg11
S'a1/83/brjcancer00049-0161.PMC2033628.pdf'
p1414
sa(dp1415
g3
VCD002731 v. 6.0 Nedocromil sodium versus sodium cromoglycate for preventing exercise-induced bronchoconstriction.rm5
p1416
sg5
S'PMC2365597'
p1417
sg7
VSTD-de-Benedictis-1994b
p1418
sg9
V18475602.xml
p1419
sg11
S'f6/04/MI-03-S35.PMC2365597.pdf'
p1420
sa(dp1421
g3
VMR000033 v. 3.0 Industry sponsorship and research outcome.rm5
p1422
sg5
S'PMC2858083'
p1423
sg7
VSTD-Popelut-2010
p1424
sg9
V20422000.xml
p1425
sg11
S'45/6c/pone.0010274.PMC2858083.pdf'
p1426
sa(dp1427
g3
g1422
sg5
S'PMC1885451'
p1428
sg7
VSTD-Bero-2007
p1429
sg9
V17550302.xml
p1430
sg11
S'8d/36/pmed.0040184.PMC1885451.pdf'
p1431
sa(dp1432
g3
g1422
sg5
S'PMC126226'
p1433
sg7
VSTD-Clifford-2002
p1434
sg9
V12213183.xml
p1435
sg11
S'59/8c/1472-6963-2-18.PMC126226.pdf'
p1436
sa(dp1437
g3
g1422
sg5
S'PMC2643439'
p1438
sg7
VSTD-Jefferson-2009
p1439
sg9
V19213766.xml
p1440
sg11
S'bd/bd/bmj.b354.PMC2643439.pdf'
p1441
sa(dp1442
g3
g1422
sg5
S'PMC2811705'
p1443
sg7
VSTD-Rasmussen-2009
p1444
sg9
V20015404.xml
p1445
sg11
S'27/96/1745-6215-10-116.PMC2811705.pdf'
p1446
sa(dp1447
g3
g1422
sg5
S'PMC2688752'
p1448
sg7
VSTD-Rattinger-2009
p1449
sg9
V19503811.xml
p1450
sg11
S'3f/45/pone.0005826.PMC2688752.pdf'
p1451
sa(dp1452
g3
VCD009147 v. 2.0 Image-guided versus blind glucocorticoid injection for shoulder pain.rm5
p1453
sg5
S'PMC2769057'
p1454
sg7
VSTD-Ekeberg-2009
p1455
sg9
V19168537.xml
p1456
sg11
S'9c/ad/bmj.a3112.PMC2769057.pdf'
p1457
sa(dp1458
g3
VCD008409 v. 3.3 Progesterone for acute traumatic brain injury.rm5
p1459
sg5
S'PMC2447617'
p1460
sg7
VSTD-Xiao-2008
p1461
sg9
V18447940.xml
p1462
sg11
S'2d/20/cc6887.PMC2447617.pdf'
p1463
sa(dp1464
g3
VCD007938 v. 4.0 Gabapentin for chronic neuropathic pain and fibromyalgia in adults.rm5
p1465
sg5
S'PMC523854'
p1466
sg7
VSTD-van-de-Vusse-2004
p1467
sg9
V15453912.xml
p1468
sg11
S'7d/c0/1471-2377-4-13.PMC523854.pdf'
p1469
sa(dp1470
g3
VCD009415 v. 2.0 Zinc supplements for treating thalassaemia and sickle cell disease.rm5
p1471
sg5
S'PMC3446117'
p1472
sg7
VSTD-Rashidi-2011
p1473
sg9
V23056757.xml
p1474
sg11
S'a9/8e/IJPD-21-008.PMC3446117.pdf'
p1475
sa(dp1476
g3
VCD001183 v. 10.0 Nedocromil sodium for preventing exercise-induced bronchoconstriction.rm5
p1477
sg5
S'PMC2365597'
p1478
sg7
VSTD-De-Benedictis-1994b
p1479
sg9
V18475602.xml
p1480
sg11
g1420
sa(dp1481
g3
VCD006424 v. 2.0 Culturally appropriate health education for type 2 diabetes mellitus in ethnic minority groups.rm5
p1482
sg5
S'PMC1489930'
p1483
sg7
VSTD-Baradaran-2006
p1484
sg9
V16709243.xml
p1485
sg11
S'6e/ad/1471-2458-6-134.PMC1489930.pdf'
p1486
sa(dp1487
g3
VCD005390 v. 4.0 Adjuvant Therapy for completely resected Stage II Colon Cancer.rm5
p1488
sg5
S'PMC1972556'
p1489
sg7
VSTD-Gray-1991
p1490
sg9
V2069842.xml
p1491
sg11
S'88/55/brjcancer00214-0009.PMC1972556.pdf'
p1492
sa(dp1493
g3
g1488
sg5
S'PMC2363941'
p1494
sg7
VSTD-Taal-2001
p1495
sg9
V11720425.xml
p1496
sg11
S'd3/8a/85-6692117a.PMC2363941.pdf'
p1497
sa(dp1498
g3
VCD002845 v. 6.0 Oral versus intra-vaginal imidazole and triazole anti-fungal treatment of uncomplicated vulvovaginal.rm5
p1499
sg5
S'PMC2364408'
p1500
sg7
VSTD-Mikamo-_x0028_1_x0029_-1995
p1501
sg9
V18475414.xml
p1502
sg11
S'7b/c2/IDOG-03-007.PMC2364408.pdf'
p1503
sa(dp1504
g3
g1499
sg5
S'PMC1784583'
p1505
sg7
VSTD-Seidman-2005
p1506
sg9
V16338779.xml
p1507
sg11
S'f0/8c/16338779.PMC1784583.pdf'
p1508
sa(dp1509
g3
g1499
sg5
S'PMC2364408'
p1510
sg7
VSTD-Mikamo-_x0028_2_x0029_-1995
p1511
sg9
V18475414.xml
p1512
sg11
g1503
sa(dp1513
g3
VCD008563 v. 2.0 Prevention of diarrhoea in children with HIV infection or exposure to maternal HIV infection.rm5
p1514
sg5
S'PMC1891438'
p1515
sg7
VSTD-Luabeya-2007
p1516
sg9
V17593956.xml
p1517
sg11
g170
sa(dp1518
g3
VCD000259 v. 11.2 Audit and feedback effects on professional practice and healthcare outcomes.rm5
p1519
sg5
S'PMC2699722'
p1520
sg7
VSTD-O_x0027_Connor-2009
p1521
sg9
V19366977.xml
p1522
sg11
S'f8/73/zdc1158.PMC2699722.pdf'
p1523
sa(dp1524
g3
g1519
sg5
S'PMC2440309'
p1525
sg7
VSTD-Schneider-2008
p1526
sg9
V18093108.xml
p1527
sg11
S'b7/f0/jep0014-0185.PMC2440309.pdf'
p1528
sa(dp1529
g3
g1519
sg5
S'PMC1868738'
p1530
sg7
VSTD-Foster-2007
p1531
sg9
V17456241.xml
p1532
sg11
S'9d/39/1471-2296-8-23.PMC1868738.pdf'
p1533
sa(dp1534
g3
VCD005528 v. 4.0 Non-clinical interventions for reducing unnecessary caesarean section.rm5
p1535
sg5
S'PMC2442595'
p1536
sg7
VSTD-Hemminki-2008
p1537
sg9
V18547413.xml
p1538
sg11
S'ed/41/1472-6963-8-126.PMC2442595.pdf'
p1539
sa(dp1540
g3
VCD006915 v. 5.0 Heliox inhalation therapy for bronchiolitis in infants.rm5
p1541
sg5
S'PMC2717432'
p1542
sg7
VSTD-Kneyber-2009
p1543
sg9
V19450268.xml
p1544
sg11
S'2b/84/cc7880.PMC2717432.pdf'
p1545
sa(dp1546
g3
VCD003751 v. 5.0 Communication skills training for healthcare professionals working with people who have cancer.rm5
p1547
sg5
S'PMC2364281'
p1548
sg7
VSTD-Razavi-2002
p1549
sg9
V12085247.xml
p1550
sg11
S'1e/d8/87-6600412a.PMC2364281.pdf'
p1551
sa(dp1552
g3
g1547
sg5
S'PMC2906741'
p1553
sg7
VSTD-Lienard-2010
p1554
sg9
V20628395.xml
p1555
sg11
S'5d/80/6605749a.PMC2906741.pdf'
p1556
sa(dp1557
g3
VCD007536 v. 2.0 Routine pre-pregnancy health promotion for improving pregnancy outcomes.rm5
p1558
sg5
S'PMC1552064'
p1559
sg7
VSTD-Elsinga-2006
p1560
sg9
V16824233.xml
p1561
sg11
S'd8/fa/1471-2296-7-41.PMC1552064.pdf'
p1562
sa(dp1563
g3
g1558
sg5
S'PMC1712341'
p1564
sg7
VSTD-Lumley-2006
p1565
sg9
V17156466.xml
p1566
sg11
S'4b/74/1471-2458-6-299.PMC1712341.pdf'
p1567
sa(dp1568
g3
VCD005200 v. 3.0 Laparoscopic versus open total mesorectal excision for rectal cancer.rm5
p1569
sg5
S'PMC3043413'
p1570
sg7
VSTD-Reis-Neto-2002
p1571
sg9
V12113422.xml
p1572
sg11
S'c4/26/jsls-6-2-163.PMC3043413.pdf'
p1573
sa(dp1574
g3
VCD006686 v. 7.0 Bradykinin beta-2 receptor antagonists for acute traumatic brain injury.rm5
p1575
sg5
S'PMC2794266'
p1576
sg7
VSTD-BRAIN-2009
p1577
sg9
V19958521.xml
p1578
sg11
S'9a/2b/1745-6215-10-109.PMC2794266.pdf'
p1579
sa(dp1580
g3
VCD004023 v. 8.0 Early versus deferred treatment for early stage multiple myeloma.rm5
p1581
sg5
S'PMC2033710'
p1582
sg7
VSTD-Riccardi-1994
p1583
sg9
V7981078.xml
p1584
sg11
S'e2/84/brjcancer00058-0171.PMC2033710.pdf'
p1585
sa(dp1586
g3
g1581
sg5
S'PMC2374495'
p1587
sg7
VSTD-Riccardi-2000
p1588
sg9
V10755397.xml
p1589
sg11
S'38/d4/82-6691087a.PMC2374495.pdf'
p1590
sa(dp1591
g3
VCD003372 v. 8.0 Single agent versus combination chemotherapy for metastatic breast cancer.rm5
p1592
sg5
S'PMC1968186'
p1593
sg7
VSTD-Fraser-S-1993
p1594
sg9
V8431375.xml
p1595
sg11
S'ba/02/brjcancer00204-0200.PMC1968186.pdf'
p1596
sa(dp1597
g3
g1592
sg5
S'PMC2025018'
p1598
sg7
VSTD-Rubens-RD-1975
p1599
sg9
V766800.xml
p1600
sg11
S'99/bc/brjcancer00321-0094.PMC2025018.pdf'
p1601
sa(dp1602
g3
VCD009008 v. 2.6 Sulphonylurea monotherapy for patients with type 2 diabetes mellitus.rm5
p1603
sg5
S'PMC3084519'
p1604
sg7
VSTD-LEAD_x002d_3-2006
p1605
sg9
V21205128.xml
p1606
sg11
S'59/a3/dom0013-0348.PMC3084519.pdf'
p1607
sa(dp1608
g3
VCD002991 v. 7.0 Inhaled corticosteroids for stable chronic obstructive pulmonary disease.rm5
p1609
sg5
S'PMC2644301'
p1610
sg7
VSTD-Calverley-2008
p1611
sg9
V19014549.xml
p1612
sg11
S'af/d2/1465-9921-9-73.PMC2644301.pdf'
p1613
sa(dp1614
g3
g1609
sg5
S'PMC2793071'
p1615
sg7
VSTD-Schermer-2009
p1616
sg9
V20037682.xml
p1617
sg11
S'eb/da/copd-4-431.PMC2793071.pdf'
p1618
sa(dp1619
g3
VCD005199 v. 7.0 Transverse verses midline incisions for abdominal surgery.rm5
p1620
sg5
S'PMC2690844'
p1621
sg7
VSTD-Halm-2009
p1622
sg9
V19259615.xml
p1623
sg11
S'4b/7c/10029_2008_Article_469.PMC2690844.pdf'
p1624
sa(dp1625
g3
VCD002151 v. 7.0 Antipyretic measures for treating fever in malaria.rm5
p1626
sg5
S'PMC2409363'
p1627
sg7
VSTD-Matsegui-2008
p1628
sg9
V18503714.xml
p1629
sg11
S'98/ef/1475-2875-7-91.PMC2409363.pdf'
p1630
sa(dp1631
g3
g1626
sg5
S'PMC3123603'
p1632
sg7
VSTD-Kofoed-2011
p1633
sg9
V21631932.xml
p1634
sg11
S'95/f3/1475-2875-10-148.PMC3123603.pdf'
p1635
sa(dp1636
g3
VCD001118 v. 10.0 Self-help interventions for smoking cessation.rm5
p1637
sg5
S'PMC2253708'
p1638
sg7
VSTD-Meyer-2008
p1639
sg9
V17995993.xml
p1640
sg11
g723
sa(dp1641
g3
VCD001425 v. 6.0 Immunotherapy for advanced renal cell cancer.rm5
p1642
sg5
S'PMC2361635'
p1643
sg7
VSTD-Donskov_x0028_ii_x0029_-2005
p1644
sg9
V16136045.xml
p1645
sg11
S'5c/d2/93-6602768a.PMC2361635.pdf'
p1646
sa(dp1647
g3
g1642
sg5
S'PMC2063040'
p1648
sg7
VSTD-Jayson-1998
p1649
sg9
V9703284.xml
p1650
sg11
S'0c/85/brjcancer00003-0090.PMC2063040.pdf'
p1651
sa(dp1652
g3
g1642
sg5
S'PMC2033601'
p1653
sg7
VSTD-DeMulder-1995
p1654
sg9
V7841054.xml
p1655
sg11
S'a1/ea/brjcancer00048-0159.PMC2033601.pdf'
p1656
sa(dp1657
g3
g1642
sg5
S'PMC2361635'
p1658
sg7
VSTD-Donskov_x0028_i_x0029_-2005
p1659
sg9
V16136045.xml
p1660
sg11
g1646
sa(dp1661
g3
g1642
sg5
S'PMC2150170'
p1662
sg7
VSTD-Henriksson-1998
p1663
sg9
V9579838.xml
p1664
sg11
S'c4/34/brjcancer00084-0117.PMC2150170.pdf'
p1665
sa(dp1666
g3
g1642
sg5
S'PMC2375150'
p1667
sg7
VSTD-Atzpodien-2001
p1668
sg9
V11710825.xml
p1669
sg11
S'c1/ad/85-6692076a.PMC2375150.pdf'
p1670
sa(dp1671
g3
VCD004106 v. 9.0 Combination fluticasone and salmeterol versus fixed dose combination budesonide and formoterol for c.rm5
p1672
sg5
S'PMC1920547'
p1673
sg7
VSTD-COMPASS
p1674
sg9
V17362472.xml
p1675
sg11
S'f8/2c/ijcp0061-0725.PMC1920547.pdf'
p1676
sa(dp1677
g3
VCD001321 v. 17.0 Cranberries for preventing urinary tract infections.rm5
p1678
sg5
S'PMC2639265'
p1679
sg7
VSTD-McMurdo-2009
p1680
sg9
V19042940.xml
p1681
sg11
S'bb/57/dkn489.PMC2639265.pdf'
p1682
sa(dp1683
g3
VCD002850 v. 9.0 Telephone counselling for smoking cessation.rm5
p1684
sg5
S'PMC2268921'
p1685
sg7
VSTD-Young-2008
p1686
sg9
V18304363.xml
p1687
sg11
g728
sa(dp1688
g3
VCD008654 v. 1.0 Pharmaceutical policies effects of restrictions on reimbursement.rm5
p1689
sg5
S'PMC1904466'
p1690
sg7
VSTD-Fretheim-2007
p1691
sg9
V17622192.xml
p1692
sg11
S'c6/16/pmed.0040232.PMC1904466.pdf'
p1693
sa(dp1694
g3
VCD001000 v. 12.0 Corticosteroids for the prevention and treatment of post-extubation stridor in neonates children an.rm5
p1695
sg5
S'PMC2206510'
p1696
sg7
VSTD-Lee-2007
p1697
sg9
V17705879.xml
p1698
sg11
S'c6/2d/cc5976.PMC2206510.pdf'
p1699
sa(dp1700
g3
VCD004306 v. 9.0 Interventions for smokeless tobacco use cessation.rm5
p1701
sg5
S'PMC2997603'
p1702
sg7
VSTD-Fagerstrom-2010
p1703
sg9
V21134997.xml
p1704
sg11
S'd0/0a/bmj.c6549.PMC2997603.pdf'
p1705
sa(dp1706
g3
VCD000009 v. 11.0 Acupuncture and related interventions for smoking cessation.rm5
p1707
sg5
S'PMC1831486'
p1708
sg7
VSTD-White-2007
p1709
sg9
V17359519.xml
p1710
sg11
S'83/a9/1472-6882-7-8.PMC1831486.pdf'
p1711
sa(dp1712
g3
VCD005978 v. 9.0 Zinc supplementation for the prevention of pneumonia in children aged 2 months to 59 months.rm5
p1713
sg5
S'PMC1891438'
p1714
sg7
VSTD-Luabeya-2007
p1715
sg9
V17593956.xml
p1716
sg11
g170
sa(dp1717
g3
VCD008273 v. 3.0 Information interventions for orienting patients and their carers to cancer care facilities.rm5
p1718
sg5
S'PMC2074537'
p1719
sg7
VSTD-Mohide-1996
p1720
sg9
V8664135.xml
p1721
sg11
S'02/34/brjcancer00040-0138.PMC2074537.pdf'
p1722
sa(dp1723
g3
VCD005987 v. 5.0 Scalpel versus electrosurgery for abdominal incisions.rm5
p1724
sg5
S'PMC2364680'
p1725
sg7
VSTD-Hemsell-1993
p1726
sg9
V18476202.xml
p1727
sg11
S'00/7e/IDOG-01-027.PMC2364680.pdf'
p1728
sa(dp1729
g3
VCD007126 v. 5.0 Single dose intravenous propacetamol or intravenous paracetamol for postoperative pain.rm5
p1730
sg5
S'PMC2615351'
p1731
sg7
VSTD-Leykin-2008
p1732
sg9
V18581586.xml
p1733
sg11
S'56/ea/ymj-49-383.PMC2615351.pdf'
p1734
sa(dp1735
g3
VCD001266 v. 7.0 Bronchodilators for bronchiolitis.rm5
p1736
sg5
S'PMC111183'
p1737
sg7
VSTD-Totapally-2002
p1738
sg9
V11983043.xml
p1739
sg11
S'0f/b3/cc-6-2-160.PMC111183.pdf'
p1740
sa(dp1741
g3
VMR000024 v. 5.0 New treatments compared to established treatments in randomized trials.rm5
p1742
sg5
S'PMC3113983'
p1743
sg7
VSTD-Dent-2011
p1744
sg9
V21542934.xml
p1745
sg11
S'9d/4a/1745-6215-12-109.PMC3113983.pdf'
p1746
sa(dp1747
g3
VCD006704 v. 7.2 Drug therapy for the management of cancer-related fatigue.rm5
p1748
sg5
S'PMC2741110'
p1749
sg7
VSTD-Smith-2003
p1750
sg9
V12799626.xml
p1751
sg11
g1141
sa(dp1752
g3
g1748
sg5
S'PMC2376376'
p1753
sg7
VSTD-Boogaerts-2003
p1754
sg9
V12671693.xml
p1755
sg11
g689
sa(dp1756
g3
g1748
sg5
S'PMC2362337'
p1757
sg7
VSTD-Thatcher-1999
p1758
sg9
V10408844.xml
p1759
sg11
g1128
sa(dp1760
g3
g1748
sg5
S'PMC2361228'
p1761
sg7
VSTD-Wilkinson-2006
p1762
sg9
V16570051.xml
p1763
sg11
g694
sa(dp1764
g3
VCD003409 v. 19.0 Methadone at tapered doses for the management of opioid withdrawal.rm5
p1765
sg5
S'PMC2773536'
p1766
sg7
VSTD-Madlung_x002d_Kratzer-2009
p1767
sg9
V19686525.xml
p1768
sg11
S'a7/eb/add0104-1549.PMC2773536.pdf'
p1769
sa(dp1770
g3
VCD006776 v. 6.0 Using alternative statistical formats for presenting risks and risk reductions.rm5
p1771
sg5
S'PMC2724738'
p1772
sg7
VSTD-Carling-2009
p1773
sg9
V19707575.xml
p1774
sg11
S'0b/98/pmed.1000134.PMC2724738.pdf'
p1775
sa(dp1776
g3
g1771
sg5
S'PMC2585274'
p1777
sg7
VSTD-Carling-2008
p1778
sg9
V19030110.xml
p1779
sg11
S'77/3e/pone.0003693.PMC2585274.pdf'
p1780
sa(dp1781
g3
VCD009017 v. 2.0 Clofibrate in combination with phototherapy for unconjugated neonatal hyperbilirubinaemia.rm5
p1782
sg5
S'PMC3446002'
p1783
sg7
VSTD-Sharafi-2010
p1784
sg9
V23056681.xml
p1785
sg11
S'a4/7a/IJPD-20-048.PMC3446002.pdf'
p1786
sa(dp1787
g3
VCD004711 v. 6.0 Heated humidification versus heat and moisture exchangers for ventilated adults and children.rm5
p1788
sg5
S'PMC1750976'
p1789
sg7
VSTD-Lorente-2006
p1790
sg9
V16884530.xml
p1791
sg11
S'0a/69/cc5009.PMC1750976.pdf'
p1792
sa(dp1793
g3
VCD001431 v. 9.0 Decision aids for people facing health treatment or screening decisions.rm5
p1794
sg5
S'PMC2653746'
p1795
sg7
VSTD-Vodermaier-2009
p1796
sg9
V19209172.xml
p1797
sg11
S'11/76/6604916a.PMC2653746.pdf'
p1798
sa(dp1799
g3
g1794
sg5
S'PMC1626460'
p1800
sg7
VSTD-Sheridan-2006
p1801
sg9
V17005051.xml
p1802
sg11
S'29/62/1472-6963-6-121.PMC1626460.pdf'
p1803
sa(dp1804
g3
g1794
sg5
S'PMC1781432'
p1805
sg7
VSTD-Thomson-2007
p1806
sg9
V17214891.xml
p1807
sg11
S'48/fb/1472-6947-7-2.PMC1781432.pdf'
p1808
sa(dp1809
g3
VMR000013 v. 10.0 Strategies to improve recruitment to randomised controlled trials.rm5
p1810
sg5
S'PMC2360384'
p1811
sg7
VSTD-Hutchison-2007
p1812
sg9
V17848908.xml
p1813
sg11
S'b5/06/6603943a.PMC2360384.pdf'
p1814
sa(dp1815
g3
VCD007419 v. 4.0 Antiangiogenic therapy with anti-vascular endothelial growth factor modalities for diabetic macular .rm5
p1816
sg5
S'PMC2963502'
p1817
sg7
VSTD-RESOLVE
p1818
sg9
V20980427.xml
p1819
sg11
S'68/ef/zdc2399.PMC2963502.pdf'
p1820
sa(dp1821
g3
VCD002747 v. 11.0 Chemotherapy alone versus endocrine therapy alone for metastatic breast cancer.rm5
p1822
sg5
S'PMC1977824'
p1823
sg7
VSTD-Dixon-1992
p1824
sg9
V1503915.xml
p1825
sg11
S'33/6d/brjcancer00060-0180.PMC1977824.pdf'
p1826
sa(dp1827
g3
VCD007945 v. 3.0 Centralisation of services for gynaecological cancer.rm5
p1828
sg5
S'PMC2612742'
p1829
sg7
VSTD-Brookfield-2009
p1830
sg9
V19125205.xml
p1831
sg11
S'62/f2/pone.0004049.PMC2612742.pdf'
p1832
sa(dp1833
g3
g1828
sg5
S'PMC2363169'
p1834
sg7
VSTD-Stockton-2000
p1835
sg9
V10638991.xml
p1836
sg11
S'da/9a/82-6690901a.PMC2363169.pdf'
p1837
sa(dp1838
g3
VCD006777 v. 3.0 Framing of health information messages.rm5
p1839
sg5
S'PMC2830888'
p1840
sg7
VSTD-Carling-2010
p1841
sg9
V20209127.xml
p1842
sg11
S'5b/73/pone.0009469.PMC2830888.pdf'
p1843
sa(dp1844
g3
VCD006425 v. 5.3 Antenatal breastfeeding education for increasing breastfeeding duration.rm5
p1845
sg5
S'PMC2636685'
p1846
sg7
VSTD-MacArthur-2009
p1847
sg9
V19181730.xml
p1848
sg11
S'71/1e/bmj.b131.PMC2636685.pdf'
p1849
sa(dp1850
g3
VCD004530 v. 8.0 Fluoroquinolones for treating typhoid and paratyphoid fever (enteric fever).rm5
p1851
sg5
S'PMC1891439'
p1852
sg7
VSTD-Pandit-2007-NPL
p1853
sg9
V17593957.xml
p1854
sg11
S'4a/ce/pone.0000542.PMC1891439.pdf'
p1855
sa(dp1856
g3
g1851
sg5
S'PMC2374894'
p1857
sg7
VSTD-Dolecek-2008-VNM
p1858
sg9
V18493312.xml
p1859
sg11
S'29/6e/pone.0002188.PMC2374894.pdf'
p1860
sa(dp1861
g3
VCD006165 v. 5.0 Interventions for latent autoimmune diabetes (LADA) in adults.rm5
p1862
sg5
S'PMC3022338'
p1863
sg7
VSTD-Thunander-2010
p1864
sg9
V21088056.xml
p1865
sg11
S'5f/09/EJE100901.PMC3022338.pdf'
p1866
sa(dp1867
g3
VCD005135 v. 5.2 Laser-assisted in-situ keratomileusis (LASIK) versus photorefractive keratectomy (PRK) for myopia.rm5
p1868
sg5
S'PMC3090298'
p1869
sg7
VSTD-Hatch-2011
p1870
sg9
V21573091.xml
p1871
sg11
S'd5/2c/opth-5-451.PMC3090298.pdf'
p1872
sa(dp1873
g3
VCD005085 v. 4.0 Oximes for acute organophosphate pesticide poisoning.rm5
p1874
sg5
S'PMC2696321'
p1875
sg7
VSTD-Eddleston-2009
p1876
sg9
V19564902.xml
p1877
sg11
S'a6/77/pmed.1000104.PMC2696321.pdf'
p1878
sa(dp1879
g3
VCD008893 v. 3.1 Effect of cocoa on blood pressure.rm5
p1880
sg5
S'PMC2712451'
p1881
sg7
VSTD-Ried-2009
p1882
sg9
V19583878.xml
p1883
sg11
S'b2/58/1472-6882-9-22.PMC2712451.pdf'
p1884
sa(dp1885
g3
g1880
sg5
S'PMC2270716'
p1886
sg7
VSTD-Fraga-2005
p1887
sg9
V15712594.xml
p1888
sg11
S'38/8f/CDI-12-011.PMC2270716.pdf'
p1889
sa(dp1890
g3
VCD007228 v. 4.0 Structured telephone support or telemonitoring programmes for patients with chronic heart failure.rm5
p1891
sg5
S'PMC1475568'
p1892
sg7
VSTD-DeWalt-2006
p1893
sg9
V16533388.xml
p1894
sg11
S'7b/55/1472-6963-6-30.PMC1475568.pdf'
p1895
sa(dp1896
g3
VCD007952 v. 2.6 Material incentives and enablers in the management of tuberculosis.rm5
p1897
sg5
S'PMC2767482'
p1898
sg7
VSTD-Martins-2009
p1899
sg9
V19858174.xml
p1900
sg11
g391
sa(dp1901
g3
VCD001781 v. 10.0 Topical treatments for cutaneous warts.rm5
p1902
sg5
S'PMC3109952'
p1903
sg7
VSTD-Cockayne-2011
p1904
sg9
V21652750.xml
p1905
sg11
S'b0/54/bmj.d3271.PMC3109952.pdf'
p1906
sa(dp1907
g3
g1902
sg5
S'PMC2703213'
p1908
sg7
VSTD-Fuchs-2004
p1909
sg9
V19675691.xml
p1910
sg11
S'58/a8/GMS-02-08.PMC2703213.pdf'
p1911
sa(dp1912
g3
VCD003366 v. 9.0 Taxane containing regimens for metastatic breast cancer.rm5
p1913
sg5
S'PMC2408916'
p1914
sg7
VSTD-TXT-Group
p1915
sg9
V12439707.xml
p1916
sg11
S'be/08/87-6600645a.PMC2408916.pdf'
p1917
sa(dp1918
g3
g1913
sg5
S'PMC2375384'
p1919
sg7
VSTD-Talbot
p1920
sg9
V11986765.xml
p1921
sg11
S'55/3b/86-6600261a.PMC2375384.pdf'
p1922
sa(dp1923
g3
VCD007407 v. 4.2 Psychological therapies for the management of chronic pain (excluding headache) in adults.rm5
p1924
sg5
S'PMC2649916'
p1925
sg7
VSTD-Lindell-2008
p1926
sg9
V19116007.xml
p1927
sg11
S'99/44/1471-2474-9-172.PMC2649916.pdf'
p1928
sa(dp1929
g3
VCD004843 v. 10.2 Music for pain relief.rm5
p1930
sg5
S'PMC2362603'
p1931
sg7
VSTD-Kotwal-1998
p1932
sg9
V18493472.xml
p1933
sg11
g1081
sa(dp1934
g3
VCD006829 v. 8.0 Combined corticosteroid and long-acting beta2-agonist in one inhaler versus long-acting beta2-agonis.rm5
p1935
sg5
S'PMC3580134'
p1936
sg7
VSTD-Rennard-2009
p1937
sg9
V19368417.xml
p1938
sg11
S'74/29/40265_2012_Article_69050549.PMC3580134.pdf'
p1939
sa(dp1940
g3
VCD004253 v. 10.0 Psychological interventions for women with metastatic breast cancer.rm5
p1941
sg5
S'PMC2360523'
p1942
sg7
VSTD-Aranda-2006
p1943
sg9
V16967054.xml
p1944
sg11
S'db/7b/95-6603320a.PMC2360523.pdf'
p1945
sa(dp1946
g3
VCD007651 v. 3.0 School-based physical activity programs for promoting physical activity and fitness in children and .rm5
p1947
sg5
S'PMC2556688'
p1948
sg7
VSTD-Jones-2008
p1949
sg9
V18718012.xml
p1950
sg11
S'00/a2/1479-5868-5-42.PMC2556688.pdf'
p1951
sa(dp1952
g3
g1947
sg5
S'PMC2827713'
p1953
sg7
VSTD-Kriemler-2010
p1954
sg9
V20179126.xml
p1955
sg11
S'b6/aa/bmj.c785.PMC2827713.pdf'
p1956
sa(dp1957
g3
g1947
sg5
S'PMC2758893'
p1958
sg7
VSTD-Gentile-2009
p1959
sg9
V19765270.xml
p1960
sg11
g618
sa(dp1961
g3
VCD008358 v. 3.0 Magnesium for alcohol withdrawal.rm5
p1962
sg5
S'PMC2265283'
p1963
sg7
VSTD-Poikolainen-2008
p1964
sg9
V18218147.xml
p1965
sg11
S'be/bd/1747-597X-3-1.PMC2265283.pdf'
p1966
sa(dp1967
g3
VCD005470 v. 5.0 Tailored interventions to overcome identified barriers to change effects on professional practice a.rm5
p1968
sg5
S'PMC1472695'
p1969
sg7
VSTD-Fretheim-2006
p1970
sg9
V16737346.xml
p1971
sg11
S'0b/0b/pmed.0030134.PMC1472695.pdf'
p1972
sa(dp1973
g3
VCD008955 v. 2.2 Interferon alpha for the adjuvant treatment of cutaneous melanoma.rm5
p1974
sg5
S'PMC2363881'
p1975
sg7
VSTD-Cameron-2001
p1976
sg9
V11379605.xml
p1977
sg11
S'37/10/84-6691623a.PMC2363881.pdf'
p1978
sa(dp1979
g3
VCD008270 v. 2.5 Abacavir-based triple nucleoside regimens for maintenance therapy in patients with HIV.rm5
p1980
sg5
S'PMC548524'
p1981
sg7
VSTD-Keiser-2005
p1982
sg9
V15647105.xml
p1983
sg11
S'a5/66/1471-2334-5-2.PMC548524.pdf'
p1984
sa(dp1985
g3
VCD005527 v. 5.4 Ribavirin monotherapy for chronic hepatitis C.rm5
p1986
sg5
S'PMC222984'
p1987
sg7
VSTD-Veldt-2003
p1988
sg9
V12948399.xml
p1989
sg11
S'6e/6e/1471-230X-3-24.PMC222984.pdf'
p1990
sa(dp1991
g3
VCD003930 v. 8.0 Restricting oral fluid and food intake during labour.rm5
p1992
sg5
S'PMC2660391'
p1993
sg7
VSTD-O_x0027_Sullivan-2009
p1994
sg9
V19318702.xml
p1995
sg11
S'99/d4/bmj.b784.PMC2660391.pdf'
p1996
sa(dp1997
g3
VCD002922 v. 9.2 Treatment for lupus nephritis.rm5
p1998
sg5
S'PMC3002764'
p1999
sg7
VSTD-MAINTAIN-Nephritis-Study
p2000
sg9
V20833738.xml
p2001
sg11
S'63/bd/ard-69-12-2083.PMC3002764.pdf'
p2002
sa(dp2003
g3
VMR000031 v. 2.3 Comparison of protocols and registry entries to published reports for randomised controlled trials.rm5
p2004
sg5
S'PMC2680945'
p2005
sg7
VSTD-Charles-2009
p2006
sg9
V19435763.xml
p2007
sg11
S'44/15/bmj.b1732.PMC2680945.pdf'
p2008
sa(dp2009
g3
VCD007464 v. 3.2 Chemotherapy for brain metastases from small cell lung cancer.rm5
p2010
sg5
S'PMC2634726'
p2011
sg7
VSTD-Neuhaus-2009
p2012
sg9
V19127261.xml
p2013
sg11
S'a2/b2/6604835a.PMC2634726.pdf'
p2014
sa(dp2015
g3
VCD004562 v. 7.0 LHRH agonists for adjuvant therapy of early breast cancer in premenopausal women.rm5
p2016
sg5
S'PMC2362097'
p2017
sg7
VSTD-MAM-01-GOCSI
p2018
sg9
V15668708.xml
p2019
sg11
S'5b/10/92-6602355a.PMC2362097.pdf'
p2020
sa(dp2021
g3
VCD000494 v. 11.0 Prostaglandins for preventing postpartum haemorrhage.rm5
p2022
sg5
S'PMC3041931'
p2023
sg7
VSTD-Pakistan-2011
p2024
sg9
V21176086.xml
p2025
sg11
S'c0/db/bjo0118-0353.PMC3041931.pdf'
p2026
sa(dp2027
g3
VCD008016 v. 3.2 Maintenance treatment with antipsychotic drugs for schizophrenia.rm5
p2028
sg5
S'PMC2924475'
p2029
sg7
VSTD-Chen-2010
p2030
sg9
V20724402.xml
p2031
sg11
S'6c/13/bmj.c4024.PMC2924475.pdf'
p2032
sa(dp2033
g3
g2028
sg5
S'PMC3172444'
p2034
sg7
VSTD-Channabasavanna-1987
p2035
sg9
V21927264.xml
p2036
sg11
g466
sa(dp2037
g3
VCD008926 v. 2.0 Toremifene versus tamoxifen for advanced breast cancer.rm5
p2038
sg5
S'PMC2223944'
p2039
sg7
VSTD-Pyrhonen-1997
p2040
sg9
V9231932.xml
p2041
sg11
S'8d/2e/brjcancer00166-0134.PMC2223944.pdf'
p2042
sa(dp2043
g3
VCD006602 v. 7.0 Monoclonal antibody for reducing the risk of respiratory syncytial virus infection in children.rm5
p2044
sg5
S'PMC2687544'
p2045
sg7
VSTD-Chirico-2009
p2046
sg9
V19490659.xml
p2047
sg11
S'85/fd/1824-7288-35-4.PMC2687544.pdf'
p2048
sa(dp2049
g3
g2044
sg5
S'PMC2816247'
p2050
sg7
VSTD-Nuijten-2010
p2051
sg9
V19967425.xml
p2052
sg11
S'3f/df/10198_2009_Article_206.PMC2816247.pdf'
p2053
sa(dp2054
g3
VCD004794 v. 3.0 Interventions to improve water quality for preventing diarrhoea.rm5
p2055
sg5
S'PMC2730258'
p2056
sg7
VSTD-Colford-2002
p2057
sg9
V11749745.xml
p2058
sg11
S'47/3e/00-1481_FinalR.PMC2730258.pdf'
p2059
sa(dp2060
g3
VCD004615 v. 5.2 Mannitol and other osmotic diuretics as adjuncts for treating cerebral malaria.rm5
p2061
sg5
S'PMC2147028'
p2062
sg7
VSTD-Namutangula-2007
p2063
sg9
V17958887.xml
p2064
sg11
S'73/3e/1475-2875-6-138.PMC2147028.pdf'
p2065
sa(dp2066
g3
VCD008226 v. 2.0 Lipid lowering efficacy of atorvastatin.rm5
p2067
sg5
S'PMC2681027'
p2068
sg7
VSTD-Rosenson-2009
p2069
sg9
V19265025.xml
p2070
sg11
S'c4/6f/zdc1087.PMC2681027.pdf'
p2071
sa(dp2072
g3
g2067
sg5
S'PMC2829413'
p2073
sg7
VSTD-Park-2010
p2074
sg9
V20195400.xml
p2075
sg11
S'd8/0a/kjim-25-27.PMC2829413.pdf'
p2076
sa(dp2077
g3
g2067
sg5
S'PMC3079135'
p2078
sg7
VSTD-Cho-2011
p2079
sg9
V21519514.xml
p2080
sg11
S'67/5a/kcj-41-149.PMC3079135.pdf'
p2081
sa(dp2082
g3
VCD009275 v. 2.0 Different types of dietary advice for women with gestational diabetes mellitus.rm5
p2083
sg5
S'PMC3198285'
p2084
sg7
VSTD-Louie-2011
p2085
sg9
V21900148.xml
p2086
sg11
S'28/60/2341.PMC3198285.pdf'
p2087
sa(dp2088
g3
g2083
sg5
S'PMC2681032'
p2089
sg7
VSTD-Moses-2009
p2090
sg9
V19279301.xml
p2091
sg11
g666
sa(dp2092
g3
VCD007913 v. 2.0 Primary prophylactic colony-stimulating factors for the prevention of chemotherapy-induced febrile n.rm5
p2093
sg5
S'PMC2628928'
p2094
sg7
VSTD-Del-Giglio-2008
p2095
sg9
V19014494.xml
p2096
sg11
S'e5/2f/1471-2407-8-332.PMC2628928.pdf'
p2097
sa(dp2098
g3
VCD006389 v. 3.0 Interventions to facilitate return to work in adults with adjustment disorders.rm5
p2099
sg5
S'PMC1885369'
p2100
sg7
VSTD-Bakker-2007
p2101
sg9
V17549228.xml
p2102
sg11
S'bc/4a/pctr.0020026.PMC1885369.pdf'
p2103
sa(dp2104
g3
VCD007566 v. 2.2 Exercise interventions on health-related quality of life for cancer survivors.rm5
p2105
sg5
S'PMC2826100'
p2106
sg7
VSTD-Oh-2010
p2107
sg9
V19880433.xml
p2108
sg11
S'b2/08/mdp479.PMC2826100.pdf'
p2109
sa(dp2110
g3
VCD005564 v. 6.0 Artemether-lumefantrine (six-dose regimen) for treating uncomplicated falciparum malaria.rm5
p2111
sg5
S'PMC1087200'
p2112
sg7
VSTD-Sutherland-2005
p2113
sg9
V15839740.xml
p2114
sg11
S'75/ac/pmed.0020092.PMC1087200.pdf'
p2115
sa(dp2116
g3
VCD003611 v. 7.0 Interventions for preventing post-operative atrial fibrillation in patients undergoing heart surgery.rm5
p2117
sg5
S'PMC1502073'
p2118
sg7
VSTD-Eslami-2005
p2119
sg9
V16943938.xml
p2120
sg11
S'f0/bd/ipej050005-00.PMC1502073.pdf'
p2121
sa(dp2122
g3
g2117
sg5
S'PMC3034455'
p2123
sg7
VSTD-Chavan-2010
p2124
sg9
V21358799.xml
p2125
sg11
S'30/f5/ipej100529-00.PMC3034455.pdf'
p2126
sa(dp2127
g3
VCD006870 v. 4.0 Statins for acute coronary syndrome.rm5
p2128
sg5
S'PMC2886041'
p2129
sg7
VSTD-FACS-2010
p2130
sg9
V20500832.xml
p2131
sg11
S'37/a6/1745-6215-11-61.PMC2886041.pdf'
p2132
sa(dp2133
g3
VCD002759 v. 7.0 Progressive resistance strength training for improving physical function in older adults.rm5
p2134
sg5
S'PMC1698486'
p2135
sg7
VSTD-Sims-2006
p2136
sg9
V17134517.xml
p2137
sg11
S'd9/20/1471-2318-6-18.PMC1698486.pdf'
p2138
sa(dp2139
g3
VCD007877 v. 2.0 Haemostatic drugs for traumatic brain injury.rm5
p2140
sg5
S'PMC2206502'
p2141
sg7
VSTD-Kluger-2007
p2142
sg9
V17686152.xml
p2143
sg11
S'1e/b2/cc6092.PMC2206502.pdf'
p2144
sa(dp2145
g3
VCD001187 v. 9.0 House dust mite control measures for asthma.rm5
p2146
sg5
S'PMC116603'
p2147
sg7
VSTD-Sheikh-2002
p2148
sg9
V12079502.xml
p2149
sg11
S'85/50/1471-2296-3-12.PMC116603.pdf'
p2150
sa(dp2151
g3
VCD003991 v. 10.0 Vasectomy occlusion techniques for male sterilization.rm5
p2152
sg5
S'PMC406425'
p2153
sg7
VSTD-Sokal-2004
p2154
sg9
V15056388.xml
p2155
sg11
S'87/00/1741-7015-2-6.PMC406425.pdf'
p2156
sa(dp2157
g3
VCD004958 v. 8.0 Single or double-level anterior interbody fusion techniques for cervical degenerative disc disease.rm5
p2158
sg5
S'PMC2899760'
p2159
sg7
VSTD-Lofgren-2010
p2160
sg9
V19763634.xml
p2161
sg11
S'01/6c/586_2009_Article_1161.PMC2899760.pdf'
p2162
sa(dp2163
g3
VCD007309 v. 5.0 Chemotherapy and supportive care versus supportive care alone for advanced non-small cell lung cance.rm5
p2164
sg5
S'PMC1971367'
p2165
sg7
VSTD-Southampton
p2166
sg9
V1691921.xml
p2167
sg11
g995
sa(dp2168
g3
g2164
sg5
S'PMC1971367'
p2169
sg7
VSTD-RLW-8351
p2170
sg9
V1691921.xml
p2171
sg11
g995
sa(dp2172
g3
g2164
sg5
S'PMC2374661'
p2173
sg7
VSTD-Manchester-1
p2174
sg9
V10945489.xml
p2175
sg11
S'fa/e3/83-6691307a.PMC2374661.pdf'
p2176
sa(dp2177
g3
VCD002256 v. 9.0 Treatments for symptomatic urinary tract infections during pregnancy.rm5
p2178
sg5
S'PMC2364502'
p2179
sg7
VSTD-Charleston-1996
p2180
sg9
V18476110.xml
p2181
sg11
S'38/cf/IDOG-04-294.PMC2364502.pdf'
p2182
sa(dp2183
g3
VCD008586 v. 2.0 Antiepileptic drugs for treating seizures in adults with brain tumours.rm5
p2184
sg5
S'PMC2687520'
p2185
sg7
VSTD-Lim-2009
p2186
sg9
V19169651.xml
p2187
sg11
S'84/38/11060_2008_Article_9781.PMC2687520.pdf'
p2188
sa(dp2189
g3
VCD002823 v. 8.2 Transcutaneous electrostimulation for osteoarthritis of the knee.rm5
p2190
sg5
S'PMC2268695'
p2191
sg7
VSTD-Itoh-2008
p2192
sg9
V18312661.xml
p2193
sg11
S'90/c5/1749-8546-3-2.PMC2268695.pdf'
p2194
sa(dp2195
g3
VCD007776 v. 3.0 Preconception care for diabetic women for improving maternal and infant health.rm5
p2196
sg5
S'PMC2453657'
p2197
sg7
VSTD-Charron_x002d_Prochownik-2008
p2198
sg9
V18411239.xml
p2199
sg11
S'93/0e/1327.PMC2453657.pdf'
p2200
sa(dp2201
g3
VCD002310 v. 11.2 Fluticasone versus beclomethasone or budesonide for chronic asthma in adults and children.rm5
p2202
sg5
S'PMC2365805'
p2203
sg7
VSTD-Ringdal-1996
p2204
sg9
V18475734.xml
p2205
sg11
S'a2/63/MI-05-382.PMC2365805.pdf'
p2206
sa(dp2207
g3
VCD009361 v. 2.2 Colesevelam for type 2 diabetes mellitus.rm5
p2208
sg5
S'PMC2494667'
p2209
sg7
VSTD-Fonseca-2008
p2210
sg9
V18458145.xml
p2211
sg11
S'e4/92/1479.PMC2494667.pdf'
p2212
sa(dp2213
g3
VCD004078 v. 4.0 Postoperative adjuvant chemotherapy in rectal cancer operated for cure..rm5
p2214
sg5
S'PMC2360162'
p2215
sg7
VSTD-Sakamoto-2007-_x0028_JFMTC15_x002d_1_x0029_
p2216
sg9
V17375049.xml
p2217
sg11
S'8f/13/6603686a.PMC2360162.pdf'
p2218
sa(dp2219
g3
g2214
sg5
S'PMC2363941'
p2220
sg7
VSTD-Taal-2001-_x0028_NACCP_x0029_
p2221
sg9
V11720425.xml
p2222
sg11
g1497
sa(dp2223
g3
VCD003318 v. 6.0 Strategies for integrating primary health services in low- and middle-income countries at the point .rm5
p2224
sg5
S'PMC2825497'
p2225
sg7
VSTD-Leon-2010
p2226
sg9
V20205841.xml
p2227
sg11
S'f3/2c/1748-5908-5-8.PMC2825497.pdf'
p2228
sa(dp2229
g3
g2224
sg5
S'PMC1831737'
p2230
sg7
VSTD-Gregson-2007
p2231
sg9
V17388666.xml
p2232
sg11
S'6f/5a/pmed.0040102.PMC1831737.pdf'
p2233
sa(dp2234
g3
VCD008776 v. 2.0 Computer-based diabetes self-management interventions for adults with type 2 diabetes mellitus.rm5
p2235
sg5
S'PMC2875437'
p2236
sg7
VSTD-Lorig-2010
p2237
sg9
V20299481.xml
p2238
sg11
S'5b/9a/zdc1275.PMC2875437.pdf'
p2239
sa(dp2240
g3
g2235
sg5
S'PMC3161305'
p2241
sg7
VSTD-Quinn-2011
p2242
sg9
V21788632.xml
p2243
sg11
S'ca/33/1934.PMC3161305.pdf'
p2244
sa(dp2245
g3
g2235
sg5
S'PMC3024339'
p2246
sg7
VSTD-Lim-2011
p2247
sg9
V21270188.xml
p2248
sg11
S'55/1c/308.PMC3024339.pdf'
p2249
sa(dp2250
g3
VCD005084 v. 6.0 Interventions for tobacco cessation in the dental setting.rm5
p2251
sg5
S'PMC1871574'
p2252
sg7
VSTD-Binnie-2007
p2253
sg9
V17475005.xml
p2254
sg11
S'99/fe/1472-6831-7-5.PMC1871574.pdf'
p2255
sa(dp2256
g3
g2251
sg5
S'PMC2685131'
p2257
sg7
VSTD-Nohlert-2009
p2258
sg9
V19405969.xml
p2259
sg11
S'83/b6/1471-2458-9-121.PMC2685131.pdf'
p2260
sa(dp2261
g3
VCD002748 v. 9.2 Prophylactic mastectomy for the prevention of breast cancer.rm5
p2262
sg5
S'PMC2361560'
p2263
sg7
VSTD-van-Sprundel-2005
p2264
sg9
V16052221.xml
p2265
sg11
S'98/62/93-6602703a.PMC2361560.pdf'
p2266
sa(dp2267
g3
VCD006895 v. 4.0 Probiotics for preventing acute upper respiratory tract infections.rm5
p2268
sg5
S'PMC2906750'
p2269
sg7
VSTD-Merenstein-2010
p2270
sg9
V20485304.xml
p2271
sg11
S'20/fb/ejcn201065a.PMC2906750.pdf'
p2272
sa(dp2273
g3
g2268
sg5
S'PMC3083335'
p2274
sg7
VSTD-West-2011
p2275
sg9
V21477383.xml
p2276
sg11
S'fe/5a/1475-2891-10-30.PMC3083335.pdf'
p2277
sa(dp2278
g3
VCD008603 v. 3.0 Oral vaccines for preventing cholera.rm5
p2279
sg5
S'PMC2396289'
p2280
sg7
VSTD-Mahalanabis-2008
p2281
sg9
V18523643.xml
p2282
sg11
S'3a/e5/pone.0002323.PMC2396289.pdf'
p2283
sa(dp2284
g3
VCD009671 v. 2.0 Selenium supplementation for the primary prevention of cardiovascular disease.rm5
p2285
sg5
S'PMC3446875'
p2286
sg7
VSTD-UK-PRECISE
p2287
sg9
V23028897.xml
p2288
sg11
S'ca/f8/pone.0045269.PMC3446875.pdf'
p2289
sa(dp2290
g3
VCD003362 v. 8.0 Male circumcision for prevention of heterosexual acquisition of HIV in men.rm5
p2291
sg5
S'PMC1262556'
p2292
sg7
VSTD-ANRS-1265
p2293
sg9
V16231970.xml
p2294
sg11
S'3b/49/pmed.0020298.PMC1262556.pdf'
p2295
sa(dp2296
g3
VCD003834 v. 5.0 Lithium for schizophrenia.rm5
p2297
sg5
S'PMC3012941'
p2298
sg7
VSTD-Dube-1981
p2299
sg9
V22058537.xml
p2300
sg11
S'88/0b/IJPsy-23-193.PMC3012941.pdf'
p2301
sa(dp2302
g3
VCD007694 v. 5.0 Regular treatment with formoterol and an inhaled corticosteroid versus regular treatment with salmet.rm5
p2303
sg5
S'PMC1920547'
p2304
sg7
VSTD-Kuna-2007
p2305
sg9
V17362472.xml
p2306
sg11
g1676
sa(dp2307
g3
g2303
sg5
S'PMC2993043'
p2308
sg7
VSTD-Maspero-2010
p2309
sg9
V20874458.xml
p2310
sg11
S'eb/19/ljas47-1106.PMC2993043.pdf'
p2311
sa(dp2312
g3
VCD001886 v. 8.0 Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion.rm5
p2313
sg5
S'PMC2246206'
p2314
sg7
VSTD-Jimenez-2007
p2315
sg9
V17988379.xml
p2316
sg11
S'75/a1/cc6173.PMC2246206.pdf'
p2317
sa(dp2318
g3
g2313
sg5
S'PMC2287179'
p2319
sg7
VSTD-Apostolakis-2008
p2320
sg9
V18361800.xml
p2321
sg11
S'dc/11/1749-8090-3-14.PMC2287179.pdf'
p2322
sa(dp2323
g3
VCD004323 v. 8.0 Quality of life after rectal resection for cancer with or without permanent colostomy..rm5
p2324
sg5
S'PMC3177872'
p2325
sg7
VSTD-Peng-2011
p2326
sg9
V21835046.xml
p2327
sg11
S'e9/16/1748-717X-6-93.PMC3177872.pdf'
p2328
sa(dp2329
g3
g2324
sg5
S'PMC2363346'
p2330
sg7
VSTD-Allal-2000
p2331
sg9
V10735495.xml
p2332
sg11
S'5c/e0/82-6691052a.PMC2363346.pdf'
p2333
sa(dp2334
g3
VCD006772 v. 4.0 Service organisation for the secondary prevention of ischaemic heart disease in primary care.rm5
p2335
sg5
S'PMC2770592'
p2336
sg7
VSTD-SPHERE
p2337
sg9
V19875426.xml
p2338
sg11
S'df/d8/bmj.b4220.PMC2770592.pdf'
p2339
sa(dp2340
g3
VCD004366 v. 11.2 Exercise for depression.rm5
p2341
sg5
S'PMC1976311'
p2342
sg7
VSTD-Pilu-2007
p2343
sg9
V17620123.xml
p2344
sg11
S'92/d9/1745-0179-3-8.PMC1976311.pdf'
p2345
sa(dp2346
g3
VCD006525 v. 5.0 Collaborative care for depression and anxiety problems.rm5
p2347
sg5
S'PMC3219630'
p2348
sg7
VSTD-Chaney-2011
p2349
sg9
V22032247.xml
p2350
sg11
S'05/ef/1748-5908-6-121.PMC3219630.pdf'
p2351
sa(dp2352
g3
g2347
sg5
S'PMC1838423'
p2353
sg7
VSTD-Landis-2007
p2354
sg9
V17338822.xml
p2355
sg11
S'49/d8/1471-2296-8-7.PMC1838423.pdf'
p2356
sa(dp2357
g3
g2347
sg5
S'PMC2770465'
p2358
sg7
VSTD-Richards-2012
p2359
sg9
V19832996.xml
p2360
sg11
S'd5/46/1472-6963-9-188.PMC2770465.pdf'
p2361
sa(dp2362
g3
g2347
sg5
S'PMC3051073'
p2363
sg7
VSTD-Waitzkin-2011
p2364
sg9
V20882400.xml
p2365
sg11
S'de/ca/10900_2010_Article_9313.PMC3051073.pdf'
p2366
sa(dp2367
g3
g2347
sg5
S'PMC2845010'
p2368
sg7
VSTD-Ell-2010
p2369
sg9
V20097780.xml
p2370
sg11
S'ab/2a/zdc706.PMC2845010.pdf'
p2371
sa(dp2372
g3
VCD002243 v. 5.2 Corticosteroids for treating severe sepsis and septic shock.rm5
p2373
sg5
S'PMC125315'
p2374
sg7
VSTD-Yildiz-2002
p2375
sg9
V12133187.xml
p2376
sg11
S'17/a1/cc1498.PMC125315.pdf'
p2377
sa(dp2378
g3
VCD005265 v. 3.3 Antibiotic prophylaxis for patients undergoing elective laparoscopic cholecystectomy.rm5
p2379
sg5
S'PMC3015970'
p2380
sg7
VSTD-Uludag-2009
p2381
sg9
V19793473.xml
p2382
sg11
S'75/80/jsls-13-3-337.PMC3015970.pdf'
p2383
sa(dp2384
g3
VCD005495 v. 5.2 Early developmental intervention programmes post-hospital discharge to prevent motor and cognitive i.rm5
p2385
sg5
S'PMC2797495'
p2386
sg7
VSTD-Spittle-2009a
p2387
sg9
V19954550.xml
p2388
sg11
S'7b/88/1471-2431-9-73.PMC2797495.pdf'
p2389
sa(dp2390
g3
VCD009235 v. 5.3 Automated versus non-automated weaning for reducing the duration of mechanical ventilation for criti.rm5
p2391
sg5
S'PMC2688118'
p2392
sg7
VSTD-Taniguchi-2009
p2393
sg9
V19171056.xml
p2394
sg11
S'4b/2e/cc7695.PMC2688118.pdf'
p2395
sa(dp2396
g3
VCD005535 v. 3.0 Addition of long-acting beta2-agonists to inhaled corticosteroids versus same dose inhaled corticost.rm5
p2397
sg5
S'PMC1971055'
p2398
sg7
VSTD-Houghton-2007
p2399
sg9
V17629923.xml
p2400
sg11
S'e8/e8/1465-9921-8-52.PMC1971055.pdf'
p2401
sa(dp2402
g3
VCD001990 v. 12.0 Chemotherapy versus best supportive care for extensive small cell lung cancer.rm5
p2403
sg5
S'PMC2247136'
p2404
sg7
VSTD-Spiro-1989
p2405
sg9
V2540788.xml
p2406
sg11
S'36/25/brjcancer00126-0096.PMC2247136.pdf'
p2407
sa(dp2408
g3
VCD003218 v. 9.0 Psychostimulants for hypersomnia (excessive daytime sleepiness) in myotonic dystrophy.rm5
p2409
sg5
S'PMC1915648'
p2410
sg7
VSTD-Wintzen-2007
p2411
sg9
V17285226.xml
p2412
sg11
S'a7/d6/415_2006_Article_186.PMC1915648.pdf'
p2413
sa(dp2414
g3
VCD008088 v. 6.0 Anti-TNF- treatment for pelvic pain associated with endometriosis.rm5
p2415
sg5
S'PMC2517154'
p2416
sg7
VSTD-Koninckx-2008
p2417
sg9
V18556683.xml
p2418
sg11
S'3c/cd/den177.PMC2517154.pdf'
p2419
sa(dp2420
g3
VCD006378 v. 3.0 Aspirin steroidal and non-steroidal anti-inflammatory drugs for the treatment of Alzheimer's diseas.rm5
p2421
sg5
S'PMC2194921'
p2422
sg7
VSTD-De-Jong-2008
p2423
sg9
V18213383.xml
p2424
sg11
S'49/06/pone.0001475.PMC2194921.pdf'
p2425
sa(dp2426
g3
VCD006876 v. 4.0 Electromechanical and robot-assisted arm training for improving generic activities of daily living .rm5
p2427
sg5
S'PMC1819386'
p2428
sg7
VSTD-Amirabdollahian-2007
p2429
sg9
V17309791.xml
p2430
sg11
S'21/72/1743-0003-4-4.PMC1819386.pdf'
p2431
sa(dp2432
g3
g2427
sg5
S'PMC1550245'
p2433
sg7
VSTD-Kahn-2006
p2434
sg9
V16790067.xml
p2435
sg11
S'ff/cc/1743-0003-3-12.PMC1550245.pdf'
p2436
sa(dp2437
g3
VCD007139 v. 3.0 Alprazolam for depression.rm5
p2438
sg5
S'PMC2988295'
p2439
sg7
VSTD-Murthy-1991
p2440
sg9
V21897464.xml
p2441
sg11
S'70/be/IJPsy-33-104.PMC2988295.pdf'
p2442
sa(dp2443
g3
VCD004082 v. 11.0 Perioperative increase in global blood flow to explicit defined goals and outcomes following surgery.rm5
p2444
sg5
S'PMC2945135'
p2445
sg7
VSTD-Jhanji-2010
p2446
sg9
V20698956.xml
p2447
sg11
S'74/20/cc9220.PMC2945135.pdf'
p2448
sa(dp2449
g3
g2444
sg5
S'PMC3218998'
p2450
sg7
VSTD-Cecconi-2011
p2451
sg9
V21624138.xml
p2452
sg11
S'ea/91/cc10246.PMC3218998.pdf'
p2453
sa(dp2454
g3
g2444
sg5
S'PMC1414018'
p2455
sg7
VSTD-Pearse-2005
p2456
sg9
V16356219.xml
p2457
sg11
S'fa/f1/cc3887.PMC1414018.pdf'
p2458
sa(dp2459
g3
g2444
sg5
S'PMC2875533'
p2460
sg7
VSTD-Mayer-2010
p2461
sg9
V20156348.xml
p2462
sg11
S'e1/c6/cc8875.PMC2875533.pdf'
p2463
sa(dp2464
g3
VCD007091 v. 5.0 5-alpha-reductase inhibitors for prostate cancer prevention.rm5
p2465
sg5
S'PMC2063039'
p2466
sg7
VSTD-Cote-1998
p2467
sg9
V9703292.xml
p2468
sg11
S'bf/87/brjcancer00003-0137.PMC2063039.pdf'
p2469
sa(dp2470
g3
VCD000214 v. 10.5 Training health professionals in smoking cessation.rm5
p2471
sg5
S'PMC1829425'
p2472
sg7
VSTD-Unrod-2007
p2473
sg9
V17372796.xml
p2474
sg11
g816
sa(dp2475
g3
VMR000012 v. 6.2 Randomisation to protect against selection bias in healthcare trials.rm5
p2476
sg5
S'PMC126226'
p2477
sg7
VSTD-Clifford-2002
p2478
sg9
V12213183.xml
p2479
sg11
g1436
sa(dp2480
g3
VCD003236 v. 7.0 Exercise training for adults with chronic kidney disease.rm5
p2481
sg5
S'PMC2796994'
p2482
sg7
VSTD-Leehey-2009
p2483
sg9
V20003224.xml
p2484
sg11
S'b9/1d/1475-2840-8-62.PMC2796994.pdf'
p2485
sa(dp2486
g3
VCD007400 v. 4.0 Topical NSAIDs for chronic musculoskeletal pain in adults.rm5
p2487
sg5
S'PMC1201146'
p2488
sg7
VSTD-Baer-2005
p2489
sg9
V16086839.xml
p2490
sg11
S'5d/1a/1471-2474-6-44.PMC1201146.pdf'
p2491
sa(dp2492
g3
VCD004697 v. 6.0 Prophylactic antibiotics to reduce morbidity and mortality in neonates with umbilical artery cathete.rm5
p2493
sg5
S'PMC2595562'
p2494
sg7
VSTD-Cowett-1977
p2495
sg9
V602256.xml
p2496
sg11
S'59/7e/yjbm00140-0025.PMC2595562.pdf'
p2497
sa(dp2498
g3
VCD007961 v. 2.0 Topical microbicides for prevention of sexually transmitted infections.rm5
p2499
sg5
S'PMC2582655'
p2500
sg7
VSTD-Halpern-2008
p2501
sg9
V19023429.xml
p2502
sg11
S'b8/d5/pone.0003784.PMC2582655.pdf'
p2503
sa(dp2504
g3
g2499
sg5
S'PMC2129116'
p2505
sg7
VSTD-Peterson-2007
p2506
sg9
V18091987.xml
p2507
sg11
S'7a/68/pone.0001312.PMC2129116.pdf'
p2508
sa(dp2509
g3
g2499
sg5
S'PMC2190795'
p2510
sg7
VSTD-Feldblum-2008
p2511
sg9
V18213382.xml
p2512
sg11
S'54/e8/pone.0001474.PMC2190795.pdf'
p2513
sa(dp2514
g3
VCD004769 v. 7.0 Oxygen therapy for dyspnoea in adults.rm5
p2515
sg5
S'PMC2409543'
p2516
sg7
VSTD-Ahmedzai-2004
p2517
sg9
V14735178.xml
p2518
sg11
S'76/e9/90-6601527a.PMC2409543.pdf'
p2519
sa(dp2520
g3
VCD003808 v. 6.0 Operative caries management in adults and children.rm5
p2521
sg5
S'PMC2265270'
p2522
sg7
VSTD-Innes-2007
p2523
sg9
V18096042.xml
p2524
sg11
S'cc/f9/1472-6831-7-18.PMC2265270.pdf'
p2525
sa(dp2526
g3
VCD004123 v. 9.2 Hyperbaric oxygen therapy for chronic wounds.rm5
p2527
sg5
S'PMC2858204'
p2528
sg7
VSTD-Londahl-2010
p2529
sg9
V20427683.xml
p2530
sg11
S'04/e9/zdc998.PMC2858204.pdf'
p2531
sa(dp2532
g3
VCD003175 v. 6.0 Adjuvant chemotherapy for endometrial cancer after hysterectomy.rm5
p2533
sg5
S'PMC2360651'
p2534
sg7
VSTD-GICOG
p2535
sg9
V16868539.xml
p2536
sg11
S'92/eb/95-6603279a.PMC2360651.pdf'
p2537
sa(dp2538
g3
VCD003222 v. 5.0 Transcutaneous electrical nerve stimulation (TENS) for chronic pain.rm5
p2539
sg5
S'PMC3476076'
p2540
sg7
VSTD-Oosterhof-2006
p2541
sg9
V16897618.xml
p2542
sg11
S'e5/b4/10194_2006_Article_309.PMC3476076.pdf'
p2543
sa(dp2544
g3
VCD001446 v. 14.0 Corticosteroids for Guillain-Barr syndrome.rm5
p2545
sg5
S'PMC2778673'
p2546
sg7
VSTD-Van-Koningsveld-2004
p2547
sg9
V17426908.xml
p2548
sg11
S'b7/83/415_2006_Article_515.PMC2778673.pdf'
p2549
sa(dp2550
g3
VCD001287 v. 10.6 Mucolytic agents for chronic bronchitis or chronic obstructive pulmonary disease.rm5
p2551
sg5
S'PMC2720945'
p2552
sg7
VSTD-Worth-2009
p2553
sg9
V19624838.xml
p2554
sg11
S'b7/51/1465-9921-10-69.PMC2720945.pdf'
p2555
sa(dp2556
g3
VCD007881 v. 3.0 Interventions for cough in cancer.rm5
p2557
sg5
S'PMC2074576'
p2558
sg7
VSTD-Moroni-1996
p2559
sg9
V8688342.xml
p2560
sg11
S'e5/e9/brjcancer00018-0149.PMC2074576.pdf'
p2561
sa(dp2562
g3
VCD007798 v. 3.0 Clinically-indicated replacement versus routine replacement of peripheral venous catheters.rm5
p2563
sg5
S'PMC2483870'
p2564
sg7
VSTD-Webster-2008
p2565
sg9
V18614482.xml
p2566
sg11
S'e6/c2/bmj-337-7662-res-00157-el.PMC2483870.pdf'
p2567
sa(dp2568
g3
g2563
sg5
S'PMC2944158'
p2569
sg7
VSTD-Rickard-2010
p2570
sg9
V20831782.xml
p2571
sg11
S'e7/4f/1741-7015-8-53.PMC2944158.pdf'
p2572
sa(dp2573
g3
VCD003048 v. 6.0 Probiotics for treating acute infectious diarrhoea.rm5
p2574
sg5
S'PMC1802727'
p2575
sg7
VSTD-Henker-2007a
p2576
sg9
V17287932.xml
p2577
sg11
S'40/76/431_2007_Article_419.PMC1802727.pdf'
p2578
sa(dp2579
g3
VCD002892 v. 7.0 Preventing occupational stress in healthcare workers.rm5
p2580
sg5
S'PMC2395320'
p2581
sg7
VSTD-Delvaux-2004
p2582
sg9
V14710215.xml
p2583
sg11
S'c5/50/90-6601459a.PMC2395320.pdf'
p2584
sa(dp2585
g3
VCD002808 v. 6.0 Depot versus daily administration of gonadotrophin-releasing hormone agonist protocols for pituitary.rm5
p2586
sg5
S'PMC3302709'
p2587
sg7
VSTD-Tehraninejad-2010
p2588
sg9
V22427771.xml
p2589
sg11
S'5e/fb/AMS-6-6-945.PMC3302709.pdf'
p2590
sa(dp2591
g3
VCD009611 v. 3.0 Intermittent versus daily inhaled corticosteroids for persistent asthma in children and adults.rm5
p2592
sg5
S'PMC2532957'
p2593
sg7
VSTD-Turpeinen-2008
p2594
sg9
V17634183.xml
p2595
sg11
S'62/a1/ADC-93-08-0654.PMC2532957.pdf'
p2596
sa(dp2597
g3
VCD004260 v. 8.0 Continuous passive motion following total knee arthroplasty in people with arthritis.rm5
p2598
sg5
S'PMC2386789'
p2599
sg7
VSTD-Lenssen-2008
p2600
sg9
V18442423.xml
p2601
sg11
g194
sa(dp2602
g3
VCD005992 v. 4.0 Legislative smoking bans for reducing secondhand smoke exposure smoking prevalence and tobacco cons.rm5
p2603
sg5
S'PMC2621339'
p2604
sg7
VSTD-Fern_x00e1_ndez-2009
p2605
sg9
V19165321.xml
p2606
sg11
S'b5/be/pone.0004244.PMC2621339.pdf'
p2607
sa(dp2608
g3
g2603
sg5
S'PMC2034550'
p2609
sg7
VSTD-Gal_x00e1_n-2007
p2610
sg9
V17760974.xml
p2611
sg11
S'a0/23/1471-2458-7-224.PMC2034550.pdf'
p2612
sa(dp2613
g3
VCD009285 v. 4.0 Tiotropium versus placebo for chronic obstructive pulmonary disease.rm5
p2614
sg5
S'PMC2629970'
p2615
sg7
VSTD-Tonnel-2008
p2616
sg9
V18686739.xml
p2617
sg11
S'1a/31/COPD-3-301.PMC2629970.pdf'
p2618
sa(dp2619
g3
g2614
sg5
S'PMC2921687'
p2620
sg7
VSTD-Bateman-2010b
p2621
sg9
V20714373.xml
p2622
sg11
S'7d/c9/copd-5-197.PMC2921687.pdf'
p2623
sa(dp2624
g3
g2614
sg5
S'PMC1913915'
p2625
sg7
VSTD-Freeman-2007
p2626
sg9
V17605774.xml
p2627
sg11
S'61/59/1465-9921-8-45.PMC1913915.pdf'
p2628
sa(dp2629
g3
g2614
sg5
S'PMC3078679'
p2630
sg7
VSTD-Trooster-2011
p2631
sg9
V21503263.xml
p2632
sg11
S'd0/1e/TORMJ-5-1.PMC3078679.pdf'
p2633
sa(dp2634
g3
g2614
sg5
S'PMC2981152'
p2635
sg7
VSTD-Cooper-2010
p2636
sg9
V21103404.xml
p2637
sg11
S'29/b2/copd-5-375.PMC2981152.pdf'
p2638
sa(dp2639
g3
VCD003423 v. 4.2 Antihistamines andor decongestants for otitis media with effusion (OME) in children.rm5
p2640
sg5
S'PMC2671765'
p2641
sg7
VSTD-Choung-2008
p2642
sg9
V19434268.xml
p2643
sg11
g1087
sa(dp2644
g3
VCD008216 v. 3.0 Autologous hematopoietic stem cell transplantation following high-dose chemotherapy for non-rhabdomy.rm5
p2645
sg5
S'PMC2394317'
p2646
sg7
VSTD-Bertuzzi-2003
p2647
sg9
V14520438.xml
p2648
sg11
S'72/e8/89-6601304a.PMC2394317.pdf'
p2649
sa(dp2650
g3
VCD005457 v. 7.0 Carbetocin for preventing postpartum haemorrhage.rm5
p2651
sg5
S'PMC1804104'
p2652
sg7
VSTD-Leung-2006
p2653
sg9
V17176279.xml
p2654
sg11
S'59/f9/bjo0113-1459.PMC1804104.pdf'
p2655
sa(dp2656
g3
VCD001544 v. 8.0 Mechanical bowel preparation for elective colorectal surgery.rm5
p2657
sg5
S'PMC2873340'
p2658
sg7
VSTD-Scabini-2010
p2659
sg9
V20433721.xml
p2660
sg11
S'98/30/1477-7819-8-35.PMC2873340.pdf'
p2661
sa(dp2662
g3
VCD007754 v. 3.0 Community-based intervention packages for reducing maternal and neonatal morbidity and mortality and.rm5
p2663
sg5
S'PMC3001155'
p2664
sg7
VSTD-Syed-2006
p2665
sg9
V17591348.xml
p2666
sg11
S'12/bb/jhpn0024-0508.PMC3001155.pdf'
p2667
sa(dp2668
g3
g2663
sg5
S'PMC3001156'
p2669
sg7
VSTD-Bari-2006
p2670
sg9
V17591349.xml
p2671
sg11
S'88/1d/jhpn0024-0519.PMC3001156.pdf'
p2672
sa(dp2673
g3
VCD000528 v. 8.4 Drugs for treating Schistosoma mansoni infection.rm5
p2674
sg5
S'PMC2666740'
p2675
sg7
VSTD-Tweyongyere-2009-UGA
p2676
sg9
V19296834.xml
p2677
sg11
S'cf/c3/1471-2334-9-32.PMC2666740.pdf'
p2678
sa(dp2679
g3
g2674
sg5
S'PMC3114749'
p2680
sg7
VSTD-Olliaro-2011-TZA
p2681
sg9
V21695161.xml
p2682
sg11
S'c7/e3/pntd.0001165.PMC3114749.pdf'
p2683
sa(dp2684
g3
g2674
sg5
S'PMC3114749'
p2685
sg7
VSTD-Olliaro-2011-MRT
p2686
sg9
V21695161.xml
p2687
sg11
g2683
sa(dp2688
g3
g2674
sg5
S'PMC3114749'
p2689
sg7
VSTD-Olliaro-2011-BRA
p2690
sg9
V21695161.xml
p2691
sg11
g2683
sa(dp2692
g3
VCD009514 v. 1.0 Relaxation techniques for pain management in labour.rm5
p2693
sg5
S'PMC2759981'
p2694
sg7
VSTD-Bergstrom-2009
p2695
sg9
V19538406.xml
p2696
sg11
S'49/6b/bjo0116-1167.PMC2759981.pdf'
p2697
sa(dp2698
g3
VCD004108 v. 9.0 Nedocromil sodium for chronic asthma in children.rm5
p2699
sg5
S'PMC2365600'
p2700
sg7
VSTD-Fiocchi-1994
p2701
sg9
V18475604.xml
p2702
sg11
S'96/d3/MI-03-S43.PMC2365600.pdf'
p2703
sa(dp2704
g3
VCD004015 v. 6.3 Lay health workers in primary and community health care for maternal and child health and the manage.rm5
p2705
sg5
S'PMC2287184'
p2706
sg7
VSTD-Kouyate-2008
p2707
sg9
V18364043.xml
p2708
sg11
g444
sa(dp2709
g3
g2705
sg5
S'PMC2636685'
p2710
sg7
VSTD-MacArthur-2009
p2711
sg9
V19181730.xml
p2712
sg11
g1849
sa(dp2713
g3
g2705
sg5
S'PMC3001156'
p2714
sg7
VSTD-Bari-2006
p2715
sg9
V17591349.xml
p2716
sg11
g2672
sa(dp2717
g3
g2705
sg5
S'PMC2628301'
p2718
sg7
VSTD-Dennis-2009
p2719
sg9
V19147637.xml
p2720
sg11
S'f3/6a/bmj.a3064.PMC2628301.pdf'
p2721
sa(dp2722
g3
g2705
sg5
S'PMC2740673'
p2723
sg7
VSTD-Zaman-2008
p2724
sg9
V18686554.xml
p2725
sg11
S'61/fd/jhpn0026-0210.PMC2740673.pdf'
p2726
sa(dp2727
g3
VCD001090 v. 10.5 Intravenous immunoglobulin for treating sepsis severe sepsis and septic shock.rm5
p2728
sg5
S'PMC153443'
p2729
sg7
VSTD-Karatzas-2002
p2730
sg9
V12512504.xml
p2731
sg11
S'9b/af/cc1837.PMC153443.pdf'
p2732
sa(dp2733
g3
g2728
sg5
S'PMC125317'
p2734
sg7
VSTD-Tugrul-2002
p2735
sg9
V12225613.xml
p2736
sg11
S'41/5a/cc1523.PMC125317.pdf'
p2737
sa(dp2738
g3
VCD001293 v. 13.0 School-based programmes for preventing smoking.rm5
p2739
sg5
S'PMC2681204'
p2740
sg7
VSTD-Johnson-2009
p2741
sg9
V19440519.xml
p2742
sg11
S'ae/71/ijerph-06-01298.PMC2681204.pdf'
p2743
sa(dp2744
g3
VCD000054 v. 10.0 Interventions for treating genital chlamydia trachomatis infection in pregnancy.rm5
p2745
sg5
S'PMC2364515'
p2746
sg7
VSTD-Edwards-1996
p2747
sg9
V18476121.xml
p2748
sg11
S'34/40/IDOG-04-333.PMC2364515.pdf'
p2749
sa(dp2750
g3
g2745
sg5
S'PMC2364533'
p2751
sg7
VSTD-Martin-1997
p2752
sg9
V18476128.xml
p2753
sg11
S'3f/58/IDOG-05-010.PMC2364533.pdf'
p2754
sa(dp2755
g3
g2745
sg5
S'PMC2364446'
p2756
sg7
VSTD-Rosenn-1995
p2757
sg9
V18476049.xml
p2758
sg11
S'99/91/IDOG-03-241.PMC2364446.pdf'
p2759
sa(dp2760
g3
g2745
sg5
S'PMC2364394'
p2761
sg7
VSTD-Turrentine-1995
p2762
sg9
V18475393.xml
p2763
sg11
S'cb/aa/IDOG-02-205.PMC2364394.pdf'
p2764
sa(dp2765
g3
VCD006099 v. 6.0 Wound drains following thyroid surgery.rm5
p2766
sg5
S'PMC1156915'
p2767
sg7
VSTD-Khanna-2005
p2768
sg9
V15946379.xml
p2769
sg11
S'ee/f4/1471-2482-5-11.PMC1156915.pdf'
p2770
sa(dp2771
g3
VCD008492 v. 3.0 Artemisinin-based combination therapy for treating uncomplicated Plasmodium vivax malaria.rm5
p2772
sg5
S'PMC2864284'
p2773
sg7
VSTD-Awab-2010-AFG
p2774
sg9
V20409302.xml
p2775
sg11
S'ec/a1/1475-2875-9-105.PMC2864284.pdf'
p2776
sa(dp2777
g3
g2772
sg5
S'PMC1261533'
p2778
sg7
VSTD-Hutagalung-2005-THA
p2779
sg9
V16179089.xml
p2780
sg11
S'b7/33/1475-2875-4-46.PMC1261533.pdf'
p2781
sa(dp2782
g3
g2772
sg5
S'PMC3022577'
p2783
sg7
VSTD-Poravuth-2010-ASIA
p2784
sg9
V21267072.xml
p2785
sg11
S'b9/05/pone.0014501.PMC3022577.pdf'
p2786
sa(dp2787
g3
VCD005231 v. 5.0 Interventions to reduce harm from continued tobacco use.rm5
p2788
sg5
S'PMC2792228'
p2789
sg7
VSTD-Kralikova-2009
p2790
sg9
V19943947.xml
p2791
sg11
S'cc/d6/1471-2458-9-433.PMC2792228.pdf'
p2792
sa(dp2793
g3
VCD004376 v. 5.0 Exercise for osteoarthritis of the knee.rm5
p2794
sg5
S'PMC1187893'
p2795
sg7
VSTD-Thorstensson-2005
p2796
sg9
V15924620.xml
p2797
sg11
S'85/8c/1471-2474-6-27.PMC1187893.pdf'
p2798
sa(dp2799
g3
VCD006655 v. 4.0 Laparoscopy versus laparotomy for the management of early stage endometrial cancer.rm5
p2800
sg5
S'PMC3015649'
p2801
sg7
VSTD-Zorlu-2005
p2802
sg9
V16381364.xml
p2803
sg11
S'8f/a3/jsls-9-4-442.PMC3015649.pdf'
p2804
sa(dp2805
g3
VCD008039 v. 4.0 Ibuprofen with or without an antiemetic for acute migraine headaches in adults.rm5
p2806
sg5
S'PMC3476139'
p2807
sg7
VSTD-Misra-2007
p2808
sg9
V17563841.xml
p2809
sg11
S'04/89/10194_2007_Article_386.PMC3476139.pdf'
p2810
sa(dp2811
g3
VCD007315 v. 2.0 Perioperative glycaemic control for diabetic patients undergoing surgery.rm5
p2812
sg5
S'PMC2671976'
p2813
sg7
VSTD-Chan-2008
p2814
sg9
V19142552.xml
p2815
sg11
S'0c/5f/cln64_1p0051.PMC2671976.pdf'
p2816
sa(dp2817
g3
VCD008651 v. 3.0 Stavudine or zidovudine in three-drug combination therapy for initial treatment of HIV infection in .rm5
p2818
sg5
S'PMC2597744'
p2819
sg7
VSTD-Li-2008
p2820
sg9
V19081791.xml
p2821
sg11
S'97/5d/pone.0003918.PMC2597744.pdf'
p2822
sa(dp2823
g3
VCD002200 v. 5.0 Follow-up strategies for patients treated for non-metastatic colorectal cancer.rm5
p2824
sg5
S'PMC2361245'
p2825
sg7
VSTD-Wattchow-2006
p2826
sg9
V16622437.xml
p2827
sg11
S'aa/da/94-6603052a.PMC2361245.pdf'
p2828
sa(dp2829
g3
VCD002967 v. 10.0 Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus.rm5
p2830
sg5
S'PMC2744824'
p2831
sg7
VSTD-Russell_x002d_Jones-2009
p2832
sg9
V19688338.xml
p2833
sg11
S'a4/5b/125_2009_Article_1472.PMC2744824.pdf'
p2834
sa(dp2835
g3
g2830
sg5
S'PMC1974817'
p2836
sg7
VSTD-Home-2007
p2837
sg9
V17403121.xml
p2838
sg11
S'd1/a1/dme0024-0618.PMC1974817.pdf'
p2839
sa(dp2840
g3
g2830
sg5
S'PMC2699702'
p2841
sg7
VSTD-Zinman-2009
p2842
sg9
V19289857.xml
p2843
sg11
S'86/69/zdc1224.PMC2699702.pdf'
p2844
sa(dp2845
g3
g2830
sg5
S'PMC2660449'
p2846
sg7
VSTD-List-2009
p2847
sg9
V19114612.xml
p2848
sg11
S'bb/43/zdc650.PMC2660449.pdf'
p2849
sa(dp2850
g3
g2830
sg5
S'PMC2699710'
p2851
sg7
VSTD-Nauck-2009b
p2852
sg9
V19366970.xml
p2853
sg11
S'a6/07/zdc1237.PMC2699710.pdf'
p2854
sa(dp2855
g3
g2830
sg5
S'PMC2606836'
p2856
sg7
VSTD-Nauck-2009a
p2857
sg9
V18931095.xml
p2858
sg11
S'f2/9a/84.PMC2606836.pdf'
p2859
sa(dp2860
g3
VCD004690 v. 6.0 Cognitive behavioural therapy for anxiety disorders in children and adolescents.rm5
p2861
sg5
S'PMC3058082'
p2862
sg7
VSTD-Melfsen-2011
p2863
sg9
V21356037.xml
p2864
sg11
S'f8/7c/1753-2000-5-5.PMC3058082.pdf'
p2865
sa(dp2866
g3
VCD000146 v. 19.3 Nicotine replacement therapy for smoking cessation.rm5
p2867
sg5
S'PMC3432241'
p2868
sg7
VSTD-T_x00f8_nnesen-2012
p2869
sg9
V22323576.xml
p2870
sg11
S'4f/b6/erj-40-03-548.PMC3432241.pdf'
p2871
sa(dp2872
g3
VCD006383 v. 3.2 Insulin detemir versus insulin glargine for type 2 diabetes mellitus.rm5
p2873
sg5
S'PMC2235909'
p2874
sg7
VSTD-Rosenstock-2008
p2875
sg9
V18204830.xml
p2876
sg11
S'df/fe/125_2007_Article_911.PMC2235909.pdf'
p2877
sa(dp2878
g3
g2873
sg5
S'PMC2875419'
p2879
sg7
VSTD-Swinnen-2010a
p2880
sg9
V20200301.xml
p2881
sg11
S'47/81/zdc1176.PMC2875419.pdf'
p2882
sa(dp2883
g3
VCD006474 v. 4.0 Prebiotics in infants for prevention of allergy.rm5
p2884
sg5
S'PMC2579424'
p2885
sg7
VSTD-Westerbeek-2010
p2886
sg9
V18947426.xml
p2887
sg11
S'b2/97/1471-2431-8-46.PMC2579424.pdf'
p2888
sa(dp2889
g3
VCD006616 v. 3.2 N-acetylcysteine for sepsis and systemic inflammatory response in adults.rm5
p2890
sg5
S'PMC522835'
p2891
sg7
VSTD-Emet-2004
p2892
sg9
V15312215.xml
p2893
sg11
S'92/22/cc2866.PMC522835.pdf'
p2894
sa(dp2895
g3
VCD004250 v. 8.7 Exercises for mechanical neck disorders.rm5
p2896
sg5
S'PMC2758937'
p2897
sg7
VSTD-Kuijper-2009
p2898
sg9
V19812130.xml
p2899
sg11
S'a5/a7/bmj.b3883.PMC2758937.pdf'
p2900
sa(dp2901
g3
g2896
sg5
S'PMC3045999'
p2902
sg7
VSTD-Martel-2011
p2903
sg9
V21303529.xml
p2904
sg11
S'51/39/1471-2474-12-41.PMC3045999.pdf'
p2905
sa(dp2906
g3
VCD007287 v. 2.0 Antigen-specific active immunotherapy for ovarian cancer.rm5
p2907
sg5
S'PMC2644666'
p2908
sg7
VSTD-Str_x00f6_hlein-2009
p2909
sg9
V19216794.xml
p2910
sg11
S'80/66/1756-9966-28-18.PMC2644666.pdf'
p2911
sa(dp2912
g3
VCD002140 v. 7.0 Concurrent chemoradiotherapy in non-small cell lung cancer.rm5
p2913
sg5
S'PMC2361263'
p2914
sg7
VSTD-Manegold-2003
p2915
sg9
V16641904.xml
p2916
sg11
S'b7/f9/94-6603115a.PMC2361263.pdf'
p2917
sa(dp2918
g3
VCD003908 v. 8.0 Rehabilitation interventions for foot drop in neuromuscular disease.rm5
p2919
sg5
S'PMC2779375'
p2920
sg7
VSTD-van-der-Kooi-2007
p2921
sg9
V17361345.xml
p2922
sg11
S'db/07/415_2006_Article_432.PMC2779375.pdf'
p2923
sa(dp2924
g3
VCD001220 v. 8.2 Population-based biomedical sexually transmitted infection control interventions for reducing HIV in.rm5
p2925
sg5
S'PMC1831737'
p2926
sg7
VSTD-Gregson-2007
p2927
sg9
V17388666.xml
p2928
sg11
g2233
sa(dp2929
g3
VCD008381 v. 2.2 Psychological and pharmacological interventions for depression in patients with diabetes mellitus an.rm5
p2930
sg5
S'PMC2782968'
p2931
sg7
VSTD-Echeverry-2009
p2932
sg9
V19729522.xml
p2933
sg11
S'39/63/zdc2156.PMC2782968.pdf'
p2934
sa(dp2935
g3
g2930
sg5
S'PMC1914073'
p2936
sg7
VSTD-Paile_x002d_Hyv_x00e4_rinen-2007
p2937
sg9
V17570858.xml
p2938
sg11
S'5f/16/1471-2296-8-34.PMC1914073.pdf'
p2939
sa(dp2940
g3
g2930
sg5
S'PMC165418'
p2941
sg7
VSTD-Paile_x002d_Hyv_x00e4_rinen-2003
p2942
sg9
V12747810.xml
p2943
sg11
S'c3/64/1471-2296-4-7.PMC165418.pdf'
p2944
sa(dp2945
g3
g2930
sg5
S'PMC3024341'
p2946
sg7
VSTD-van-Bastelaar-2011
p2947
sg9
V21216855.xml
p2948
sg11
S'4a/de/320.PMC3024341.pdf'
p2949
sa(dp2950
g3
VCD004125 v. 6.0 Drugs for preventing postoperative nausea and vomiting.rm5
p2951
sg5
S'PMC2448633'
p2952
sg7
VSTD-Campbell-1991
p2953
sg9
V1853495.xml
p2954
sg11
S'd2/ac/ulstermedj00076-0044.PMC2448633.pdf'
p2955
sa(dp2956
g3
g2951
sg5
S'PMC3015295'
p2957
sg7
VSTD-Dabbous-1998
p2958
sg9
V9876753.xml
p2959
sg11
S'c6/a3/jsls-2-3-273.PMC3015295.pdf'
p2960
sa(dp2961
g3
VCD000941 v. 13.0 Vaginal misoprostol for cervical ripening and induction of labour.rm5
p2962
sg5
S'PMC524504'
p2963
sg7
VSTD-_x0030_13-Papanikolaou-2004
p2964
sg9
V15450119.xml
p2965
sg11
S'98/cc/1477-7827-2-70.PMC524504.pdf'
p2966
sa(dp2967
g3
VCD003410 v. 20.2 Heroin maintenance for chronic heroin-dependent individuals.rm5
p2968
sg5
S'PMC1613238'
p2969
sg7
VSTD-RIOTT-2010
p2970
sg9
V17002810.xml
p2971
sg11
S'eb/a4/1477-7517-3-28.PMC1613238.pdf'
p2972
sa(dp2973
g3
VCD000006 v. 8.0 Absorbable suture materials for primary repair of episiotomy and second degree tears.rm5
p2974
sg5
S'PMC2449154'
p2975
sg7
VSTD-McElhinney-2000
p2976
sg9
V10881642.xml
p2977
sg11
S'45/d2/ulstermedj00055-0030.PMC2449154.pdf'
p2978
sa(dp2979
g3
VCD002137 v. 8.2 Reduced or modified dietary fat for preventing cardiovascular disease.rm5
p2980
sg5
S'PMC2732152'
p2981
sg7
VSTD-Strychar-2009
p2982
sg9
V19542011.xml
p2983
sg11
S'be/c5/zdc1597.PMC2732152.pdf'
p2984
sa(dp2985
g3
VMR000023 v. 4.2 When and how to update systematic reviews.rm5
p2986
sg5
S'PMC212708'
p2987
sg7
VSTD-Barrowman-2003
p2988
sg9
V12877755.xml
p2989
sg11
S'8d/73/1471-2288-3-13.PMC212708.pdf'
p2990
sa(dp2991
g3
VCD003869 v. 10.0 Whole brain radiotherapy for the treatment of newly diagnosed multiple brain metastases.rm5
p2992
sg5
S'PMC2634726'
p2993
sg7
VSTD-Neuhaus-2009
p2994
sg9
V19127261.xml
p2995
sg11
g2014
sa(dp2996
g3
VCD006250 v. 4.0 Bisphosphonates for advanced prostate cancer.rm5
p2997
sg5
S'PMC2228066'
p2998
sg7
VSTD-Kylmala-1997
p2999
sg9
V9328156.xml
p3000
sg11
g1011
sa(dp3001
g3
VCD007071 v. 4.0 In-service training for health professionals to improve care of the seriously ill newborn or child i.rm5
p3002
sg5
S'PMC2229665'
p3003
sg7
VSTD-Opiyo-2008
p3004
sg9
V18270586.xml
p3005
sg11
S'11/d9/pone.0001599.PMC2229665.pdf'
p3006
sa(dp3007
g3
VCD007107 v. 2.4 Prophylactic antibiotics or G-CSF for the prevention of infections and improvement of survival in ca.rm5
p3008
sg5
S'PMC2363948'
p3009
sg7
VSTD-Sculier-2001
p3010
sg9
V11720426.xml
p3011
sg11
S'c2/be/85-6692114a.PMC2363948.pdf'
p3012
sa(dp3013
g3
VCD006663 v. 7.0 Enzyme replacement therapy for Anderson-Fabry disease.rm5
p3014
sg5
S'PMC1913555'
p3015
sg7
VSTD-Vedder-2007
p3016
sg9
V17622343.xml
p3017
sg11
S'8a/7b/pone.0000598.PMC1913555.pdf'
p3018
sa(dp3019
g3
VCD006185 v. 5.0 Electromechanical-assisted training for walking after stroke.rm5
p3020
sg5
S'PMC2708184'
p3021
sg7
VSTD-Westlake-2009
p3022
sg9
V19523207.xml
p3023
sg11
S'2f/3c/1743-0003-6-18.PMC2708184.pdf'
p3024
sa(dp3025
g3
VCD005460 v. 6.0 Traditional birth attendant training for improving health behaviours and pregnancy outcomes.rm5
p3026
sg5
S'PMC3032994'
p3027
sg7
VSTD-Gill-2011
p3028
sg9
V21292711.xml
p3029
sg11
S'63/69/bmj.d346.PMC3032994.pdf'
p3030
sa(dp3031
g3
VCD007897 v. 2.2 Remediating buildings damaged by dampness and mould for preventing or reducing respiratory tract sym.rm5
p3032
sg5
S'PMC1626393'
p3033
sg7
VSTD-Kercsmar-2006
p3034
sg9
V17035145.xml
p3035
sg11
S'05/70/ehp0114-001574.PMC1626393.pdf'
p3036
sa(dp3037
g3
VCD001224 v. 5.0 Voluntary counseling and testing (VCT) for changing HIV-related risk behavior in developing countrie.rm5
p3038
sg5
S'PMC2865634'
p3039
sg7
VSTD-Cremin-2010
p3040
sg9
V19623481.xml
p3041
sg11
S'8f/48/10461_2009_Article_9592.PMC2865634.pdf'
p3042
sa(dp3043
g3
VCD006282 v. 4.0 Drug treatment for spinal muscular atrophy types II and III.rm5
p3044
sg5
S'PMC2924376'
p3045
sg7
VSTD-Swoboda-2010
p3046
sg9
V20808854.xml
p3047
sg11
S'8c/f3/pone.0012140.PMC2924376.pdf'
p3048
sa(dp3049
g3
VCD007277 v. 3.0 Abatacept for rheumatoid arthritis.rm5
p3050
sg5
S'PMC2564802'
p3051
sg7
VSTD-Schiff-2008
p3052
sg9
V18055472.xml
p3053
sg11
S'39/77/ARD-67-08-1096.PMC2564802.pdf'
p3054
sa(dp3055
g3
VCD004525 v. 6.51 Etanercept for the treatment of rheumatoid arthritis.rm5
p3056
sg5
S'PMC2689524'
p3057
sg7
VSTD-Combe-2006
p3058
sg9
V18794178.xml
p3059
sg11
S'e2/61/ard-68-07-1146.PMC2689524.pdf'
p3060
sa(dp3061
g3
VCD008449 v. 2.0 Mirror therapy for improving motor function after stroke.rm5
p3062
sg5
S'PMC3097892'
p3063
sg7
VSTD-Ietswaart-2011
p3064
sg9
V21515905.xml
p3065
sg11
S'38/97/awr077.PMC3097892.pdf'
p3066
sa(dp3067
g3
g3062
sg5
S'PMC3309215'
p3068
sg7
VSTD-Yun-2010
p3069
sg9
V22506139.xml
p3070
sg11
S'f7/e5/arm-35-316.PMC3309215.pdf'
p3071
sa(dp3072
g3
VCD005956 v. 3.0 Interventions to improve adherence to exercise for chronic musculoskeletal pain in adults.rm5
p3073
sg5
S'PMC2673355'
p3074
sg7
VSTD-Hurley-2007
p3075
sg9
V17907147.xml
p3076
sg11
S'0a/db/art0057-1211.PMC2673355.pdf'
p3077
sa(dp3078
g3
g3073
sg5
S'PMC1525193'
p3079
sg7
VSTD-Nour-2006
p3080
sg9
V16734904.xml
p3081
sg11
S'2f/42/1479-5868-3-12.PMC1525193.pdf'
p3082
sa(dp3083
g3
g3073
sg5
S'PMC509247'
p3084
sg7
VSTD-Ersek-2004
p3085
sg9
V15285783.xml
p3086
sg11
S'3b/f6/1471-2318-4-7.PMC509247.pdf'
p3087
sa(dp3088
g3
g3073
sg5
S'PMC1382224'
p3089
sg7
VSTD-Smeets-2006
p3090
sg9
V16426449.xml
p3091
sg11
S'cd/d0/1471-2474-7-5.PMC1382224.pdf'
p3092
sa(dp3093
g3
VCD003030 v. 6.5 Continuing education meetings and workshops effects on professional practice and health care outcom.rm5
p3094
sg5
S'PMC153535'
p3095
sg7
VSTD-Forsetlund-2003
p3096
sg9
V12694632.xml
p3097
sg11
S'94/46/1472-6920-3-2.PMC153535.pdf'
p3098
sa(dp3099
g3
VCD010292 v. 3.0 Serotonin and noradrenaline reuptake inhibitors (SNRIs) for fibromyalgia syndrome.rm5
p3100
sg5
S'PMC2840539'
p3101
sg7
VSTD-Chappell-2008
p3102
sg9
V20428412.xml
p3103
sg11
S'6e/99/ijgm-1-91.PMC2840539.pdf'
p3104
sa(dp3105
g3
VCD008152 v. 2.4 Primaquine for reducing Plasmodium falciparum transmission.rm5
p3106
sg5
S'PMC3269419'
p3107
sg7
VSTD-Kolaczinski-2012
p3108
sg9
V22303437.xml
p3109
sg11
S'a9/36/pone.0028957.PMC3269419.pdf'
p3110
sa(dp3111
g3
g3106
sg5
S'PMC2111052'
p3112
sg7
VSTD-El_x002d_Sayed-2007
p3113
sg9
V18074034.xml
p3114
sg11
S'23/e7/pone.0001311.PMC2111052.pdf'
p3115
sa(dp3116
g3
g3106
sg5
S'PMC1665467'
p3117
sg7
VSTD-Ledermann-2006
p3118
sg9
V17105658.xml
p3119
sg11
S'27/7b/1475-2875-5-108.PMC1665467.pdf'
p3120
sa(dp3121
g3
g3106
sg5
S'PMC1995753'
p3122
sg7
VSTD-Shekalaghe-2007
p3123
sg9
V17925871.xml
p3124
sg11
S'24/ba/pone.0001023.PMC1995753.pdf'
p3125
sa(dp3126
g3
VCD001735 v. 17.4 Support surfaces for pressure ulcer prevention.rm5
p3127
sg5
S'PMC2924330'
p3128
sg7
VSTD-Mistiaen-2009
p3129
sg9
V20687915.xml
p3130
sg11
S'e8/ad/1472-6963-10-226.PMC2924330.pdf'
p3131
sa(dp3132
g3
VCD000493 v. 8.0 Interventions for treating cholestasis in pregnancy.rm5
p3133
sg5
S'PMC3420230'
p3134
sg7
VSTD-PITCH-2012
p3135
sg9
V22695903.xml
p3136
sg11
S'22/60/bmj.e3799.PMC3420230.pdf'
p3137
sa(dp3138
g3
VCD004744 v. 6.0 Rivastigmine for vascular cognitive impairment.rm5
p3139
sg5
S'PMC2656338'
p3140
sg7
VSTD-Mok-2007
p3141
sg9
V19300631.xml
p3142
sg11
S'30/25/NDT-3-943.PMC2656338.pdf'
p3143
sa(dp3144
g3
VCD009187 v. 2.0 Interventions for recruiting smokers into cessation programmes.rm5
p3145
sg5
S'PMC3438078'
p3146
sg7
VSTD-Carlini-2012
p3147
sg9
V22768793.xml
p3148
sg11
S'6b/14/1471-2458-12-507.PMC3438078.pdf'
p3149
sa(dp3150
g3
VCD008286 v. 3.0 Combined pharmacotherapy and behavioural interventions for smoking cessation.rm5
p3151
sg5
S'PMC1871574'
p3152
sg7
VSTD-Binnie-2007
p3153
sg9
V17475005.xml
p3154
sg11
g2255
sa(dp3155
g3
VCD006133 v. 5.0 Steroidal contraceptives effect on carbohydrate metabolism in women without diabetes mellitus.rm5
p3156
sg5
S'PMC3233272'
p3157
sg7
VSTD-_x00c5_gren-2011
p3158
sg9
V22066891.xml
p3159
sg11
S'e1/03/dejc16-444.PMC3233272.pdf'
p3160
sa(dp3161
g3
VCD008618 v. 2.0 Exercise for improving outcomes after osteoporotic vertebral fracture.rm5
p3162
sg5
S'PMC2830179'
p3163
sg7
VSTD-Bennell-2010
p3164
sg9
V20163739.xml
p3165
sg11
S'09/bf/1471-2474-11-36.PMC2830179.pdf'
p3166
sa(dp3167
g3
VMR000028 v. 2.4 How effects on health equity are assessed in systematic reviews of interventions.rm5
p3168
sg5
S'PMC2944371'
p3169
sg7
VSTD-Jepson-2010
p3170
sg9
V20825660.xml
p3171
sg11
S'c2/bb/1471-2458-10-538.PMC2944371.pdf'
p3172
sa(dp3173
g3
g3168
sg5
S'PMC2921286'
p3174
sg7
VSTD-Bambra-2010
p3175
sg9
V19692738.xml
p3176
sg11
S'5b/27/jech082743.PMC2921286.pdf'
p3177
sa(dp3178
g3
g3168
sg5
S'PMC2679412'
p3179
sg7
VSTD-Darmstadt-2009
p3180
sg9
V19426469.xml
p3181
sg11
S'c6/73/1471-2393-9-S1-S6.PMC2679412.pdf'
p3182
sa(dp3183
g3
g3168
sg5
S'PMC2412872'
p3184
sg7
VSTD-Main-2008
p3185
sg9
V18505545.xml
p3186
sg11
S'78/eb/1471-2458-8-178.PMC2412872.pdf'
p3187
sa(dp3188
g3
g3168
sg5
S'PMC2679409'
p3189
sg7
VSTD-Yakoob-2009
p3190
sg9
V19426466.xml
p3191
sg11
S'b2/85/1471-2393-9-S1-S3.PMC2679409.pdf'
p3192
sa(dp3193
g3
g3168
sg5
S'PMC2679410'
p3194
sg7
VSTD-Menezes-2009
p3195
sg9
V19426467.xml
p3196
sg11
S'8a/52/1471-2393-9-S1-S4.PMC2679410.pdf'
p3197
sa(dp3198
g3
g3168
sg5
S'PMC2679411'
p3199
sg7
VSTD-Haws-2009
p3200
sg9
V19426468.xml
p3201
sg11
S'c3/d4/1471-2393-9-S1-S5.PMC2679411.pdf'
p3202
sa(dp3203
g3
g3168
sg5
S'PMC3226237'
p3204
sg7
VSTD-Shea-2009
p3205
sg9
V19828063.xml
p3206
sg11
S'f8/b9/1472-698X-9-S1-S5.PMC3226237.pdf'
p3207
sa(dp3208
g3
g3168
sg5
S'PMC2841444'
p3209
sg7
VSTD-Barros-2010
p3210
sg9
V20233384.xml
p3211
sg11
S'53/2a/1471-2393-10-S1-S3.PMC2841444.pdf'
p3212
sa(dp3213
g3
VCD008402 v. 2.0 Foot orthoses for patellofemoral pain in adults.rm5
p3214
sg5
S'PMC2572211'
p3215
sg7
VSTD-Collins-2008a
p3216
sg9
V18952682.xml
p3217
sg11
S'72/9d/bmj.a1735.PMC2572211.pdf'
p3218
sa(dp3219
g3
VCD007483 v. 3.0 Artemisinin-based combination therapy for treating uncomplicated malaria.rm5
p3220
sg5
S'PMC2405936'
p3221
sg7
VSTD-Yeka-2007-UGA
p3222
sg9
V18545692.xml
p3223
sg11
S'db/22/pone.0002390.PMC2405936.pdf'
p3224
sa(dp3225
g3
g3220
sg5
S'PMC1697822'
p3226
sg7
VSTD-Van-den-Broek-2004-ZAR
p3227
sg9
V17125496.xml
p3228
sg11
S'23/2b/1475-2875-5-113.PMC1697822.pdf'
p3229
sa(dp3230
g3
g3220
sg5
S'PMC1181876'
p3231
sg7
VSTD-Yeka-2004-UGA
p3232
sg9
V16033307.xml
p3233
sg11
S'4e/bb/pmed.0020190.PMC1181876.pdf'
p3234
sa(dp3235
g3
g3220
sg5
S'PMC1919387'
p3236
sg7
VSTD-Faye-2003-SEN
p3237
sg9
V17570848.xml
p3238
sg11
S'2c/66/1475-2875-6-80.PMC1919387.pdf'
p3239
sa(dp3240
g3
g3220
sg5
S'PMC2040506'
p3241
sg7
VSTD-Grande-2005-PER
p3242
sg9
V17971864.xml
p3243
sg11
S'2e/14/pone.0001101.PMC2040506.pdf'
p3244
sa(dp3245
g3
g3220
sg5
S'PMC1940006'
p3246
sg7
VSTD-Mukhtar-2005-SDN
p3247
sg9
V17631681.xml
p3248
sg11
S'2a/9e/1475-2875-6-92.PMC1940006.pdf'
p3249
sa(dp3250
g3
g3220
sg5
S'PMC2625364'
p3251
sg7
VSTD-Kobbe-2007-GHA
p3252
sg9
V19099594.xml
p3253
sg11
S'cf/cd/1475-2875-7-261.PMC2625364.pdf'
p3254
sa(dp3255
g3
g3220
sg5
S'PMC1876597'
p3256
sg7
VSTD-Kamya-2006-UGA
p3257
sg9
V17525792.xml
p3258
sg11
S'0a/a2/pctr.0020020.PMC1876597.pdf'
p3259
sa(dp3260
g3
g3220
sg5
S'PMC2600646'
p3261
sg7
VSTD-Mens-2007-KEN
p3262
sg9
V19017387.xml
p3263
sg11
S'98/11/1475-2875-7-237.PMC2600646.pdf'
p3264
sa(dp3265
g3
g3220
sg5
S'PMC1868032'
p3266
sg7
VSTD-Bonnet-2004-GIN
p3267
sg9
V17477865.xml
p3268
sg11
S'3e/7d/1475-2875-6-54.PMC1868032.pdf'
p3269
sa(dp3270
g3
g3220
sg5
S'PMC1488893'
p3271
sg7
VSTD-Bukirwa-2005-UGA
p3272
sg9
V16871329.xml
p3273
sg11
S'f5/47/pctr.0010007.PMC1488893.pdf'
p3274
sa(dp3275
g3
g3220
sg5
S'PMC1261533'
p3276
sg7
VSTD-Hutagalung-2002-THA
p3277
sg9
V16179089.xml
p3278
sg11
g2781
sa(dp3279
g3
g3220
sg5
S'PMC1887535'
p3280
sg7
VSTD-Menard-2006-MDG
p3281
sg9
V17519010.xml
p3282
sg11
S'bf/90/1475-2875-6-65.PMC1887535.pdf'
p3283
sa(dp3284
g3
g3220
sg5
S'PMC2430614'
p3285
sg7
VSTD-Owusu_x002d_Agyei-2006-GHA
p3286
sg9
V18575626.xml
p3287
sg11
S'60/28/pone.0002530.PMC2430614.pdf'
p3288
sa(dp3289
g3
g3220
sg5
S'PMC2631542'
p3290
sg7
VSTD-Kayentao-2006-MLI
p3291
sg9
V19128455.xml
p3292
sg11
S'32/4c/1475-2875-8-5.PMC2631542.pdf'
p3293
sa(dp3294
g3
VCD001977 v. 8.0 Acupuncture for peripheral joint osteoarthritis.rm5
p3295
sg5
S'PMC102323'
p3296
sg7
VSTD-Sangdee-2002-_x002a_
p3297
sg9
V11914160.xml
p3298
sg11
S'0f/bd/1472-6882-2-3.PMC102323.pdf'
p3299
sa(dp3300
g3
g3295
sg5
S'PMC102323'
p3301
sg7
VSTD-Sangdee-2002-_x002a__x002a_
p3302
sg9
V11914160.xml
p3303
sg11
g3299
sa(dp3304
g3
VCD007775 v. 2.0 Pharmacological therapies for maintenance treatments of opium dependence.rm5
p3305
sg5
S'PMC293465'
p3306
sg7
VSTD-Assadi-2003
p3307
sg9
V14624703.xml
p3308
sg11
S'14/30/1471-244X-3-16.PMC293465.pdf'
p3309
sa(dp3310
g3
VCD006794 v. 5.0 Early amniotomy and early oxytocin for prevention of or therapy for delay in first stage spontaneo.rm5
p3311
sg5
S'PMC2988803'
p3312
sg7
VSTD-Nachum-2010
p3313
sg9
V21054896.xml
p3314
sg11
S'f5/89/1477-7827-8-136.PMC2988803.pdf'
p3315
sa(dp3316
g3
VCD010398 v. 1.2 The effect of pharmacist-provided non-dispensing services on patient outcomes health service utilis.rm5
p3317
sg5
S'PMC2200659'
p3318
sg7
VSTD-Zwarenstein-2007
p3319
sg9
V17892588.xml
p3320
sg11
S'82/9f/1748-5908-2-30.PMC2200659.pdf'
p3321
sa(dp3322
g3
VCD004186 v. 10.0 Amitriptyline for depression.rm5
p3323
sg5
S'PMC3013310'
p3324
sg7
VSTD-Quadri-1980
p3325
sg9
V22058460.xml
p3326
sg11
S'bd/1c/IJPsy-22-182.PMC3013310.pdf'
p3327
sa(dp3328
g3
VCD003412 v. 8.0 Interventions for basal cell carcinoma of the skin.rm5
p3329
sg5
S'PMC2223779'
p3330
sg7
VSTD-Avril-1997
p3331
sg9
V9218740.xml
p3332
sg11
S'82/8b/brjcancer00165-0104.PMC2223779.pdf'
p3333
sa(dp3334
g3
VCD000331 v. 10.2 Epidural versus non-epidural or no analgesia in labour.rm5
p3335
sg5
S'PMC1764008'
p3336
sg7
VSTD-Nafisi-2006
p3337
sg9
V17176461.xml
p3338
sg11
S'a0/56/1471-2253-6-15.PMC1764008.pdf'
p3339
sa(dp3340
g3
VCD003380 v. 12.1 Psychological and educational interventions for preventing depression in children and adolescents.rm5
p3341
sg5
S'PMC2841102'
p3342
sg7
VSTD-Zehnder-2010
p3343
sg9
V20181120.xml
p3344
sg11
S'dd/cc/1753-2000-4-7.PMC2841102.pdf'
p3345
sa(dp3346
g3
VCD000230 v. 7.7 Zinc supplementation for improving pregnancy and infant outcome.rm5
p3347
sg5
S'PMC2928084'
p3348
sg7
VSTD-Ghana-2009
p3349
sg9
V19902797.xml
p3350
sg11
S'16/f9/jhpn0027-0619.PMC2928084.pdf'
p3351
sa(dp3352
g3
VCD003327 v. 5.0 Surgical versus endoscopic treatment of bile duct stones.rm5
p3353
sg5
S'PMC2443081'
p3354
sg7
VSTD-Kapoor-1996
p3355
sg9
V8725454.xml
p3356
sg11
S'f9/e7/HPB-09-145.PMC2443081.pdf'
p3357
sa(dp3358
g3
VCD005207 v. 9.0 Colony stimulating factors (including erythropoietin granulocyte colony stimulating factor and anal.rm5
p3359
sg5
S'PMC3221969'
p3360
sg7
VSTD-Yip-2011
p3361
sg9
V21269484.xml
p3362
sg11
S'39/f5/cc10002.PMC3221969.pdf'
p3363
sa(dp3364
g3
VCD007814 v. 2.0 Histamine type 2 receptor antagonists as adjuvant treatment for resected colorectal cancer.rm5
p3365
sg5
S'PMC2375187'
p3366
sg7
VSTD-Matsumoto-2002
p3367
sg9
V11870500.xml
p3368
sg11
S'0c/0c/86-6600048a.PMC2375187.pdf'
p3369
sa(dp3370
g3
VCD003243 v. 6.0 Medical versus surgical management for gastro-oesophageal reflux disease (GORD) in adults.rm5
p3371
sg5
S'PMC2565581'
p3372
sg7
VSTD-LOTUS-Trial-2008
p3373
sg9
V18469091.xml
p3374
sg11
S'69/52/GUT-57-09-1207.PMC2565581.pdf'
p3375
sa(dp3376
g3
VCD000012 v. 10.0 Alternative versus conventional institutional settings for birth.rm5
p3377
sg5
S'PMC3187863'
p3378
sg7
VSTD-Bernitz-2011
p3379
sg9
V21749629.xml
p3380
sg11
S'cb/bc/bjo0118-1357.PMC3187863.pdf'
p3381
sa(dp3382
g3
VCD001067 v. 9.0 Antibiotic regimens for endometritis after delivery.rm5
p3383
sg5
S'PMC1852268'
p3384
sg7
VSTD-Scalambrino-1989
p3385
sg9
V12839630.xml
p3386
sg11
S'c4/12/IDOG-11-027.PMC1852268.pdf'
p3387
sa(dp3388
g3
g3383
sg5
S'PMC2364549'
p3389
sg7
VSTD-Chatwani-1997
p3390
sg9
V18476152.xml
p3391
sg11
S'2e/9b/IDOG-05-280.PMC2364549.pdf'
p3392
sa(dp3393
g3
g3383
sg5
S'PMC2364413'
p3394
sg7
VSTD-Chatwani-1995
p3395
sg9
V18475417.xml
p3396
sg11
S'a3/0f/IDOG-03-028.PMC2364413.pdf'
p3397
sa(dp3398
g3
g3383
sg5
S'PMC1852268'
p3399
sg7
VSTD-Roy-2003
p3400
sg9
V12839630.xml
p3401
sg11
g3387
sa(dp3402
g3
VCD002014 v. 8.0 Behavioural treatment for chronic low-back pain.rm5
p3403
sg5
S'PMC2527421'
p3404
sg7
VSTD-van-der-Roer-2008
p3405
sg9
V18663487.xml
p3406
sg11
S'6c/80/586_2008_Article_718.PMC2527421.pdf'
p3407
sa(dp3408
g3
VCD006132 v. 5.2 Interventions for improving adherence to ocular hypotensive therapy.rm5
p3409
sg5
S'PMC3299559'
p3410
sg7
VSTD-Nakakura-2012
p3411
sg9
V22419858.xml
p3412
sg11
S'a7/48/opth-6-369.PMC3299559.pdf'
p3413
sa(dp3414
g3
VCD003619 v. 6.0 Weight reduction for non-alcoholic fatty liver disease.rm5
p3415
sg5
S'PMC2945152'
p3416
sg7
VSTD-Lazo-2010
p3417
sg9
V20664019.xml
p3418
sg11
S'a3/fc/zdc2156.PMC2945152.pdf'
p3419
sa(dp3420
g3
VCD008530 v. 2.0 Antibiotic therapy for preventing infections in patients with acute stroke.rm5
p3421
sg5
S'PMC2373885'
p3422
sg7
VSTD-Harms-2008
p3423
sg9
V18478129.xml
p3424
sg11
S'db/00/pone.0002158.PMC2373885.pdf'
p3425
sa(dp3426
g3
VCD007496 v. 2.0 Male circumcision for prevention of homosexual acquisition of HIV in men.rm5
p3427
sg5
S'PMC2443289'
p3428
sg7
VSTD-Begley-2008
p3429
sg9
V18628946.xml
p3430
sg11
S'f1/3a/pone.0002731.PMC2443289.pdf'
p3431
sa(dp3432
g3
g3427
sg5
S'PMC2888758'
p3433
sg7
VSTD-Lane-2011
p3434
sg9
V19662523.xml
p3435
sg11
S'88/e2/10461_2009_Article_9598.PMC2888758.pdf'
p3436
sa(dp3437
g3
VCD008122 v. 4.0 Rapid diagnostic tests for diagnosing uncomplicated P. falciparum malaria in endemic countries.rm5
p3438
sg5
S'PMC2571107'
p3439
sg7
VSTD-Abeku-2008a
p3440
sg9
V18834523.xml
p3441
sg11
S'92/82/1475-2875-7-202.PMC2571107.pdf'
p3442
sa(dp3443
g3
g3438
sg5
S'PMC2571107'
p3444
sg7
VSTD-Abeku-2008b
p3445
sg9
V18834523.xml
p3446
sg11
g3442
sa(dp3447
g3
g3438
sg5
S'PMC2667629'
p3448
sg7
VSTD-Msellem-2009
p3449
sg9
V19399156.xml
p3450
sg11
S'6c/d9/pmed.1000070.PMC2667629.pdf'
p3451
sa(dp3452
g3
g3438
sg5
S'PMC2478667'
p3453
sg7
VSTD-Bharti-2008
p3454
sg9
V18620560.xml
p3455
sg11
S'b5/a4/1475-2875-7-126.PMC2478667.pdf'
p3456
sa(dp3457
g3
VCD007076 v. 5.0 Pregabalin for acute and chronic pain in adults.rm5
p3458
sg5
S'PMC2565674'
p3459
sg7
VSTD-Arezzo-2008
p3460
sg9
V18796160.xml
p3461
sg11
S'8a/dc/1471-2377-8-33.PMC2565674.pdf'
p3462
sa(dp3463
g3
VCD005429 v. 5.0 Which anticholinergic drug for overactive bladder symptoms in adults.rm5
p3464
sg5
S'PMC2680337'
p3465
sg7
VSTD-Choo-2008
p3466
sg9
V19143854.xml
p3467
sg11
S'a9/f7/ijcp0062-1675.PMC2680337.pdf'
p3468
sa(dp3469
g3
VCD006423 v. 4.0 Glucagon-like peptide analogues for type 2 diabetes mellitus.rm5
p3470
sg5
S'PMC2871176'
p3471
sg7
VSTD-L-_x002d_-LEAD-1-Marre-2009
p3472
sg9
V19317822.xml
p3473
sg11
S'37/01/dme0026-0268.PMC2871176.pdf'
p3474
sa(dp3475
g3
g3470
sg5
S'PMC3068287'
p3476
sg7
VSTD-Lixi-_x002d_-Ratner-2010
p3477
sg9
V20722676.xml
p3478
sg11
S'ac/58/dme0027-1024.PMC3068287.pdf'
p3479
sa(dp3480
g3
g3470
sg5
S'PMC2699710'
p3481
sg7
VSTD-T-_x002d_-Nauck-2009
p3482
sg9
V19366970.xml
p3483
sg11
g2854
sa(dp3484
g3
g3470
sg5
S'PMC2752910'
p3485
sg7
VSTD-A-_x002d_-Rosenstock-2009
p3486
sg9
V19592625.xml
p3487
sg11
S'6b/bb/zdc1880.PMC2752910.pdf'
p3488
sa(dp3489
g3
g3470
sg5
S'PMC2606836'
p3490
sg7
VSTD-L-_x002d_-LEAD-2-Nauck-2009
p3491
sg9
V18931095.xml
p3492
sg11
g2859
sa(dp3493
g3
g3470
sg5
S'PMC2744824'
p3494
sg7
VSTD-L-_x002d_-LEAD-5-Russell_x002d_J-2009
p3495
sg9
V19688338.xml
p3496
sg11
g2834
sa(dp3497
g3
g3470
sg5
S'PMC2699702'
p3498
sg7
VSTD-L-_x002d_-LEAD-4-Zinman-2009
p3499
sg9
V19289857.xml
p3500
sg11
g2844
sa(dp3501
g3
g3470
sg5
S'PMC2948428'
p3502
sg7
VSTD-T_x002d_-Ratner-2010
p3503
sg9
V20536952.xml
p3504
sg11
S'c6/7d/dme0027-0556.PMC2948428.pdf'
p3505
sa(dp3506
g3
VCD006583 v. 5.0 Laparoscopic entry techniques.rm5
p3507
sg5
S'PMC3015351'
p3508
sg7
VSTD-Feste-2000
p3509
sg9
V10772522.xml
p3510
sg11
S'9b/70/jsls-4-1-11.PMC3015351.pdf'
p3511
sa(dp3512
g3
g3507
sg5
S'PMC3015718'
p3513
sg7
VSTD-Venkatesh-2007
p3514
sg9
V17761080.xml
p3515
sg11
S'ff/6e/jsls-11-2-198.PMC3015718.pdf'
p3516
sa(dp3517
g3
VCD007672 v. 2.3 Interventions to improve continuity of care in the follow-up of patients with cancer.rm5
p3518
sg5
S'PMC2364768'
p3519
sg7
VSTD-Wells-2004
p3520
sg9
V15238983.xml
p3521
sg11
S'06/df/91-6601998a.PMC2364768.pdf'
p3522
sa(dp3523
g3
g3518
sg5
S'PMC2634705'
p3524
sg7
VSTD-King-2009
p3525
sg9
V19107130.xml
p3526
sg11
S'5b/91/6604836a.PMC2634705.pdf'
p3527
sa(dp3528
g3
g3518
sg5
S'PMC2361245'
p3529
sg7
VSTD-Wattchow-2006
p3530
sg9
V16622437.xml
p3531
sg11
g2828
sa(dp3532
g3
g3518
sg5
S'PMC2364271'
p3533
sg7
VSTD-Hanks-2002
p3534
sg9
V12232756.xml
p3535
sg11
S'40/9a/87-6600522a.PMC2364271.pdf'
p3536
sa(dp3537
g3
VCD007498 v. 3.5 Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infections.rm5
p3538
sg5
S'PMC2717450'
p3539
sg7
VSTD-Hochreiter-2009
p3540
sg9
V19493352.xml
p3541
sg11
S'e8/84/cc7903.PMC2717450.pdf'
p3542
sa(dp3543
g3
VCD004565 v. 3.0 Interventions before consultations for helping patients address their information needs.rm5
p3544
sg5
S'PMC2375236'
p3545
sg7
VSTD-Brown-2001
p3546
sg9
V11720460.xml
p3547
sg11
g318
sa(dp3548
g3
g3544
sg5
S'PMC2363012'
p3549
sg7
VSTD-Brown-1999
p3550
sg9
V10390003.xml
p3551
sg11
S'86/81/80-6690346a.PMC2363012.pdf'
p3552
sa(dp3553
g3
VCD006519 v. 3.0 Polymer-based oral rehydration solution for treating acute watery diarrhoea.rm5
p3554
sg5
S'PMC2217593'
p3555
sg7
VSTD-Ramakrishna-2008
p3556
sg9
V18270575.xml
p3557
sg11
S'e7/22/pone.0001587.PMC2217593.pdf'
p3558
sa(dp3559
g3
VCD008101 v. 3.0 Continuous glucose monitoring systems for type 1 diabetes mellitus.rm5
p3560
sg5
S'PMC2945155'
p3561
sg7
VSTD-Juvenile-2009
p3562
sg9
V20696865.xml
p3563
sg11
S'63/25/zdc2175.PMC2945155.pdf'
p3564
sa(dp3565
g3
g3560
sg5
S'PMC2782985'
p3566
sg7
VSTD-Raccah-2009
p3567
sg9
V19767384.xml
p3568
sg11
S'bd/6f/zdc2245.PMC2782985.pdf'
p3569
sa(dp3570
g3
g3560
sg5
S'PMC3064030'
p3571
sg7
VSTD-Battelino-2011
p3572
sg9
V21335621.xml
p3573
sg11
S'dd/29/795.PMC3064030.pdf'
p3574
sa(dp3575
g3
VCD003709 v. 5.0 Vasopressors for hypotensive shock.rm5
p3576
sg5
S'PMC1550871'
p3577
sg7
VSTD-Luckner-2006
p3578
sg9
V16542484.xml
p3579
sg11
S'7a/e5/cc4845.PMC1550871.pdf'
p3580
sa(dp3581
g3
g3576
sg5
S'PMC2750187'
p3582
sg7
VSTD-Morelli-2009
p3583
sg9
V19664253.xml
p3584
sg11
S'f0/83/cc7990.PMC2750187.pdf'
p3585
sa(dp3586
g3
VCD003367 v. 9.0 Antitumour antibiotic containing regimens for metastatic breast cancer.rm5
p3587
sg5
S'PMC1968186'
p3588
sg7
VSTD-Fraser-1993
p3589
sg9
V8431375.xml
p3590
sg11
g1596
sa(dp3591
g3
g3587
sg5
S'PMC2362871'
p3592
sg7
VSTD-Harper_x002d_Wynne-1999
p3593
sg9
V10496359.xml
p3594
sg11
S'dd/33/81-6690694a.PMC2362871.pdf'
p3595
sa(dp3596
g3
VCD007179 v. 3.0 Antibiotics for treating human brucellosis.rm5
p3597
sg5
S'PMC459220'
p3598
sg7
VSTD-Karabay-2004
p3599
sg9
V15214959.xml
p3600
sg11
S'bf/e7/1471-2334-4-18.PMC459220.pdf'
p3601
sa(dp3602
g3
VCD001134 v. 9.0 Psychosocial and psychological interventions for preventing postpartum depression.rm5
p3603
sg5
S'PMC1479326'
p3604
sg7
VSTD-Lumley-2006
p3605
sg9
V16483383.xml
p3606
sg11
S'bd/59/1471-2458-6-37.PMC1479326.pdf'
p3607
sa(dp3608
g3
g3603
sg5
S'PMC2628301'
p3609
sg7
VSTD-Dennis-2009
p3610
sg9
V19147637.xml
p3611
sg11
g2721
sa(dp3612
g3
VCD007844 v. 3.0 Behavioral interventions to promote condom use among women living with HIV.rm5
p3613
sg5
S'PMC2292251'
p3614
sg7
VSTD-Gilbert-2008
p3615
sg9
V18431475.xml
p3616
sg11
S'ef/98/pone.0001988.PMC2292251.pdf'
p3617
sa(dp3618
g3
VCD000076 v. 11.0 Electroconvulsive therapy for schizophrenia.rm5
p3619
sg5
S'PMC2951534'
p3620
sg7
VSTD-Girish-2003
p3621
sg9
V21206808.xml
p3622
sg11
S'c0/40/IJPsy-45-21.PMC2951534.pdf'
p3623
sa(dp3624
g3
g3619
sg5
S'PMC3011123'
p3625
sg7
VSTD-Agarwal-1985
p3626
sg9
V21927109.xml
p3627
sg11
S'cb/59/IJPsy-27-233.PMC3011123.pdf'
p3628
sa(dp3629
g3
g3619
sg5
S'PMC3012902'
p3630
sg7
VSTD-Bagadia-1981
p3631
sg9
V22058556.xml
p3632
sg11
S'e0/69/IJPsy-23-324.PMC3012902.pdf'
p3633
sa(dp3634
g3
g3619
sg5
S'PMC3012948'
p3635
sg7
VSTD-Janakiramiah-1981
p3636
sg9
V22058544.xml
p3637
sg11
S'e9/6d/IJPsy-23-230.PMC3012948.pdf'
p3638
sa(dp3639
g3
VCD006047 v. 5.4 Household interventions for preventing domestic lead exposure in children.rm5
p3640
sg5
S'PMC1241771'
p3641
sg7
VSTD-Jordan-2003
p3642
sg9
V14644671.xml
p3643
sg11
S'eb/60/ehp0111-001947.PMC1241771.pdf'
p3644
sa(dp3645
g3
VCD000978 v. 13.0 Interventions for preventing oral mucositis for patients with cancer receiving treatment.rm5
p3646
sg5
S'PMC2074575'
p3647
sg7
VSTD-Symonds-1996
p3648
sg9
V8688343.xml
p3649
sg11
S'af/5e/brjcancer00018-0152.PMC2074575.pdf'
p3650
sa(dp3651
g3
g3646
sg5
S'PMC2376383'
p3652
sg7
VSTD-Stokman-2003
p3653
sg9
V12671696.xml
p3654
sg11
S'f5/46/88-6600824a.PMC2376383.pdf'
p3655
sa(dp3656
g3
g3646
sg5
S'PMC2033386'
p3657
sg7
VSTD-Jebb-1994
p3658
sg9
V7917930.xml
p3659
sg11
S'e9/0c/brjcancer00056-0162.PMC2033386.pdf'
p3660
sa(dp3661
g3
g3646
sg5
S'PMC2246575'
p3662
sg7
VSTD-Mills-1988
p3663
sg9
V3390377.xml
p3664
sg11
S'47/3d/brjcancer00138-0080.PMC2246575.pdf'
p3665
sa(dp3666
g3
g3646
sg5
S'PMC2363753'
p3667
sg7
VSTD-Hartmann-2001
p3668
sg9
V11161394.xml
p3669
sg11
S'58/95/84-6691611a.PMC2363753.pdf'
p3670
sa(dp3671
g3
VCD008328 v. 2.8 Airway clearance techniques for chronic obstructive pulmonary disease.rm5
p3672
sg5
S'PMC1269449'
p3673
sg7
VSTD-Vargas-2005
p3674
sg9
V16137351.xml
p3675
sg11
S'16/ce/cc3724.PMC1269449.pdf'
p3676
sa(dp3677
g3
VCD009419 v. 2.0 Neuromuscular electrical stimulation for muscle weakness in adults with advanced disease.rm5
p3678
sg5
S'PMC3071998'
p3679
sg7
VSTD-N_x00e1_polis-2011
p3680
sg9
V21552662.xml
p3681
sg11
S'4e/d4/cln-66-03-401.PMC3071998.pdf'
p3682
sa(dp3683
g3
VCD005595 v. 3.0 Rehabilitation for ankle fractures in adults.rm5
p3684
sg5
S'PMC2760502'
p3685
sg7
VSTD-Nilsson-2009
p3686
sg9
V19781053.xml
p3687
sg11
S'1e/c3/1471-2474-10-118.PMC2760502.pdf'
p3688
sa(dp3689
g3
VCD004974 v. 9.0 Immunostimulants for preventing respiratory tract infection in children.rm5
p3690
sg5
S'PMC2573879'
p3691
sg7
VSTD-Wahl-2008
p3692
sg9
V18831749.xml
p3693
sg11
S'25/7b/1472-6882-8-56.PMC2573879.pdf'
p3694
sa(dp3695
g3
VCD004425 v. 10.0 Combined oral contraceptive pills for treatment of acne.rm5
p3696
sg5
S'PMC3233274'
p3697
sg7
VSTD-Mansour-2011
p3698
sg9
V21995590.xml
p3699
sg11
S'68/28/dejc16-430.PMC3233274.pdf'
p3700
sa(dp3701
g3
VCD008465 v. 2.0 Exercise interventions on health-related quality of life for people with cancer during active treatm.rm5
p3702
sg5
S'PMC2615347'
p3703
sg7
VSTD-Hwang-2008
p3704
sg9
V18581595.xml
p3705
sg11
S'c9/e3/ymj-49-443.PMC2615347.pdf'
p3706
sa(dp3707
g3
g3702
sg5
S'PMC2762035'
p3708
sg7
VSTD-Adamsen-2009
p3709
sg9
V19826172.xml
p3710
sg11
S'9d/be/bmj.b3410.PMC2762035.pdf'
p3711
sa(dp3712
g3
g3702
sg5
S'PMC2826100'
p3713
sg7
VSTD-Oh-2010
p3714
sg9
V19880433.xml
p3715
sg11
g2109
sa(dp3716
g3
VCD008160 v. 3.0 Workplace interventions for neck pain in workers.rm5
p3717
sg5
S'PMC1915628'
p3718
sg7
VSTD-Voerman-2007
p3719
sg9
V17260162.xml
p3720
sg11
S'6d/42/10926_2007_Article_9066.PMC1915628.pdf'
p3721
sa(dp3722
g3
VCD005211 v. 6.0 Exercise interventions for upper-limb dysfunction due to breast cancer treatment.rm5
p3723
sg5
S'PMC2615347'
p3724
sg7
VSTD-Hwang-2008
p3725
sg9
V18581595.xml
p3726
sg11
g3706
sa(dp3727
g3
VCD005473 v. 3.0 Pharmacotherapy augmentation strategies in treatment-resistant anxiety disorders.rm5
p3728
sg5
S'PMC547907'
p3729
sg7
VSTD-Carey-2005
p3730
sg9
V15667657.xml
p3731
sg11
g1380
sa(dp3732
g3
VCD006145 v. 6.0 Exercise for the management of cancer-related fatigue in adults.rm5
p3733
sg5
S'PMC2615347'
p3734
sg7
VSTD-Hwang-2008
p3735
sg9
V18581595.xml
p3736
sg11
g3706
sa(dp3737
g3
g3733
sg5
S'PMC2762035'
p3738
sg7
VSTD-Adamsen-2009
p3739
sg9
V19826172.xml
p3740
sg11
g3711
sa(dp3741
g3
g3733
sg5
S'PMC2826100'
p3742
sg7
VSTD-Oh-2010
p3743
sg9
V19880433.xml
p3744
sg11
g2109
sa(dp3745
g3
VCD004703 v. 6.0 Transabdominal pre-peritoneal (TAPP) vs totally extraperitoneal (TEP) laparoscopic techniques for in.rm5
p3746
sg5
S'PMC3015374'
p3747
sg7
VSTD-Lepere-2000
p3748
sg9
V10917122.xml
p3749
sg11
S'6d/82/jsls-4-2-147.PMC3015374.pdf'
p3750
sa(dp3751
g3
VCD003766 v. 11.2 Continuous support for women during childbirth.rm5
p3752
sg5
S'PMC1936417'
p3753
sg7
VSTD-Bruggemann-2007
p3754
sg9
V17612408.xml
p3755
sg11
S'85/02/1742-4755-4-5.PMC1936417.pdf'
p3756
sa(dp3757
g3
VCD003445 v. 8.0 Supportive care for patients with gastrointestinal cancer.rm5
p3758
sg5
S'PMC2033463'
p3759
sg7
VSTD-Cascinu-1995
p3760
sg9
V7819058.xml
p3761
sg11
S'b2/51/brjcancer00047-0099.PMC2033463.pdf'
p3762
sa(dp3763
g3
VCD005004 v. 4.0 Green tea (Camellia sinensis) for the prevention of cancer.rm5
p3764
sg5
S'PMC2360636'
p3765
sg7
VSTD-Kikuchi-2006
p3766
sg9
V16804523.xml
p3767
sg11
S'98/f0/95-6603230a.PMC2360636.pdf'
p3768
sa(dp3769
g3
g3764
sg5
S'PMC2364221'
p3770
sg7
VSTD-Hoshiyama-2002
p3771
sg9
V12177800.xml
p3772
sg11
S'f9/df/87-6600487a.PMC2364221.pdf'
p3773
sa(dp3774
g3
g3764
sg5
S'PMC2409667'
p3775
sg7
VSTD-Suzuki-2004
p3776
sg9
V15054454.xml
p3777
sg11
S'7b/8f/90-6601652a.PMC2409667.pdf'
p3778
sa(dp3779
g3
g3764
sg5
S'PMC2374337'
p3780
sg7
VSTD-Key-1999
p3781
sg9
V10584890.xml
p3782
sg11
S'3f/2e/81-6690837a.PMC2374337.pdf'
p3783
sa(dp3784
g3
g3764
sg5
S'PMC2567088'
p3785
sg7
VSTD-Li-2008
p3786
sg9
V18766189.xml
p3787
sg11
S'c1/ad/6604645a.PMC2567088.pdf'
p3788
sa(dp3789
g3
VCD007275 v. 2.0 Effects of communicating DNA-based disease risk estimates on risk-reducing behaviours.rm5
p3790
sg5
S'PMC2440307'
p3791
sg7
VSTD-Wright-2008
p3792
sg9
V18261131.xml
p3793
sg11
S'16/14/cge0073-0306.PMC2440307.pdf'
p3794
sa(dp3795
g3
VCD001973 v. 9.0 Interventions for treating oral mucositis for patients with cancer receiving treatment.rm5
p3796
sg5
S'PMC3232086'
p3797
sg7
VSTD-Baharvand-2010
p3798
sg9
V22615593.xml
p3799
sg11
S'ef/5b/DARU-18-046.PMC3232086.pdf'
p3800
sa(dp3801
g3
VCD006842 v. 3.0 Oscillating devices for airway clearance in people with cystic fibrosis.rm5
p3802
sg5
S'PMC2922723'
p3803
sg7
VSTD-Osman-2010
p3804
sg9
V19703826.xml
p3805
sg11
g505
sa.